Ultrastructural Changes Following Experimentally-Induced Renal Papillary Necrosis and Upper Urothelial Carcinoma. by Ijomah, Patricia.
ULTRASTRÜCTURAL CHANGES FOLLOWING EXPERIMENTALLY- INDUCED 
RENAL PAPILLARY NECROSIS AND UPPER UROTHELIAL CARCINOMA
By
PATRICIA IJOMAH BSC. (Aberdeen), MSc. (Wales)
A thesis submitted for fulfilment of degree of Doctor of 
Philosophy
SEPTEMBER 1991
Robens Institute, 
University of Surrey, 
Guildford, Surrey,
GUI 5XH.
ProQuest Number: 27605351
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27605351
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
ACKNOWLEDGEMENT
I would like to thank Dr. PH Bach for his help during 
this project.
I am very grateful to Mr DE Hall and Dr. DF Lewis for 
reading this thesis and for their suggestions. Thanks 
also to Professors JW Bridges, P Grasso, G Hard and LJ 
King for their comments.
I am indebted to Miss D Chescoe (Micro structural 
unit, university of Surrey) and her staff for their help 
and for making their department and microscopes available 
to me outside working hours. Many thanks.
Finally I would like to thank my parents and my 
brothers and sisters for all the moral support and 
encouragement during the course of this project.
ABSTRACT
Analgesic abuse can lead to renal papillary necrosis 
(RPN) and subsequently to upper urothelial carcinoma 
(UUC). Ultrastructural changes in renal papillary 
necrosis and upper urothelial carcinoma were studied in 
rats. RPN was induced using a papillotoxin; 2
-bromoethanamine hydrobromide (BEA) and UUC was initiated 
using low dose of a bladder carcinogen; N-butyl-N-(4- 
hydroxybutyl)-nitrosamine (BBN). A single intraperitoneal 
injection of BEA resulted in cellular swelling and damage 
to interstitial cells, collecting ducts, mitochondria, 
capillaries , renal concentration mechanism and the thin 
limbs of Henle. RPN was present in most rats by 12hr 
after treatment. The thin limbs of Henle were the last 
structures to show damage. Damage to interstitial cells, 
collecting duct cells and mitochondria occurred before 
the concentration mechanism was significantly damaged. 
The swelling of cells resulted in complete or partial 
closure of ducts of Bellini. It was concluded from this 
results that (1) since the concentration mechanism was 
still intact when interstitial cells , collecting duct 
cells and mitochondria were damaged, damage to these 
structures could be by cytotoxicity as a result of 
hyperconcentration of BEA at the papilla. (2) This 
initial cytotoxic damage would be followed by a secondary
damage of medullary ischaemia as a result of the damaged 
interstitial cells and collecting ducts (sites of 
prostaglandin synthesis) and pressure exerted on the 
capillary walls by swollen collecting duct cells. (3)
That the cortical tubule dilation often associated with 
analgesic nephropathy and experimentally-induced RPN, 
could have been brought about by the back pressure 
created in those tubules whose ducts of Bellini were 
blocked by swollen cells.
Urothelium initiated with low doses of BBN was promoted 
to carcinogenesis following a single ip dose of BEA. It 
was suggested from this result that if, as has frequently 
been proposed, BEA behaves similarly to analgesics, then 
this implies that analgesics are either complete
! : i
carcinogen (since they seem capable of initiating and 
promoting the urothelium to carcinogenesis) or that 
analgesics could merely be promoters which, following 
abuse, induce upper urothelial carcinoma only in people 
with prior initiated urothelium as a result of exposure 
to carcinogenic environmental contaminants such as 
nitrosamines, rubber, dye and cigarette smoke.
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CHAPTER 1
INTRODUCTION
Anti-inflammatory, analgesic and antipyretic drugs are 
heterogeneous groups of compounds which though often 
chemically unrelated (fig. 1) share many therapeutic 
actions and side effects. Following the introduction of 
the prototype drug, aspirin in the 1890's many other 
drugs with similar effects have been manufactured 
(section 1.1). The diverse beneficial effects of these 
compounds have often resulted in their being regarded as 
panaceas for all ills and has consequently led to abusive 
consumption of these agents. Ingestion of large amounts 
of pain - relieving drugs over long periods of time has 
been shown to be associated with the development of a 
type of kidney disease that can lead to renal failure. 
Since this problem was first reported in the 1950's 
analgesic - associated kidney disease has become 
recognised as a significant, costly and potentially 
preventable health problem. While research has shown an 
association between analgesic abuse and kidney disease , 
there continues to be debate about the specific drugs 
that cause it, the mechanism by which the lesion occurs 
and the extent to which this illness contribute to the 
overall burden of chronic renal disease in our society.
Renal papillary necrosis (RPN) is a lesion caused by 
abusive consumption of analgesics (see Prescott, 1982; 
Nanra, 1983; Bach and Bridges,1985; Pulliam and Bennett,
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1985; Patrono, 1986; Drukker et al. 198 6; Buckalew and 
Schey, 1986; Schwarz, 1987; Henrich, 1988; Segasothy et 
al, 1988; Sabatini,1988; Kincaid-Smith, 1988; McCredie et 
al. 1989; Sandler et al. 1989; DuBach et al. 1991). The 
lesion develops silently and often leads to recurrent 
bacterial infection, renal calculi, hypertension and 
eventually to chronic renal failure or upper urothelial 
carcinoma. The pathological genesis of RPN and "the 
subsequent" upper urothelial carcinoma is poorly 
understood because (1) in humans the lesion occurs after 
a long period of analgesic abuse, the disease is slowly 
progressive and commonly asymptomatic until severe renal 
failure occurs, (2) in laboratory animals the lesion 
develops only after a protracted period of administration 
of very large quantities of analgesics, the severity of 
the resultant lesion varies widely within the same dose 
group and the lesion is very difficult to reproduce even 
within the same laboratory.
Some non-analgesic papi1lotoxins notably 2- 
bromoethanamine hydrobromide and ethyleneimine have 
become useful tools in the study of pathological genesis 
of analgesic-induced RPN. These agents following acute 
dosage produce in "all" animals RPN very similar to that 
induced following chronic analgesic administration (see 
Bach and Bridges, 1985)
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1.1, HISTORY OF ANALGESICS
Medicinal effects of the willow plant have been 
known to several cultures for centuries. As early as 500 
BC Hippocrates recommended the leaves of the willow tree 
for facilitating child birth. During the first century AD 
Celsus used willow leaves boiled in vinegar for treating 
prolapse of the uterus and in the second century AD Galen 
also used willow leaves for the treatment of wounds and 
ulcers (see Bowman and Rand, 1980; Parkhouse, 1979; A1 
-Ani, 1980).
In England in the mid-eighteenth century Reverend 
Edmund Stone described in a letter to the president of 
the Royal Society "an account of the success of the bark 
of the willow in the cure of agues" (fever). He had 
accidentally tasted the bark of the common white willow, 
Salix alba vulgaris and found that the bitterness was 
similar to that of cinchona bark, the source of quinine. 
He reasoned that since the willow grew in damp wet areas 
"where agues chiefly abound" it would probably have 
curative properties appropriate to that condition (see 
Bowman and Rand, 1980; Parkhouse, 1979 ).
The active ingredient in the willow bark, salicin, 
was first isolated in pure form by Leroux in 1829, who
12
also demonstrated its antipyretic effect. Eight years 
after this Piria procured an acidic derivative of salicin 
which he called salicylic acid. The synthetic manufacture 
of salicylic acid from phenol was accomplished in 1860 by 
Kolbe and Lautemann and the sodium salt of the acid 
(sodium salicylate) was introduced as an antipyretic by 
Buss in 1875.
The great success of salicylic acid in the treatment 
of rheumatic fever and arthritis prompted Hoffman to 
prepare acetylsalicylic acid. After demonstrating its 
anti-inflammatory effects this compound was introduced 
into general medicine in 1899 by Dresar under the name 
aspirin. These synthetic salicylates soon displaced the 
more expensive compound obtained from natural sources. In 
the years that followed, other groups of compounds which 
also share some or all the actions of the naturally 
occurring drug were synthesised. These include, the 
pyrazolon derivatives ( phenylbutazone, oxyphenlbutazone, 
antipyrine, aminopyrine, dipyrone, apazone) and the 
paraaminophenol derivatives (phenacetin and paracetamol).
A host of other new agents have also been introduced 
over the past 3 0 years. These include, indomethacin and 
sulindac, tolmetin, piroxicam and the propionic acid 
derivatives (ibuprofen, naproxen, and fenoprofen). While
13
these latter compounds are also described as aspirin­
like, they are mainly used for their anti-inflammatory 
effect.
1.1.1, Main Action Of Aspirin-like Drugs.
Aspirin-like drugs share many therapeutic actions 
which include analgesic activity, anti-inflammatory 
activity and antipyretic activity. The reason why such an 
array of chemicals should have the same actions is not 
known and over the years many attempts have been made to 
clarify their therapeutic mechanism(s). It is now 
thought that inhibition of prostaglandin synthesis by 
these agents is not only responsible for their 
therapeutic actions but also for one of their toxic 
effects, namely analgesic nephropathy (sections 1.3,
1.5.2) .
Some of the evidence for inhibition of prostaglandin 
synthesis as a mechanism of action of aspirin-like drugs 
include, (1) Prostaglandins El and E2 produce headache 
and pain on injection to humans and these agents also 
sensitize "pain" receptors to other noxious substances 
such as histamine and bradykinin (see Parkhouse et al. 
1979). (2) Prostaglandins (especially the E series )
14
produce fever when infused into cerebral ventricles or 
when injected into the hypothalamus (see Parkhouse et al. 
1979). (3) Aspirin-like drugs do not prevent the
hypothermia induced by intracerebral injection of 
prostaglandin but prevent the rise in prostaglandin 
concentration seen during fever and the time course of 
antipyretic action and the suppression of prostaglandin 
increase run parallel (see Milton 1982).
15
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1.2, THE URINARY SYSTEM.
The urinary system consists of the kidneys, ureters and 
urethra. The kidneys function as regulatory organs 
helping to maintain the constancy of the internal 
environment with regard to its volume and composition. 
The ureters are continuous with each kidney and transport 
urine down their lengths by peristaltic contractions of 
smooth muscle located within their walls.
A detailed review of the structure and function of 
the urinary system is beyond the scope of this thesis and 
can be found in numerous publications including, that by 
Moffat (1979); Bloom and Fawcett, (1986) and Brenner 
(1986). This section aims to provide a general background 
against which RPN and upper urothelial carcinoma (UUC) 
will be discussed.
1.2.1, The Kidney.
The kidneys are paired abdominal organs that occupy 
a retroperitoneal position on each side of the vertebral 
column. The mammalian kidney is roughly bean shaped with 
a concavity (the hilum) at the mid point of the medial 
aspect. A tough fibrous capsule surrounds the kidneys and
17
is joined at the hilum to the renal artery and vein, 
lymphatics, nerves and the renal pelvis. On the saggital
surface of a bisected kidney two distinct regions can be 
seen; a pale inner region, the medulla and a darker outer 
region, the cortex.
The medulla of human, pig, seal, and beaver kidneys 
is divided into 8 to 18 striated conical masses, the 
pyramids of which are positioned with their bases on the 
corticomedullary boundary. The apex of each pyramid 
extends towards the renal pelvis forming a papilla. In 
contrast the rat kidney is unipapillate. Ten to twenty 
small openings are present on the surface of each 
papilla, these represent the distal end of the collecting 
ducts (ducts of Bellini). In the multipapillate kidney 
urine from the collecting ducts drain into one of the 
minor calyces. Several minor calyces coalesce to form one 
of the two or sometimes three major calyces. The pelvis 
of the unipapillate kidney is not ramified and the single 
papilla of an undivided medulla project directly into the 
pelvis.
The nephron is the functional unit of the kidney. 
In sequence, the nephron is composed of the glomerulus 
and Bowmans capsule, loop of Henle and collecting duct 
(fig. 2). Two main groups of nephron are present in the 
mammalian kidney ; the cortical and juxtamedullary 
nephrons. The cortical nephrons have short loops of Henle
18
that frequently do not enter the medulla while the 
juxtamedullary nephrons have long loops that descend to
the inner medulla.
Based on the region of the nephron located at 
various levels in the medulla, the medulla of the 
mammalian kidney can be divided into an inner and outer 
zone. The latter can be further divided into an inner and 
outer strip (fig.2). The inner medullary zone contains 
both descending and ascending thin limbs and large 
collecting ducts. The inner stripe of the outer zone 
contains descending thin limbs, ascending thick limbs and 
collecting ducts and the outer stripe of the outer zone 
contains the terminal segments of the proximal tubule, 
the ascending thick limbs of the distal tubule and 
collecting ducts.
19
Tig.2, Diagram showing the segmentation of short and 
long-looped nephrons and zonation of the kidney.
X
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1.2.2 Renal Concentrating Mechanism
It is now universally accepted that the elaboration 
of a concentrated urine involves osmotic equilibration of 
collecting duct urine with a medullary interstitium that 
becomes progressively more hypertonic as one proceeds 
from the corticomedullary junction to the tip of the 
papilla and that this osmotic gradient is generated by 
countercurrent multiplication in the loop of Henle 
(Jamison 1983, Hogg and Kokko, 1986). This high 
osmolality at the papilla tip is a result of differential 
permeability of the limbs of the loops of Henle and the 
collecting ducts to water and ions. The thick ascending 
limb is relatively impermeable to water and has an active 
transport mechanism which pumps chloride out of the lumen 
and into the interstitium. This active transport of 
chloride is followed by passive flux of sodium (Kokko 
1982) . The descending limb is freely permeable to water 
but not to sodium ion. The high ion concentration in the 
interstitium causes water to be drawn out of the 
descending limb thus increasing the osmolality towards 
the "hair-pin turn " of the loop of Henle. This is 
augmented by urea in the interstitium, some of which re­
enters the ascending loop of Henle and is recycled. The 
collecting ducts regulate the final urine concentration 
by controlling the amount of water reabsorbed. The 
passage of water out of the tubules is mediated by cyclic 
adenosine monophosphate (cAMP) the synthesis of which is
21
stimulated by antidiuretic hormone (ADH). In the presence 
of ADH, the collecting ducts become permeable to water. 
In the absence of ADH the collecting duct is relatively 
impermeable to water. The net result of this latter 
condition is very little reabsorption of water and,
hence, secretion of dilute urine.
This increasing concentration gradient from the 
cortex to the papilla tip has been suggested as a 
possible mechanism of RPN on the ground that some 
compounds could be concentrated to a level high enough to 
exert a direct toxic effect on papillary structures 
(section 1.5.1 ) .
1.2.3 Renal Interstitium.
The interstitium is the tissue compartment outside 
the tubules and vessels. It consists of interstitial 
cells and an extracellular space filled with flocculent 
material now thought to be sulphated and nonsulphated 
glucosaminoglycans. Three types of interstitial cells 
have been identified in the kidney. Cell types 2 and 3 
are sparsely distributed in the cortex and the medulla. 
Cell type 1 are more numerous than types 2 and 3, 
especially in the inner medulla where they make up about 
40% of tissue volume. The shapes of interstitial cells
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are varied; they may be round, fusiform or most commonly, 
of irregular star shape with long cytoplasmic projections.
The type 1 interstitial cells have been most 
frequently studied due to the suggestion that they may 
have endocrine functions (see Mandai and Bohman,1980).
In the outer medulla these cells are irre— : gularly shaped 
with large invaginations, towards the papilla tip they 
appear round. The most distinguishing feature of type 1 
interstitial cells is the presence of lipid droplets 
which comprise about 2 to 4% of the total cell volume.
The biological role played by type 1 interstitial 
cells is still not clear. Several possible functions have 
been suggested. These cells are thought to secrete the 
proteoglycan matrix in which they are embedded ( Muirhead 
and Pitcock, 1980). Phagocytic activity has been 
suggested following the observation that administered 
iron dextran complex concentrates within these cells 
(Moffat, 1981) . There have been suggestions that 
interstitial cells specialise in prosaglandin (PG) 
production and that their lipid droplets serve as a store 
of PG precursor (Mandai and Bohman, 1980,). This latter 
suggestion has been challenged following observations 
that PG production is not a unique feature of 
interstitial cells. 50% of medullary PG synthetase is 
located in the collecting ducts with the remaining 50% 
spread out in other cells including interstitial cells.
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Also the fatty acids present in the interstitial cell's 
lipid droplets often do not appear to be PG precursors 
(Mandai and Bohman, 1980). Medullary PG synthesis is 
nevertheless important since inhibition of PG synthesis 
may play a role in the pathogenesis of RPN (section
1.5.2). It has also been proposed that interstitial cells 
may be involved in the regulation of blood pressure 
(Muirhead and Pitcock, 1985, Muirhead,1986, Susie, 1988, 
Mistry and Nasjletti, 1988). A reduction in the number of 
interstitial cell lipid droplets have been noted in 
experimentally induced hypertension in the rat (Mandai 
and Bohman 198 0) and various vasoactive compounds have 
been isolated from the medulla or from cultured 
interstitial cells (Muirhead at al. 1983). These include 
the prostaglandins (PGS), antihypertensive "polar" 
renomedullary lipid and antihypertensive "neutral" 
renomedullary lipid. Elevated arterial blood pressure in 
experimentally induced, spontaneously occurring and 
pathologically precipitated hypertensive states have been 
reduced by subcutaneous transplants of renal papillary 
fragments or cultured interstitial cells and by systemic 
administration of either "polar" or "neutral" 
renomedullary lipids in the rat, rabbit, and the dog 
(Mandai and Bohman, 1980, Muirhead et al. 1983, Muirhead 
and Pitcock, 1985; Muirhead, 1986).
24
1.2.4, Renal Prostaglandins.
Prostaglandins are unsaturated fatty acids 
synthesized from 20-carbon fatty acids, the most abundant 
of which is arachidonic acid. A variety of PGS are 
synthesized in the kidney (fig.3). Glomerular and 
vascular epithelium (Schlondoff, 1986), collecting ducts 
(Dunn and Zambraski, 1980; Pugliese et al. 1983) and
renomedullary interstitial cells (Mandai and Bohman, 
1980, Schlondoff, 1986 ) have all been shown to be sites 
of renal PG production. The PG synthesizing enzymes are 
collectively known as prostaglandin synthetase. The 
enzymes in this group include fatty acid cyclooxygenase, 
endoperoxide reductase and prostaglandin synthetase. The 
biological effects of prostaglandins include smooth 
muscle contraction, vasodilation, gastrointestinal 
secretion, release of other hormones, central nervous 
system stimulation and depression, and mediation of 
inflammatory response (see Clive at al. 1984). Only
those prostaglandin related actions which are modified 
during renal papillary necrosis will be further 
discussed.
1.2.4a, Prostaglandins And Renal Blood Flow.
Renal prostaglandins (with the exception of PGF2 
and thromboxane) are primarily vasodilators. Studies in
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the dog and the rabbit show that PGE2, PGD2 and PGI2 
reduce total renal resistance and increase blood flow 
whereas PGF2 and 6-keto PGFl had little or no effect on 
renal blood flow (Levenson et al. 1982, Clive and Stoff, 
1984, Black, 1986). Despite these vasoactive properties 
of exogenous renal prostaglandins (RPG) and the high 
capacity for endogenous RPG synthesis, inhibition of PG 
synthesis by nonsteroidal anti-inflammatory drugs (NSAID) 
has virtually no effect on renal blood flow of normal 
animals and humans (Susie 1988, Black, 1986, Dunn et al. 
1984). Swain et al. (1975) found that administration of
indomethacin had no effect on renal blood flow of normal 
dogs and baboons. Donker et al. (1976) found no change in
the renal blood flow of normal human subjects following 
the inhibition of PG synthesis.
In contrast, inhibition of PG synthesis has a 
profound effect on renal blood flow when it is 
superimposed on a preceding haemodynamic insult (Susie 
1988, Black,1986). In dogs subjected to hypotensive 
haemorrhage, salt depletion or anaesthesia and in an 
experimental model of biliary cirrhosis (Blasingham and 
Nasjletti, 1980, Zambraski and Dunn, 1981) renal blood 
flow is reduced following treatment with inhibitors of PG 
synthesis. The common factors in all the above conditions 
are activation of renin-angiotensin system and 
sympathetic nerves, and enhanced release of endogenous
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catecholamines and vasopressin. All these pressor 
mechanisms increase blood pressure by producing both 
systemic and renal vasoconstriction. Prostaglandins 
counteract this vasoconstriction produced by these 
agents.
1.2.4b, Prostaglandins And Renal Water Excretion.
Many lines of evidence indicate that PGS regulate 
the maintenance of water balance in animal and man. 
Endogenous and exogenous PGS have been shown to promote 
water excretion (Gullner et al. 1980) while inhibitors of 
PG synthesis impair diuresis and increase urinary 
osmolality (Stoff et al 1981; Walker et a l . 1981).
Several loci of PG action on water metabolism have been 
identified. These include, antagonism of the hydrosmotic 
activity of antidiuretic hormone, inhibition of active 
chloride transport by the medullary thick ascending limb 
and regulation of medullary blood flow (Lifschitz, 1981, 
Brenner and Rector 1986).
1.2.4c, Prostaglandins And Renal Sodium Excretion.
There is evidence to suggest that in the well 
hydrated conscious animal, vasodilator prostaglandins 
enhance renal sodium excretion. Infusion of arachidonic
27
acid, PGE2, PGD2, or PGI2 in experimental animals and 
humans produces brisk natriuresis (Weeks and Compton, 
1979 ; Patrono et ai. 1982 ) . On the other hand, 
administration of non steroid anti-inflammatory drugs 
(NSAID) to anaesthetized, dehydrated animals (Gagnon and 
Felipe, 1979) or to conscious "salt loaded" animals 
(Clive and Stoff, 1984, Levenson et al. 1982, Brenner 
and Rector, 1986) produces a reduction in sodium chloride 
excretion.
The observation that intrarenal infusion of various 
PGS produces vasodilation led to the suggestion that PGS 
are natriuretic because of their capacity to increase 
renal blood flow. While the effect of PGS on renal blood 
flow may play a role in the natriuretic effects of these 
agents ( arachidonic acid induced natriuresis is 
abolished if the concurrent rise in renal blood flow is 
prevented (Bay et al. 1979)) other mechanisms are also 
involved. The infusion of PGE2 in the presence of 
acetylcholine induced maximal renal vasodilation results 
in a rise in sodium excretion without any further 
augmentation in renal blood flow (Shea-Donohue et al. 
1978). Other ways in which PGS could affect renal sodium 
excretion include ; (1) antagonism of the effect of
angiotensin 11 on proximal tubular reabsorption (Ichikawa 
and Brenner, 1980) and (2) by a direct effect on 
transport properties of distal nephron. Several in vitro 
studies show that PGE2 inhibits sodium reabsorption in
28
cortical and medullary collecting tubules when applied to 
the peritubular surface (Lino and Imai, 1978).
Fig.3, Biosynthesis Of Products Of Arachidonic Acid.
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1.2.5, Renal Xenoblotic Metabolism.
Although the liver is the primary site of drug 
metabolism, significant xenobiotic biotransformation 
occurs in the kidney. Metabolism of xenobiotics is 
generally a detoxification process but it can sometimes 
lead to formation of reactive intermediates 
(electrophiles and free radicals). These intermediates 
normally combine with excess intercellular nucleophiles 
such as reduced glutathione, but when these are depleted 
they will bind covalently to critical cellular components 
such as proteins, RNA, and DNA thus causing tissue 
damage. This type of tissue damage has been proposed for 
various types of chemically-induced lesion including RPN 
and some bladder cancers (Zenser et al. 1979, 1984; Kluwe 
and Hook, 1980, Bach et al. 1984, Ford and Hook, 1984).
The kidney has two main enzyme systems for 
biotransformation of chemicals; the renal cytochrome P- 
450 mixed function oxidase mediated drug metabolism and 
the prostaglandin endoperoxide synthetase enzyme system. 
The renal cytochrome P-450 enzyme system is localised 
mainly in the cortex whereas the PG endoperoxide enzyme 
system is localised mainly in the inner medulla (Zenser,
1984). There is data on metabolic activation of compounds 
by both of these enzymes. Early work on the possible 
involvement of metabolic activation in the genesis of RPN 
concentrated mainly around phenacetin, which was then
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thought to be the sole cause of the lesion. Nery (1971) 
suggested that RPN was caused by metabolic activation of 
phenacetin to N-hydroxy phenacetin and/or N-hydroxy-4- 
phenetidine. Hinson (1983) subsequently identified four 
possible routes by which phenacetin could be converted to 
a reactive intermediate by the cytochrome P-450 enzyme 
system. It has, however, been pointed out that the very 
short half life of these toxic intermediates suggests 
that they can only exert their effects very close to 
their site of formation and that the virtual absence of 
this enzyme system in the inner medulla makes its role in 
the genesis of RPN doubtful.
Attention on the involvement of metabolic activation 
in the genesis of RPN is now focussed on the enzyme 
prostaglandin synthetase. This enzyme is localised 
mainly in the inner medulla and is responsible for 
conversion of prostaglandin G2 (PGGg) to prostaglandin Hg 
(PGHg). During this reaction, suitable electron donors 
are oxidised. Based on the localisation of this enzyme 
and the observation that the initial lesion of RPN occurs 
in the renal papilla, Zenser et al. (1984) proposed that
certain toxins and carcinogens could serve as a substrate 
in this reduction with the result that they are activated 
to forms which react with cellular macromolecules. 
Conversion of paracetamol and p-phenetidine to reactive 
intermediates by this enzyme system has been demonstrated 
(Mohandas et al. 1981; Anderson, 1983).
31
1.3, ANALGESIC NEPHROPATHY; an overview-
Analgesic nephropathy is associated with abusive 
consumption of analgesics, especially analgesic mixtures. 
The primary lesion of analgesic nephropathy (AN) is renal 
papillary necrosis with secondary cortical damage. If 
analgesic abuse is continued, this initial lesion 
progresses to end stage renal failure or upper urothelial 
carcinoma (Kincaid-Smith, 1978, 1980, 1986 1988;
Prescott, 1982; Nanra, 1983; Bach and Bridges, 1985; 
Drukker et al. 1986; Schwarz, 1987; Sabatini, 1984,
1988). The association between analgesic abuse and this 
form of kidney damage was first recognised by Spuhler and 
Zollinger (1953), who observed that 13 out of 44 patients 
with interstitial nephritis had chronically consumed 
phenacetin containing analgesics. Renal papillary 
necrosis (RPN) was present in 22 out of 33 patients with 
chronic interstitial nephritis. This lesion differed from 
that associated with diabetes in that the infiltration 
zone of leucocytes at the junction of necrotic tissue was 
often not present. They (Spuhler and Zollinger, 1953) 
concluded that this was a new form of renal disease which 
has increased in frequency since 1945.
Although in those patients described by Spuhler and 
Zollinger (1953) phenacetin was only one of the component 
of a proprietary mixture containing phenacetin, caffeine.
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diethyldioxotetrahydropyridine and isopropylantipyrine, 
phenacetin was subsequently universally accepted as the 
most likely cause of analgesic-induced renal disease 
since it was the only component present in all the 
analgesic mixtures which were associated with the lesion. 
This "obsession" with phenacetin is exemplified in 
earlier publications by the adoption of terms such as 
"phenacetin kidney" and "phenacetin nephritis" for 
categorising analgesic induced kidney damage and by the 
measurement of analgesic abuse in terms of kilograms of 
phenacetin consumed without identifying any other 
analgesic taken in combination. Brown and Pell-Ilderton 
(1964) in a publication titled "Phenacetin and the 
kidney" reported "phenacetin nephropathy" in a male 
patient whose case history showed that he had consumed 
18g of sodium amylobarbitone daily for an unspecified 
period of time, 50mg of methadone daily for an 18 month 
period, 3 0 tablets of APC (a mixture containing aspirin 
(42%), phenacetin (42%), and caffeine (16%)) together 
with an unspecified amount of sodium amylobarbitone daily 
for a 9 month period, 30 tablets of sonaligin (a 
proprietary preparation containing butobarbitone (60mg), 
codeine phosphate (lOmg), and phenacetin (225mg)) daily 
for the 7.5 years prior to his death. In another 
publication titled "chronic phenacetin nephropathy" 
Sanerkin and Weaver (19 64) reported that a 54 year old 
woman died of analgesic nephropathy after a 40 year abuse 
of an analgesic mixture containing phenacetin. The amount
33
of phenacetin consumed during this period was given as 8 
kilograms. No mention was made of the quantity or 
identity of the other constituents in the analgesic 
mixture.
Phenacetin is mostly used in combination. In 
experimental studies except when this compound was used 
at inflated doses, virtually no renal disease has been 
reported with phenacetin alone (see Prescott 1982) . In
contrast aspirin is frequently used alone and at moderate 
doses, has been reported to cause renal papillary 
necrosis (RPN) and is often one of the constituents of 
phenacetin containing analgesic mixtures (see Rosner, 
1976; Prescott, 1982). These observations led to the 
suggestion that aspirin, rather than phenacetin, is 
responsible for analgesic nephropathy. There are studies 
in which the importance of aspirin/phenacetin in AN were 
compared. Patients with rheumatoid arthritis represent a 
population of individuals who consume analgesics on 
regular basis. The prevalence of renal disease in 
patients with rheumatoid arthritis taking aspirin alone 
and those taking phenacetin-containing compounds have 
been investigated. Felt and Pridgen (1979) , in a study 
involving 639 patients with rheumatoid arthritis, looked 
for clinical evidence of analgesic associated renal 
disease and found that patients taking phenacetin- 
containing compounds had a significantly higher
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prevalence of renal disease than those taking aspirin 
alone. Lawson and Maclean (1966) also came to a similar 
conclusion after comparing the autopsy incidence of 
either RPN or nonobstructive pyelonephritis in 61 
patients with rheumatoid arthritis who had consumed 
either aspirin alone or phenacetin containing drugs. Both 
of these studies support the view that phenacetin 
containing compounds are more nephrotoxic than aspirin 
alone.
Phenacetin has now been removed from nonprescription 
analgesics in most countries. These restrictions have 
led to reduction in incidence of AN in many countries. 
In Finland, phenacetin became available on prescription 
only from 1965. In 1973, Kasanen reported that the 
incidence of papillary necrosis in Finland had fallen 
from the pre-phenacetin restriction value of 8.9% to 
3.8%. Phenacetin became a prescription only drug in 
Sweden from 1961. Hood et al. (1967) found that death
from non-obstructive pyelonephritis fell slightly from 
the pre-phenacetin restriction level of 7.9/yr/lOO,000 to 
7.4/yr/lOO,000 in period between 1961 and 1965. This 
decline was more evident in the female population from 
13/yr/lOO,000 to lO/yr/100,000. A decline in the 
incidence of renal disease and/or death rate from 
interstitial nephritis has also been reported for Denmark 
(Mabeck and Wichmann, 1979), Scotland (Murray, 1972) and 
Canada (Wilson and Gault,1982).
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In contrast to the above, data from Australia show 
that in this country removal of phenacetin from analgesic 
mixtures made virtually no difference to the prevalence 
of AN. In Australia, most habitual analgesic consumers 
take proprietary compound analgesics called Vincent's or 
Bex. Vincent's replaced phenacetin with salicymide in 
1967 and Bex replaced phenacetin with paracetamol in 
1976. Burry et al (1974,1977) studied the incidence of 
RPN at autopsy in Brisbane, and concluded that the 
removal of phenacetin from Vincent's powder in 1967 
produced a fall in autopsy incidence of RPN without 
affecting the prevalence of habitual analgesic 
consumption. Stewart et al. (1975) failed to find any
beneficial effect in the removal of phenacetin from 
Vincent's. These authors noted that the annual 
prevalence of AN in end-stage renal disease (ESRD) 
population was unchanged in the period between 19 67 and 
1974. Disney and Row (1974) also found no change in the 
prevalence of AN in ESRD in Australia. In a more recent 
paper Kincaid-Smith (1988) reported that data collected 
up to 1983 showed that the removal of phenacetin from 
Vincent's in 1967 and from Bex in 1975 produced no 
decline in the incidence of analgesic nephropathy but 
that, since the legislation prohibiting the sale of over 
the counter mixed analgesics was introduced in Australian 
states between 1979 and 1980, the percentage of cases of 
end-stage renal failure due to analgesic nephropathy had
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declined steadily each year since 1983. In 1987 only 13% 
of all cases of ESRD were attributed to analgesic 
nephropathy compared with 20 - 25% between 1973 and 1983. 
McCredie et a l . (1989) also studied the effect of
withdrawal of phenacetin from analgesic mixtures and the 
effect of prohibition of sale of compound analgesic 
mixture on the incidence of analgesic nephropathy in New 
South Wales. They found that the withdrawal of 
phenacetin from analgesic mixtures only resulted in a 
slight decrease in the incidence of analgesic nephropathy 
whereas prohibition of sale of compound analgesic 
resulted in a sharp decrease in incidence of analgesic 
nephropathy This observation is consistent with the now 
widely held view that mixed analgesics rather than any 
one single analgesic on its own is more likely to cause 
RPN, that phenacetin is probably not nephrotoxic but that 
its mood alteration properties could lead to increased 
abuse of mixed analgesics containing this agent.
1.3.1, Epidemiology.
There are now numerous reports of incidents of 
analgesic nephropathy (AN) from most parts of the world 
(see Prescott, 1982; Bach and Bridges, 1985; Drukker et 
al 1986; Schwarz, 1987 Elseviers 1988). With the 
exception of one report of high incidence of AN in a 
predominantly male work force of a Swedish factory where
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there was a history of abusive consumption of an analgesic 
mixture containing antipyrine, phenacetin and caffeine 
(See Schwarz, 1987), AN occurs predominantly in females. 
Nanra et al. (1978) found the female to male ratio to be
6.5 to 1 and Murray (1978) found it to be 4 to 1. Males 
also present at significantly older age than females; 
58.9 and 50.6 years respectively, (Murray, 1978). 
Analgesic nephropathy is common in the fourth and fifth 
decade of life and is very rare before the age of 30 
years (Murray and Goldberg, 1978; Nanra et al. 1978).
The prevalence of daily ingestion of analgesics is high 
in older people and several investigators have noted a 
familial occurrence of AN (See Bach and Bridges, 1985, 
Murray, 1978). Murray (1978) noted that 43% of his 
patients had a relative who also abused analgesics. If 
not clouded by denial, patients with AN usually have a 
history of heavy analgesic consumption (accumulative dose 
of l-5kg over a period of 5-2 0 years) prior to 
development of the lesion.
There is a geographical distribution in the 
occurrence of AN and the incidence runs parallel with the 
national use of analgesics (table 1) . The estimated 
annual per capita consumption of analgesics are ; 4 0g 
for Australia, 12g for Scotland, lOg for the United 
states, and 6-7g for Canada ( Burry, 1968; Gloor, 1978). 
This is in conformity with the autopsy incidence of RPN;
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Australia, 3.7-12.4%, Europe, 0.3-1.3% and United states, 
0.1-0.26% (see Nanra 1983). The geographic distribution 
of AN also conforms with the number of patients with 
advanced renal disease referred for dialysis or renal 
transplantation. Here again Australia has the highest 
incidence, with up to 3 0% of referred patients with end 
stage renal disease. The corresponding figures for the 
United States and Canada are 2-10% and 2.5% respectively 
(see Nanra, 1983, Murray and Goldberg, 1978). The 
incidence of this lesion also varies from one region to 
another in the same country. For example, Belgium is
divided into nine provinces, the prevalence of AN is
highest in the province of Antwerp (100 patients per 
million adult population) and the adjacent province of
East Flanders (70 patients per million). In the central
area (province of Brabant) the incidence is less (38 
patients per million) . The prevalence is even 
substantially lower in the remaining six regions (Drukker 
et al. 1986). In the United Kingdom a higher incidence of 
AN is found in Scotland compared with the rest of the 
country. Of a total of 225 cases of AN reported in 
Britain by 1972, 169 of these cases came from Scotland 
with 70% from Glasgow area ( Murray, 1978) . Similar 
variations in incidence of AN has been reported for the 
United States (Murray and Goldberg, 1978), and Australia 
(Stewart,1978). Several hypothesis have been proposed to 
explain this unequal distribution of AN. These include: 
(1) that the poor socio-economic status of the local
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population could contribute to a high incidence of 
addiction. Murray (1978) studied 51 analgesic abusers and 
found that they were predominantly from lower social 
classes, generally unskilled, poorly educated and were 
more likely than the control group to have had 
psychiatric treatment. Drukker et ai. (1986) have 
however pointed out that the high prevalence of AN in 
some parts of Belgium could not be attributed to poor 
socio-economic status since the provinces of Antwerp and 
East Flanders which have the highest incidence of AN in 
this country are also among the most prosperous, (2) 
vigorous sales promotion and advertising of locally made 
products has been suggested. The province of Antwerp 
which has the highest incidence of analgesic nephropathy 
in Belgium contains analgesic manufacturing factories 
(Drukker et ai. 1986) and Glasgow which also has the 
highest incidence of AN in Scotland again has an 
analgesic manufacturing factory (Murray, 1978), and a (3) 
hot climate has also been suggested as a possible 
contributory factor to the high incidence of AN in some 
hot countries. Data from experimental animal studies show 
that experimentally-induced kidney damage is more 
pronounced in dehydrated animals (see Rosner, 1976, 
Prescott, 1982). Also a close relationship has been 
demonstrated between autopsy incidence of RPN and the 
mean monthly temperature (Nanra et al. 1970, Kincaid- 
Smith, 1970).
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Table 1, Prevalence Of AN In Different Countries
Country References
Australia 20 Stewart, 1978
22 Kincaid-Smith, 1979
20 Nanra, 1980
Switzerland 20 Bengtsson, 1979
18 Brynger at al. 1980
18 Jacob et al. 1981
South Africa 2 0 Furmanet al.1976
Belgium
(Aalst)
11 Jacob et al. 1981
18 Vanherweghem et al.1982
44 Drukker et al. 1986
United States
(North Carolina) 
(Washington DC)
7-10 Murray and Goldberg,1978 
10 Gonwa et al. 1981 
3 McAnally, 1983
Federal Republic of 
Germany
5 Brynger et al. 1980
8 Wing et al. 1983
10 Drukkeret al 1986
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Table 1, Prevalence Of AN In Different Countries 
(continued).
Country References
United Kingdom
(Glasgow)
(Nottingham)
1 Brynger et al, 1980
26 Murray, 1978
10 Knapp and Avioli, 1982
1.3.2, Clinical Features Of Analgesic Nephropathy
The diagnosis of analgesic nephropathy requires an 
accurate history of analgesic abuse and the demonstration 
of RPN. The precise quantity of analgesic consumed is 
usually difficult to determine since patients tend to 
conceal or minimise the habit (Murray, 1978; Drukker et 
al, 1986). The lesion is often associated with a variety 
of malfunctions such as peptic ulcer, anaemia, premature 
aging with early greying of hair, accelerated 
atherosclerosis and ischaemic heart disease (Pulliam and 
Bennett, 1985, Nanra, 1980 Kincaid-Smith, 1980; Knapp and 
Avioli, 1982). Headache occurs in 90% of patients with AN 
and is the most common reason given for analgesic abuse. 
Psychological disturbances are common and are reflected 
in the frequency of addictive habits such as smoking.
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alcoholism, laxative abuse and use of psychotropic drugs 
and sleeping tablets (Murray, 1978). Personality disorders 
which include introversion and neuroticism and organic 
features which include hallucination and 
elctroencephalographic abnormalities have also been 
reported ( Murray, 1978). Pregnancy and gonadal 
manifestation such as toxaemia of pregnancy, 
postmaturity, teratogenicity, congenital malfunction and 
infertility have also been reported in association with 
analgesic abuse (Nanra 1980).
Laboratory abnormalities such as impaired 
concentrating ability, sterile pyuria, urinary tract 
infection, proteinuria, haematuria, tubular epithelial 
celluria, elevated blood urea nitrogen and creatinine 
levels, renal tubular acidosis and sodium wastage are 
also associated with this lesion (Pulliam and Bennet,
1985).
1.3.3, Pathology Of Analgesic Nephropathy.
The pathological consequences of analgesic 
nephropathy are RPN and interstitial nephritis. Burry 
(1967) has categorised the changes which occur during the 
development of RPN into early, intermediate and total 
papillary.
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In early papillary necrosis, changes were confined 
to the papilla tip and the inner medulla and consist of 
patchy necrosis of the loop of Henle, the capillaries and 
interstitial cells, thickening of the basement membrane 
in the affected tubules and accumulation of lipid 
material in the necrosed tissue.
In intermediate papillary necrosis there was 
extension of lesion to the junction of the inner and the 
outer medulla. Towards the papilla the necrosis involves 
all anatomical elements with the exception of the 
collecting ducts. Calcium deposits can be seen in the 
necrosed areas and the outer medulla may show atrophy, 
some degree of fibrosis and sclerosis. Bone formation may 
also occur in the necrosed papilla (Blohme and 
Johansson,1981).
In total papillary necrosis the whole of the inner 
medulla is necrosed. This sometimes leads to formation of 
a cavity within the medulla. The necrosed papilla may 
remain attached or it may detach from the medulla. Where 
the papilla has detached, the medullary cavity becomes 
reepithelised.
Cortical changes previously described as "chronic 
interstitial nephritis" are secondary to extensive 
papillary necrosis. These include, tubular atrophy and
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dilation, interstitial fibrosis and inflamiaatory cell 
inf iItration.
1.3.4, Analgesic Abuse And Uroepithelial Tumours.
A relationship between tumours of the urinary tract 
and analgesic abuse was first suspected by Hultengren and 
coworkers (1965). They observed renal pelvic tumours in 6 
patients with RPN, 5 of these patients were known 
analgesic abusers and all 6 were women. There are now 
numerous similar findings, Bengtsson and coworker (1968) 
found renal pelvic carcinoma in 9 patients and bladder 
tumours in 2 patients out of a total of 104 analgesic 
abusers followed up for an average of 5 years. No tumour 
was found in 88 control patients with non-obstructive 
pyelonephritis. The same workers also found, from 
retrospective studies, that another 14 out of 29 patients 
with renal pelvic tumours had abused phenacetin 
containing analgesics and that the majority of these 
patients were women. Angervall et al, (1969), found that 
10 out of 15 patients with renal pelvic tumours seen in 
Jonkoping (Sweden) during an 8 year period had a history 
of analgesic abuse. Similar findings were also reported 
by Orell et al. 1979; Mihatsch and Knusli,1982 ; Drukker 
et al, 1986).
The incidence of renal pelvic tumours in non­
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analgesic abusers is very low. For example, in Sweden, 
the annual average incidence is about 1 case per 180,000 
population (see Prescott, 1982). The disease occur 
predominantly in males. The estimated male to female
ratio is 4: 1 (Drukker et a l . 1986). This ratio is
reversed in analgesic abusers and the tumours tend to 
occur at an earlier age and to be more invasive 
(Bengtsson et al. 1978). There is also an increased risk 
of bladder cancer and cancer of the ureter in analgesic 
abusers (Gonwa et al. 1980, McCredie et a l . 1983,
Derbyshire et al. 1989, Bach and Bridges 1985, Piper et 
al. 1985). Mihatsch et al. (1982) estimated this risk of
developing cancers of the ureter, renal pelvis and 
bladder in analgesic abusers to be 89, 77 and 17 times 
respectively, higher than in non abusers.
As with analgesic nephropathy, there is a geographic 
variation in the incidence of uroepithelial tumours. The 
incidence is particularly high in Sweden, Switzerland and 
Australia and low in Finland, West Germany and the United 
States. This corresponds to the reported incidence of 
analgesic nephropathy ( see Prescott, 1982; Drukker at 
al. 1986; Schwarz, 1987). The diagnosis of uroepithelial 
tumours is often made too late because the main feature, 
gross haematuria does not alert patients or doctors since 
it is also a feature of AN, a condition that usually 
precedes the tumour.
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1.4, EXPERIMENTALLY INDUCED RENAL PAPILLARY NECROSIS 
AND UPPER UROTHELIAL CARCINOMA.
Long term analgesic abuse can lead to RPN and 
subsequently to end stage renal disease (ESRD) or upper 
urothelial carcinoma (UUC) (Kincaid-Smith, 1980, 1988;
Prescott, 1982; Bach and Bridges, 1985; Drukker at al. 
1986; Schwarz, 1987; Sabatini, 1988). Research into RPN 
and its relationship to ESRD or UUC in man is hampered by 
the long latent period and by the fact that the lesion is 
"silent" and can only be diagnosed with some degree of 
accuracy at an advanced stage. Functional changes such as 
urine concentration and acidification defects, 
electrolyte wastage and bone changes (Fassett et al. 
1982, Pulliam and Bennett, 1985) associated with RPN are 
only detectable at an advanced stage of the lesion and 
none of these are indicative of just RPN though they can 
play a supportive role to the radiological diagnosis 
which also becomes possible only at the advanced stage 
(see Prescott, 1982).
A number of animal experimental models have proved 
useful for studying the development and course of RPN. 
These include: fat-free diet (Holland, 1982), Gunn rat
(Henry and Tange, 1983, 1984, 1987) and chemical
induction using analgesics (Holland, 1976; Macklin and 
Szot, 1980 ; Henry and Tange, 1983, 1987) or with non­
analgesic papillotoxins (Murray at al. 1972 ; Hill et al.
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1972; Sabatini, 1988; Chapter 3, this thesis). Attempts 
to induce RPN experimentally using analgesics or NSAID 
have proved difficult because this usually requires their 
administration in large quantities for long periods of 
time (see Prescott, 1982). Even when the lesion is 
successfully induced, there is a high degree of 
variability in its extent and severity within the same 
species and the same dose group. Nanra and Kincaid-Smith 
(1973 ) observed RPN in only 50% of rats given 
acetylsalicylic acid (200mg/kg/day) for 10 to 66 weeks. 
Holland (1978) reported "intermediate" RPN in 3 out of 5 
rats given a daily dose of paracetamol (900mg/kg) for 3 6 
weeks. Mclver and Hobbs (1975) were unable to induce RPN 
in pigs with a total dose of 2kg aspirin/animal given 
over a lOmonth period. Philips at a l . (1976) also
reported negative results after the administration to 
rats of aspirin (20, 60, or 125mg/kg/day)for 42 weeks.
Attempts have been made to increase the percentage of 
animals responding by using dehydration (Nanra and 
Kincaid-Smith, 1970, 1973) or unilateral nephrectomy
(Holland, 1976; Henry and Tange 1983, 1987) in addition 
to analgesics. While the use of these techniques has led 
to pronounced increment in response in the Gunn rats, in 
the more resistant strain of animals only marginal 
increments were obtained (Nanra and Kincaid-Smith 197 0, 
1973; Prescott, 1982). More importantly the relevance of 
these modified models to analgesic nephropathy in man is 
questionable (see Rosner, 1976) , however, the
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demonstration in animals of a type of nephrotoxicity 
similar to the type of injury reported in humans lends 
weight to the causal association between analgesic abuse 
and kidney disease.
Several non-analgesic compounds which include middle 
distillates of shale oil and petroleum (Easley et ai. 
1982) , and a polychlorinated biphenyl, Arochlor 1242 (see 
Bach and Bridges 1985) have been used to produce RPN but 
there is very little published data on the time course 
changes or the mechanism by which any of these compounds 
cause the lesion. The most widely used non analgesic 
papillotoxins are ethyleneimine (EL) and 2- 
bromoethanamine hydrobromide (BEA). A single dose of 
either of these compounds will cause RPN in all treated 
animals in a matter of days (Murray et ai.1972; Hill et 
al. 1972; Sabatini et ai. ,1982, Sabatini, 1988; chapter 
3, this thesis). The pathophysiological changes observed 
following El- and BEA- induced RPN have been extensively 
investigated (see Bach and Bridges,1985).
1.4.1, Non-analgesic Papillotoxic Compounds.
El is an alkylating agent with some mutagenic 
activity and was first reported to cause RPN by Levaditi 
(1901). The chemistry and toxicology of this compound has 
been reviewed by several authors.
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BEA is used in organic synthesis and was reported to 
cause RPN which is histologically indistinguishable from 
the El induced lesion by Oka (1913) who suggested that 
the BEA lesion could be mediated by cyclisation to form 
El. BEA is readily soluble in water and, in aqueous 
solution, rapidly undergoes ring closure forming El 
according to the following reaction:
BrCHzCHzNHz • HBr
bea c H ,  -  CH2 +  2HBr.
\ /
NH
EL
A variety of BEA dose regimes have been used to induce 
RPN. These have ranged from, single doses of 50 to 
2 5 Omg/kg administered subcutaneously (sc) or 
intraperitoneally (ip) , 50 to 300mg/kg administered
intravenously (iv) and 500 to lOOOmg/kg administered 
orally (po) (see Bach and Bridges, 1985). in view of this 
broad range of dosage Bach et al. (1983) studied the dose
response relationship in the rat and found that BEA 
(single dose) produced apex limited RPN at 50mg/kg ip and
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sc or lOOitig/kg po and total destruction of the medulla at 
doses greater than 150mg/kg ip and sc or lOOOmg/kg po. 
Wolf and Carlton (1990) using Swiss ICR mice also studied 
dose-response relationships after administration of BEA. 
They found that the mortality and the extent of renal 
lesion were dose dependent. Thus the percentage of mice 
with tubular necrosis varied from 0 in the mice given 
lOOmg BEA /kg to 100 in mice given 400mg BEA/ kg . The 
percentage of mice with renal papillary necrosis was also 
dose dependent and varied from 0 in mice given lOOmg BEA 
/kg to 72 in mice given 40Omg BEA /kg.
The morphological and functional changes following 
BEA induced RPN have been extensively studied and 
reviewed. Many of these changes are similar to those seen 
in human analgesic induced RPN (sections 1.4.2, 1.4.3).
1.4.2, Morphological Changes Associated With BEA Induced 
RPN.
Morphological changes following BEA treatment have 
been studied by several investigators among whom are 
Murray et al. (1972); Hill et al. (1972); Cuppage and
Tate, (1975); Sabatini et al. (1982), Sabatini, (1988);
Bach et al. (1983) and the present investigator, chapter 
3, this thesis)
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Murray et al. (1972) using light microscopy found, 
following administration of BEA (250mg/kg/day, iv) to 
female Holtzman rats, no apparent ultrastructural changes 
at up to 6hr after dose and only mild dilation of 
papillary collecting ducts at 12hours. By 24hr there was 
occasional loss of papilla tip covering epithelium and 
the appearance of eosinophilic casts in thick ascending 
limbs. No apparent change was noted in interstitial cells 
at this point. These changes progressively became more 
marked and by 2 days the limbs of Henle were 
structureless and there was obvious loss of vasa recta, 
capillaries and covering epithelium as well as appearance 
of mitotic figures in collecting ducts. At 7 days there 
was complete necrosis of all papillary tissue (with the 
exception of a few collecting d u c t s ) . A line of 
demarcation appeared between the dead and living tissue 
and the papilla tip had no covering epithelium. The dead 
papilla separated from the rest of the kidney between 14 
and 21 days and re-epithelisation of the remaining 
papilla "stump" was complete by 2 months after dose. Bach 
et al. (1983) using different strain of rats (Wistar),
lower dosage (5 Omg/kg) and different route of 
administration (ip), also monitored BEA-induced 
morphological changes using light microscopy and noted 
changes similar to those reported by Murray et al. (1972)
except that these changes occurred at earlier time points 
(from 3hr onwards) and the response was biphasic (a
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recovery period between 8 and 12hr after dose, followed 
by deterioration). Calton and Engelhardt (1989) 
administered BEA as a single or multiple dose (ip) to 
Syrian hamsters and noted, with light microscopic 
technique, medullary lesions which included, tubular 
protein casts, reduced cellularity, interstitial edema, 
pyknotic nuclei, congested blood vessels, "ghost" of thin 
loops of Henle, hypertrophy and hyperplasia of papillary 
epithelium. These changes did not become more severe with 
multiple dosage. They (Calton and Engelhardt ,1989) 
concluded that this lack of increased severity of BEA- 
induced damage with multiple dosage may be related to the 
importance of urinary concentration in the development of 
BEA- induced papillary necrosis and that the initial dose 
probably damages the concentrating mechanism to such an 
extent that subsequent doses do not markedly increase the 
severity of the lesion. This result is in contrast with 
that reported by Shimamura (1972) who found that, in rat, 
repeated dose of BEA did result in a more pronounced 
lesion. This investigator also found that necrosis did 
not extend to the outer zone of the papilla in any of the 
experimental animals even after the sixth injection. 
Perhaps the difference in these two results lies in the 
possibility that Calton and Engelhardt( 1989), either by 
using more sensitive animals and / or higher dose, were 
able to produce in one dose what Shimamura achieved after 
multiple doses, that is, damage to the renal papilla up 
to the outer zone. After this point, further drug
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administration will not result in increments in response 
(Shimamura 1972). Species variation has been noted in 
response to administration of BEA. Rats given 50 or 10Omg 
BEA/kg body weight developed papillary necrosis (Murray 
et al, 1972; Shimamura, 1972; Bach and Bridges, 1985). 
Oka (1913) found that 40mg/kg body weight of BEA produced 
no lesion in rabbits but rabbits given lOOmg/ kg did not 
survive past 3 days of treatment. Hamsters did not 
develop renal lesion when given 50mg BEA or less but 
developed renal lesion in a dose-related manner when 
given 75mg BEA/kg. Wolf and Calton (1990) found that, in 
ICR mice, 10Omg BEA/kg produced no renal papillary 
necrosis and that 400mg BEA/kg only produced 74% renal 
papillary necrosis.
Hill et al. (1972) monitored the morphological i
changes following BEA (single dose, 250mg/kg, iv) 
administration to female Holtzman rats using transmission 
electron microscopy. They noted that with this technique, 
ultrastructural changes appeared at an earlier time point 
than was reported in the light microscopic study of 
Murray et al. (1972). Thus, at 3hr after dose, there were
marked changes in the vasa recta and thin limb which 
included condensation of portions of the cytoplasm, 
shrinkage and darkening of mitochondria, appearance of 
vacuoles in cytoplasm, focal separation of cells from 
basement membranes, chromatin aggregation on nuclear 
membrane, slight wrinkling of nucleus and retraction of
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nucleus from outer nuclear membrane. Very slight versions 
of these changes were also seen in the interstitial cells 
and collecting ducts at this time point. At 6hr these 
changes became more marked with the interstitial cells 
and collecting ducts now showing obvious damage. At 12hr 
in addition to the afore mentioned changes, there was 
severe swelling of both vascular and tubular cells, 
pyknotic nuclei in the vasa recta, rupture and denudation 
of capillary basement membrane and attachment of 
platelets to denuded basement membrane. At 24hr the thin 
limbs, the vessels and the interstitial cells were 
completely necrosed but occasional collecting ducts were 
still preserved. By 48hr after dose there was necrosis of 
all cellular elements and regenerative activity was 
evident in the thin limbs.
Cuppage and Tate (1974) using both light and 
transmission electron microscopy, and in a longer term 
study (24hr - 6months) probably provided a more rounded 
view of morphological changes following BEA 
administration. However as their earliest time point was 
at 24hr these authors may have missed some of the earlier 
changes described above (Murray et al. 1972; Hill et al. 
1972; Bach et a l . 1983). The changes observed by
Cuppage and Tate (1974) were:- platelet and erythrocyte 
aggregates within capillary lumen, necrosis of thin limbs 
but intact collecting ducts (at 24hr), necrosis of all 
medullary structures, edematous interstitium and
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appearance of fibrin strands within the capillaries (at 3 
days), appearance of regenerative cells (at 7-14days), 
loss of papilla tip, focal fibrosis and occasional 
calcification of the interstitium and focal atrophy or 
dilation of nephron segments within the cortex (1-6 
months). They (Cuppage and Tate, 1974) concluded that the 
presence of platelet aggregates within the capillaries at 
24hr suggested that thrombosis and ischaemia were 
probably important mechanisms in the pathogenesis of BEA- 
induced RPN.
Sabatini et al (1982, 1984) using scanning electron 
microscopy reported that this technique, unlike light and 
electron microscopy only showed changes at much later 
time-points. Thus superficial glomeruli, juxtamedullary 
glomeruli and the papilla tip appeared normal at 24hr 
after BEA but by 4 weeks, juxtamedullary glomeruli showed 
scarring and sclerosis with total loss of foot processes 
and the papilla was detached and found lying free in the 
renal pelvis. The present author has also studied the 
morphological changes following BEA administration to 
rats using the scanning electron microscopic technique 
(chapter 3, this thesis).
Many of the BEA-induced changes are similar to those 
observed in analgesic nephropathy in man. Burry (1967) 
examined kidney tissues taken at autopsy from 59 
analgesic abusers and found degeneration of epithelium of
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loops of Henle, basement membrane thickening, calcium 
deposition, interstitial edema, fibrosis, inflammatory 
infiltration, tubular atrophy and hyelinisation. Gault
(1971), using light and electron microscopy, studied 
kidney tissues obtained by biopsy from 26 analgesic 
abusers and observed interstitial fibrosis, cast 
formation, basement membrane thickening, collagenisation, 
hyculinisation, atrophy, inflammatory infiltration, loss 
of cells and glomeruli sclerosis. Maniglia et al. (1988)
studied retrospectively the case history of 13 patients 
who were taking nonsteroidal anti-inflammatory drugs and 
had exhibited abnormal urinalysis or a deterioration in 
renal function. Renal biopsies from 9 of these patients 
were also studied using light microscopy, 
immunofluorescence and electron microscopy. They 
(Maniglia et ai. 1988) noted, from analysis of urinary 
sediments, the presence of granular casts, red cells, 
white blood cells, glucose, hyaline casts, multiple 
tubular and epithelial cells and, from the light and 
electron microscopy studies, glomerular fibrosis, 
glomerulosclerosis, basement membrane thickening, 
inflammatory infiltrate, effacement of foot processes, 
tubular atrophy and collagenisation.
There are also similarities between BEA-induced RPN and 
experimental analgesic-induced RPN in animals. Molland 
(1976, 1978) observed necrosis of vasa recta and
interstitial cells and appearance of collagen fibres
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after the administration of various analgesics to rats 
for 20 to 52weeks. Henry et ai. (1983) administered a 
single iv dose of aspirin (2.5mM/kg), phenazone (5mM/kg), 
paracetamol (6mM/kg), or p-aminophenol to 
uninephrectomised female Gunn rats and noted tubular 
necrosis in one rat and RPN in all aspirin treated rats, 
RPN in all phenazone treated rats, RPN in 3 out of 10 
rats and proximal tubule necrosis in all paracetamol 
treated rats, proximal tubule necrosis but no RPN in all 
p-aminophenol treated rats. They (Henry et al. (1983))
concluded that the nephrotoxicity of paracetamol and p- 
aminophenol (both derivatives of phenacetin) is directed 
mainly against the proximal tubule while that of aspirin 
and phenazone is directed towards the papilla. They 
suggested that this may explain why AN is often 
associated with abuse of compound preparations rather 
than exposure to single analgesics since the 
nephrotoxicity of a mixture containing any of the 
phenacetin derivative and aspirin or phenazone will be 
additive. Henry and Tange (1983), administered aspirin 
(2.5mM/kg) to uninephrectomised female homozygous Gunn 
rats and observed, damage to the interstitial cells, 
swelling and vacuolation of the epithelial cells of 
collecting ducts and loop of Henle, detachment of cells 
from basement membrane, platelet thrombi formation in 
capillaries and extensive necrosis of a large part of the 
papilla. They concluded that because damage to the 
capillaries was late in onset, RPN was probably due to a
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direct toxic effect rather than to ischaemia. A more 
recent publication by these authors (Henry and Tange, 
1987) supports this conclusion; they gave
uninephrectomised female homozygous Gunn rats a single iv. 
dose of paracetamol (6mM/kg) and, in addition to 
inflammatory cell infiltrates which was evident as early 
as Ihr after dose they again noted that damage to the 
interstitial cells was followed by damage to collecting 
ducts and tubules and then damage to the capillaries. 
Burrell et al (1990) also administered aspirin and 
paracetamol to rats (Fischer 344 rats) and observed 
papillary necrosis with both drugs. However, unlike Henry 
et al. (1983) and Henry and Tange (1983, 1987) they did
not observe that the nephrotoxicity of paracetamol is 
directed against the proximal tubule, while that of 
aspirin is directed against the papilla. Also, unlike the 
findings of most other investigators that the renal 
papillary necrosis induced by BEA or analgesics always 
start at the papilla tip, Burrell et ai. (1990) found 
that the initial degenerative changes following long term 
analgesic administration to rats appeared at the mid- 
papillary region. They concluded that (1) this provides 
evidence against the hypothesis that analgesics produce 
their toxic effects at the site of maximum concentration 
which, because of the medullary concentration mechanism, 
is assumed to be the papilla tip (2) that the fact that, 
in their study, both interstitial cells and the 
concentration mechanism were damaged very early suggests
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that analgesics, by damaging the interstitial cells, 
cause a breakdown in renal proteoglycan and that loss 
of concentration mechanism is a direct result of 
breakdown in renal proteoglycan. Proteoglycans are 
synthesised by interstitial cells (see Mandai and Bohman, 
1980) and Blood and Kupchella have demonstrated a direct 
relationship between the amount of papillary proteoglycan 
and the ability to produce concentrated urine (see 
Burrell et al. 1990) (3) that damage appeared first in
the mid-papillary region because there are less 
interstitial cells in this region compared with the 
papilla tip and that the higher number of interstitial 
cells at the papilla tip will initially offer some 
protection against analgesic-induced damage.
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1.4.3, Functional Changes associated with BEA - induced
RPN.
The functional changes following BEA-induced RPN 
have been extensively studied. Shimamura (1976) observed 
after the administration of BEA (single dose, 5Omg/rat, 
iv.) to male Fisher rats, 30% and 50% reduction in 
glomerular filtration rate (GFR) at 2days and 29months 
after dose, respectively. Mehta et al. (1977) also found
that the administration of similar dose of BEA to rats 
caused a reduction in GFR in addition to a reduction in 
urine osmolality and free water reabsorption, sodium 
wastage but no change in free water clearance, urine 
acidification or potassium excretion.
Sabatini et a l . (1978, 1981, 1982) monitored
changes in electrolyte balance and urine acidification 
following a single dose of BEA (5Omg/rat, iv) to male 
Sprague-Dawley rats and observed sodium chloride, 
phosphate and calcium wastage, potassium wastage if 
potassium intake was limited but no change in urinary 
acidification. The intact urinary acidification is 
consistent with data reported by Mehta et al. (1977) but
in contrast to those of Finkelstein and Hayslet (1974) 
who demonstrated that total acid and ammonium ion 
excretion were lower in chronically papillectomised 
animals.
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Arruda et al. (1979) in contrast to Shimamura 
(1976) and Mehta et al. (1977) did not find any change in
GFR or free water reabsorption at 24hr after BEA (single 
dose, 5Omg, iv) administration to rats. No change was 
also observed in the renal concentrations of sodium, 
potassium and water, free water clearance and bicarbonate 
reabsorption under normal conditions. However, when 
sodium intake was restricted to zero, increased urine 
flow and sodium excretion were noted and, when potassium 
intake was restricted to zero, sodium, chloride, and 
calcium wastage were noted.
The data reported by Gobé and Axelsen (1982) may 
offer some explanation for the discrepancies in the data 
reported above. Gobé and Axelsen (1982) monitored renal 
function at 3days and 4weeks after the administration of 
BEA (40-125mg/kg) to rats. The resultant RPN was 
classified into 2 types on the basis of severity. Sub­
total RPN was used to describe necrosis of renal 
papillary structures with the exception of the collecting 
ducts and total RPN to describe necrosis of all 
structures in the distal papilla. It was found that 
glomerular filtration rate (GFR) and free water 
reabsorption were significantly reduced in animals with 
total RPN but not in those with sub-total RPN and that 
the osmolality was significantly reduced in both subtotal 
and total RPN. They concluded that, since free water
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reabsorption was not impaired in subtotal RPN (when most 
nephron elements with the exception of collecting ducts 
were damaged), impairment of free water reabsorption most 
likely results from damage to the collecting ducts.
Many of the functional changes observed following BEA 
treatment are also characteristic of AN in man and 
experimental analgesic-induced RPN in animals. Thus Nanto 
et ai. (1964) noted that addition of phenacetin 
(440mg/kg) daily to rat feed produced a mild transient 
aminoaciduria and progressive changes in the chemical 
composition and electrophoretic pattern of urinary acid 
mucopolysaccharides. The same workers also found 
abnormalities in the urinary mucopolysaccharide excretion 
in patients with analgesic nephropathy. Fordham et al. 
(1965) noted a rise in blood urea nitrogen and acidosis 
in rats given 3,00mg/kg of phenacetin daily for 4weeks. 
Eisolo and Talanti (1961) noted focal cortical tubular 
degeneration with loss of enzyme activity in 5 out of 17 
rats given 36Omg of paracetamol for 4weeks. Peters et al,
(1972) noted proteinuria and increased urinary tubular 
cell excretion following the administration of 
paracetamol (8 00-3,OOOmg/kg/day) to rats for 35 to 
60days. Dubach and Josch (19 67) noted increased urinary 
excretion of lactic dehydrogenase, B - glucuronidase, 
alkaline phosphatase and arylamidase after a daily dose 
of 3. 5g of aspirin in man (see Prescott 1982 for
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references).
1.4.4, Experimental Analgesic - induced Uroepithelial 
Tumour.
As with analgesic nephropathy most of the earlier 
investigations on the possible association between 
analgesic abuse and UUC were concentrated mainly around 
phenacetin as it was also thought to be the causative 
agent of this condition. Several workers failed to induce 
any tumour by chronic administration of phenacetin to 
experimental animals (see Prescott, 1982). On the other 
hand, Angervall (1976) fed phenacetin (0.54%) to female 
Sprague-Dawley rats for 96 to 110 weeks and noted 
urothelial hyperplasia in 87% of the treated animals. 
Carcinogenic metabolites of phenacetin such as those 
produced by N-hydroxylation have been isolated from the 
urine of rats fed phenacetin (see Gonwa et al. 1980). 
Isaka et al. (1979) fed Sprague Dawley rats of both sexes
with phenacetin (1.25 or 2.5%) for 18 months and observed 
tumours of the nasal cavity and myeloid leukemia with 
both dose levels and in both sexes, and urinary 
transitional cell hyperplasia and carcinoma of the upper 
ureter in animals fed the higher dose. Nakanishi et al. 
(1982) fed phenacetin (1.25 or 0.6)to B6C3F1 mice of both 
sexes for 96 weeks and noted a dose related incidence of
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renal dysplasia, adenoma and carcinoma in male mice and 
bladder hyperplasia at high dose level in both sexes. It 
was concluded from these findings that phenacetin had a 
general carcinogenic effect. Macklin and Szot (1980) 
have, however, pointed out that the formulation of test 
compounds into pellets may create optimal conditions for 
the formation of potentially carcinogenic N-oxidation 
products and nitrosated amines (see Prescott, 1982).
Urothelial hyperplasia has been observed following 
the administration of flufenamic acid or N-pheny1- 
anthranilic acid (Hardy,1970) and following the 
administration of aspirin or feeding of fat free diet 
(Molland, 1976, 1982). Urothelial hyperplasia is also a 
common finding in analgesic abusers, in spontaneously 
occurring RPN and RPN induced with ethyleneimine (see 
Bach and Bridges, 1985, Axelsen, 1978) and that induced 
with 2- bromoethanamine hydrobromide (chapter 3, this 
thesis). Whether these hyperplastic changes represent a 
transition stage in the development of UUC is still not 
certain, but it is possible that they may represent a 
nonspecific response to injury which if persistent could 
progress to malignant change.
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1.5, MOLECULAR PATHOGENESIS OF RPN AND UUC.
The precise mechanisms of analgesic induced RPN and 
UUC is not known. The several hypothesis that have been 
proposed are discussed below.
1.5.1, Counter-Current Concentration Mechanism.
The counter current concentration hypothesis is 
based on the assumption that a concentration gradient 
(increasing from cortex to papilla) of some compounds 
exists in the kidney. The resultant increased drug 
concentration at the papilla is thought to be high enough 
to exert a direct toxic effect on renal structures. There 
is data to support of this theory. Paracetamol is 
distributed within the renal medulla and the cortex in a 
ratio of 10 to 1 for conjugated paracetamol and as high 
as 19 to 1 for free paracetamol (Shelley, 1978). The data 
for a medullary concentration gradient of aspirin is 
conflicting. Gault (1971) demonstrated a gradient for 
aspirin of 1 to 7 in the rabbit and 1 to 3 in the guinea 
pig. The same investigator also demonstrated a gradient 
of 1 to 3.6 for phenacetin in the rabbit. Bluemle and 
Goldberg (1968), however, did not find any concentration 
gradient for aspirin in the dog and Molland (1978) 
reported that aspirin is concentrated more in the cortex
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than in the medulla (see Shelley, 1978 for references).
While the counter - current concentration mechanism 
model of RPN is very plausible, it has been pointed out 
that : - (1) most of the studies on the intrarenal
distribution of analgesics were based on single dose 
administration and this is probably not representative 
of events that precede RPN which have been shown to 
occur only after long period of analgesic administration, 
(2) high concentrations of chemical at the papilla tip is 
not, in itself, an obligatory cause of RPN. Urea is 
concentrated to a high level at the papilla tip but does 
not cause RPN. Furthermore, antipyrine (an agent which
has been shown to cause RPN) is concentrated more in the
cortex than in the medulla (Moffat, 1981) and (3) loss of 
urine concentrating ability is an early consequence of 
analgesic abuse (Nanra, 1980) and data from BEA induced
RPN shows that concentrating ability is lost well before
any morphological degeneration is detected (Murray at al. 
1972) .
1.5.2, Perturbation of Arachidonic Acid Metabolism.
Many of the pharmacological and toxicological 
effects of the acidic anti-inflammatory drugs have been 
explained on the basis of their inhibitory effect on PG
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synthesis (see Flower, 1974) . One of the most quoted 
hypothesis for the pathogenesis of analgesic nephropathy 
is that inhibition of PG synthesis by aspirin-like drugs 
could lead to medullary ischaemia and thence to RPN 
(Nanra et al. 1973; Molland, 1976, 1978, Shelley, 1978, 
Prescott 1982, Bach and Bridges, 1985). Prostaglandins 
play a modulatory role in the body by counteracting the 
vasoconstriction effects produced by endogenous hormones 
and chemical messengers such as angiotensin 11 and 
catecholamines (Brenner and Rector, 1986). Aspirin-like 
drugs by their inhibitory action on PG synthesis 
interfere with this modulatory role. Data reported by 
several workers are in support of this model. Nanra et 
al (1973) observed reduced medullary perfusion in rats 
treated for 2 0 weeks with a variety of analgesics under 
condition of dehydration and/or oligemic shock. Medullary 
ischaemia was found to precede histological evidence of 
damage. Rosner (1976) has, however, pointed out that the 
dose of analgesics used (3,OOOmg/kg/day for phenacetin, 
paracetamol or N-phenylanthranic acid) were so high that 
this study cannot be reflective of what happens in the 
clinical situation. Molland (1978) found that the 
earliest changes in experimental aspirin-induced RPN 
occurred in the interstitial cells. Interstitial cells 
are an important site of PG synthesis and their 
destruction could lead to a reduction in medullary 
prostaglandins. (see Mandai and Bohman, 1980). RPN has
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been induced by long-term feeding of fat-free diet 
(Molland, 1982). This could be due to limited ingestion 
of linoleic acid, a precursor of arachidonic acid which, 
in turn, is a precursor of the prostaglandins (fig. 3) .
The PG inhibition hypothesis is attractive in that 
it is consistent with the well established nephrotoxicity 
of the acidic anti-inflammatory analgesics and the 
suggested relatively low renal toxicity of phenacetin and 
paracetamol which have less anti-inflammatory activity 
and activity against PG synthetase. Ischaemic injury, 
however, affects the cortex and the outer medulla 
(Torhorst et al. 1982) rather than the inner medulla which 
is necrosed following chemically-induced RPN. Ischaemia 
is thus probably only one of the factors which additively 
causes RPN.
1.5.3, Immunological Changes.
The possible involvement of immunological changes in 
the pathogenesis of RPN has been suggested. This 
hypothesis was prompted by the observations that RPN has 
a slow onset, not all human analgesic abusers develop the 
lesion, several anaIgesics/NSAIDS effect the immune 
system (Gibson et al. 1983) and some metabolites of
phenacetin can cause hypersensitivity (see Rosner,
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1976; Hook et al. 1979). There is no convincing evidence 
to support this model. Gault et al. (1971) could not find
any immunodeposit in the medulla or cortex of patients 
with early analgesic nephropathy. Murray and Vonstowasser 
(197 6) observed that the immunological changes occurred 
in the cortex 7 days after an acutely induced RPN. No 
immunological changes were found in the medulla. Thus it 
seems that RPN precedes immunological changes.
1.5.4, Metabolic Activation.
Drug metabolism sometimes leads to the formation of 
reactive intermediates which are capable of disrupting 
normal cellular function by binding covalently to 
cellular macromolecules (Snyder et al. 1981; Bach et al. 
1984 ). Metabolic activation has been proposed as a
possible mechanism for RPN because some analgesics can be 
activated to reactive intermediates (section 1.2.5). Some 
of the evidence in support of this theory includes (1) 
proximal tubular necrosis has been induced with a single 
dose of paracetamol (750mg/kg, sc.) in male Fisher rats 
(see Henry and Tange, 1987). This damage is thought to 
involve the generation of reactive intermediates which 
binds to cellular macromolecules following depletion of 
glutathione. Thus renal tubular damage produced by 
paracetamol in rat and in man following overdosage can be
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prevented by administration of glutathione precursors 
such as L-cysteine and N -acetyl-cysteine (Prescott 
1982) and (2) the acute renal toxicity of salicylates is 
also thought to be due to the formation of a reactive 
metabolite. Aspirin has been shown to acetylate renal 
tissue proteins and, in common with paracetamol, to cause 
depletion of renal glutathione (Duggin, 1977).
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1.6, THE PRESENT INVESTIGATION
Since the discovery of an association between 
analgesic abuse and renal disease (Spulhler and 
Zollinger, 1953) this problem has been enthusiastically 
investigated but still the pathophysiological mechanism 
remains unclear.
In most of the documented reports, mainly light and 
electron microscopic techniques were used. With the 
exception of two studies (Al-Ani, 1980; Sabatini et al. 
1982) there is virtually no ultrastructural study of this 
problem using scanning electron microscopic technique.
The aim of this investigation was to study the 
ultrastructural changes following experimentally induced 
renal papillary necrosis and upper urothelial carcinoma 
using mainly scanning electron microscopy. Light and 
transmission electron microscopy were occasionally used 
to provide complimentary information.
The investigations were carried out using 2- 
bromoethanamine hydrobromide, a model papillotoxin which, 
following acute dosage, produces RPN with pathological 
features very similar to those seen in analgesic 
nephropathy and N-butyl-N-(4-hydroxybutyl)nitrosamine, a 
known bladder carcinogen.
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CHAPTER 2
MATERIALS AND METHODS
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2.1, Chemicals.
2-bromoethanamine hydrobromide was purchased from 
Aldrich chemicals (Gillingham, Dorset, UK). 
Glutaraldehyde, osmium tetroxide, Spurr resin, toluidine 
Blue and trisodium citrate were purchased from TAAB 
chemicals (Reading, Berks., UK). Paraformaldehyde was 
obtained from Polyscience Ltd. (Northampton, Uk). Sagatal 
(Dietylether), Sodium hydroxide and Sodium chloride were 
purchased from May & Baker (Dagenham, UK). N-butyl-N-(4- 
hydroxybutyl)-nitrosamine was obtained from Midwest 
Research Institute ( Kansas city, Missouri, USA). Sodium 
dihydrogen orthophosphate was purchased from BDH 
chemicals (Poole, Dorset, UK). Lead nitrate and borax 
were purchased from Sigma chemicals (Poole, Dorset, UK) . 
Wescor inc. 5100 vapour pressure osmometer was obtained 
from Chemlab Scientific ltd. (Hornchurch, Essex, UK) . 
All other reagents used were of analytical grade or of 
the highest commercially available grade.
2.2, Experimental Animals.
Male Wistar rats from the University of Surrey stock 
were used. Animals were randomly allocated to 
experimental groups and were allowed 1 week 
acclimatisation period prior to commencement of studies.
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During this period the rats were handled regularly in 
order to minimise stress response during investigation.
The animals were housed in translucent "shoe box" 
type cages (14" W x 24" L x 11" D) and bedded on 
sterilised soft wood shaving (Mulbaz, Chertsey, UK) . The 
beddings were changed weekly at the start of experiments 
and twice weekly once RPN has been induced (RPN is 
associated with increased urine production). The number 
of animals/cage did not exceed 8 rats of up to 300g 
weight each or 5 rats of up to 600g weight each . Sick 
animals were removed and kept in separate cages until 
death or recovery. Recovered animals were put back into 
their respective cages.
The rats were kept on a 12hr. light/dark cycle with 
the light cycle starting at OVOOhr GMT. Food (Lab diet 
No.1, Spratts, Barking, UK) and tap water were available 
ad libitum. Temperature and humidity were controlled at 
21° C and 50% respectively.
Animals were tail marked with waterproof marker pens 
for studies lasting up to 24hr. For longer term studies 
they were ear marked using an "ear punch" (Junior punch, 
Browick, Ward & Co, London, UK) .
Dosing solutions were made-up fresh . Oral
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administrations were performed using stainless steel 
cannula. Orally dosed drugs were suspended in 20% ethanol 
while intraperitoneally dosed drugs were dissolved in 
distilled water. During the study period animals were 
checked each day for treatment related signs.
2.3, FIXATION AND PREPARATION OF KIDNEY SAMPLES FOR LIGHT 
AND TRANSMISSION ELECTRON MICROSCOPIC ANALYSIS
2.3.1 Intravascular Perfusion Of The Rat Kidney.
The animals were anaesthetised with an 
intraperitoneal injection of sagatal, 60mg/kg, and placed 
on a dissection board. The abdominal cavity was opened 
and urine sample withdrawn from the bladder with a 
syringe. The osmolality of the urine was measured and 
the osmolality of the fixative adjusted to match that of 
the rat's urine by addition of sodium chloride.
The descending aorta was exposed and ligature A 
(fig. 4) loosely looped round the vessel without 
occluding blood flow. The superior mesenteric artery was 
located and tiahtlv ligated, (ligature D) . An arterial 
clamp was applied at the "aortic area" about 1cm below 
the kidney.
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An incision was made just above the bifurcation of 
the aorta at the tail end of the animal and a polythene 
cannula inserted and tied in at positions B and C (fig. 
4). After this the loosely looped ligature A was 
tiqhtlv secured, the arterial clamp was removed and the 
kidneys intravascularly perfused with 2% solution of 
Karnovsky's fixative (paraformaldehyde/ glutaraldehyde) 
for approximately 2 minutes. Successful perfusion was 
characterised by a change in colour of the kidney (from 
brown to yellow) and by hardening of the kidney.
The perfused fixed kidney was removed and two thin 
slices (about 1mm thick each) cut longitudinally from the 
middle section of the kidney. The aim was to have a 
section of the papilla tip present in each cut sample. 
Since, in the rat, the papilla tip normally dips into the 
upper part of the ureter, the point of attachment of the 
ureter to the kidney was used as a rough guide of area 
from which samples were cut from. Cut sections were 
further fixed in the same batch of Karnovsky's fixative 
for about 12hr, washed in phosphate buffer (pH 7.4), 
osmicated, dehydrated, infiltrated, embedded and 
polymerised.
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Fig.4, calculation Procedure For intravascular Perfusion 
Of The Rat Kidney.
CD
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2.3.1.1, Osmication And Dehydration
The papilla was dissected out from the Karnovsky's 
fixative fixed tissue sections and washed for 6hr in 3 
changes of phosphate buffer (pH, 7.4). The samples were 
then fixed for Ihr at room temperature in 1% solution of 
osmium tetroxide, washed for 15min in 2 changes of 
phosphate buffer and dehydrated in a series of acetone of 
increasing strength; 25% (15min), 50% (15min), 75%
(3Omin) and 100% (2 changes over a 2hr period). The
samples were then embedded and polymerised.
2.3.1.2, Infiltration.
The osmicated and dehydrated samples were 
transferred to small glass vials containing 4ml of a 
mixture of acetone (50%) and Spurr resin embedding medium 
(50%). The vials were placed on a rotatory mixer (Rotator 
Type N, TAAB, Reading, Berkshire, UK) at 10 rpm for 
1.5hr. After this all liquid was drained from the vials 
and a mixture containing 75% Spurr resin and 25% acetone 
added and the vials replaced on the rotatory mixer for 
another 1.5hr. The samples were then transferred to vials 
containing 100% embedding medium, placed on the rotatory 
mixer and infiltrated for about 18hr.
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2.3.1.3, Embedding And Polymerisation.
Silicone rubber embedding mold (TAAB, Reading, Berks, 
UK) were filled with the embedding medium. The 
infiltrated specimens were transferred to the mold and 
the samples polymerised in an oven at 70° C for 12hr.
2.3.2, Preparation Of Tissue Blocks For Light 
Microscopic And Transmission Electron Microscopic 
Examinations.
Resin blocks were cut on an ultra microtone 
(Reichert, Omuz, Slough, Berkshire, UK) using a diamond 
knife (Dupont, UK, Ltd, Herts.). Thick sections 
approximately 5-7/x were stained with toluidine blue and 
examined under the light microscope (Vickers, student 
microscope). Thinner sections (about 0.05/x) were mounted 
onto copper grids, doubly stained with uranyl acetate and 
lead citrate and examined under a Phillips 4GOT electron 
microscope at 80 KV. The images were photographed.
Exposed photographic plates (Kodak 4489 electron 
image) were developed using kenknol developer (May & 
Baker, UK). Typical processing times were ; 4min in 
developer, 30sec wash in 2% acetic acid, 3min in fixer 
(Amifix, May & Baker, UK), 3 Omin wash (tap water)
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followed by drying in a film drying cabinet (Marrut, 
Edenbridge, Kent, Uk) with warm air flow.
The films were printed on Ilford multigrade paper 
using Ilford universal developer and fixer. Typical 
processing times were; Imin in developer, 15sec in acetic 
acid, 30sec in fixer, 2min wash (tap water) followed by 
drying in an infra-red drier.
2.3.3, RETROGRADE PERFUSION OF THE KIDNEY.
The rat was anaesthetised with sagatal (60mg/kg, ip). 
The abdominal cavity was opened and the ureter freed and 
cleared of surface fats. A ligature was tied at position 
A (fig.5) and a period of about 2min allowed so that the 
ureters would be distended with urine. An incision was 
made at position B and a thin polythene cannula inserted 
into the ureter and tied in at positions C and D (fig.5). 
A hole for elimination of perfusate was made at the 
cortical area of the kidney using a syringe needle. After 
this the kidney was slowly manually perfused with 4 ml of 
glutaraldehyde (2%, in phosphate buffer, pH 7.4) which 
was injected from a syringe attached to the opposÂ^te- end 
of the urethral cannula. Each perfusion lasted about 
2min. The perfused kidney together with attached ureter 
was dissected out and all the edges of the kidney trimmed 
so that only a square section containing the papilla
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remained. The samples, together with attached ureter, 
were then further fixed in the same batch of 
glutaraldehyde for a minimum of 3days.
As with intravascular perfusion, successful 
perfusion was characterised by change in colour and by 
hardening of the kidney.
Pig.7, Diagrammatic Representation Of The Cannulation 
Procedure For Retrograde Perfusion Of The Kidney.
Right
kidney
Left ureter
Right ureter
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2.3.3.1, Osmication, Dehydration And Critical Point 
Drying.
The kidney and attached ureter was fixed as 
described in section 2.4. The papilla was dissected out 
and the ureter cut longitudinally in half. All sections 
(papilla, pelvis and ureter) were washed in 3 changes of 
phosphate buffer (pH 7.4) for 12hr and then fixed for Ihr 
at room temperature in a 1% solution of osmium tetroxide. 
The osmium fixed samples were washed again in 2 changes 
of phosphate buffer for 15min and then dehydrated in a 
series of acetone of increasing strength; 25% (15min),
50% (15min.), 75% (30min.) and 100% (2 changes over a
2hr. period) . The samples were critical point dried in a 
Hitachi HCP-1 critical point drier.
2.3.4, Scanning Electron Microscopic (SEM) Examination.
The critical point dried specimens were mounted on 
aluminium stubs (TAAB laboratories, Reading, Berks, UK) 
using double sided adhesive tape. They were earthed with 
colloidal silver paint and gold coated in an Edward's 
S150B sputter coater. Topographic examinations were 
carried out at 2 0kV on a Cambridge S250 scanning electron 
microscope. Samples which were not examined immediately
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after gold coating were stored in a desiccator under 
vacuum to prevent moisture absorption and cracking of the 
gold coat. SEM images were photographed using a Nikon 
camera. Exposed films were developed using Ilford IDll 
developer. Typical processing time was 6.5min. in 
developer, 2seconds wash (tap water), 30min. in fixer 
(Amifix, May & Baker, UK), 3 Omin wash (tap water) 
followed by drying in a film drying unit (Marrut, 
Edenbridge, Kent UK) with warm air flow. The films were 
printed on Ilford multigrade paper using Ilford universal 
developer and fixer.
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CHAPTER 3
EXPERIMENTAL
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3.1, Scanning Electron Microscopic Study of 2- 
Bromoethanamine Induced Renal Papillary Necrosis.
3.1.1, INTRODUCTION
The analgesic model of RPN requires long-term 
administration of the compound; the resultant lesion 
often varies extensively within the same strain of 
animals and is very difficult to reproduce.
The BEA model of RPN offers some advantage over the 
analgesic model in that a single dose of this compound 
induces, in all animals in a matter of days, renal 
functional and pathological changes which are very 
similar to those produced following chronic analgesic 
administration (see Bach and Bridges, 1985).
Numerous reports are currently available on the 
light and transmission electron microscopic study of the 
BEA-induced lesion (Murray et al, 1972; Hill et al. 
1972; Cuppage and Tate, 1975; Shimamura, 197 6; Mehta, 
1977; Sabatini et al. 1978, 1981, 1982, 1984; Arruda,
1979; Axelsen,1982; Wilks et al. 1985; Mattingley et al. 
1985; Bach et al. 1983, 1985, 1988; Thielemann et al.
1990). In contrast very little data exists on the study 
of this lesion using the scanning electron microscope. 
The present study aims to redress this balance.
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3.1.1, Animals And Treatment.
Forty-eight male Wistar rats (200 - 250g) were dosed 
(ip) with BEA (lOOmg/kg) dissolved in distilled water. 
The control group (4 animals) were untreated. Four rats 
from the treated group were killed at the following time 
intervals Ihr , 2, 3, 4, 6, 9, 12, 24, 48, 72, 96, and
168hr after BEA treatment. The kidneys were retrograde 
perfused with phosphate-buffered glutaraldehyde (2%, PH 
7.4) as shown in section 2.4. The papilla, the pelvic 
area adjacent to the papilla tip and the upper two- 
thirds of the ureter were prepared for SEM analysis 
(section 2.3).
3.1.3, Results.
3.1.3a, Papilla Tip
The normal rat renal papilla under the scanning 
electron microscope looks like a cone with a rounded end 
(plate la). The papilla tip contains about 14 slit-like 
openings (the ducts of Bellini). The surface cells of the 
rat papilla are polygonal shaped with raised cell 
boundaries and a turf-like covering of microvilli (plate 
lb) .
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Following BEA treatment there was swelling of cells 
(evident as early as Ihr after dose), disappearance of 
the raised cell boundaries, enlargement and rounding of 
surface microvilli, complete or partial closure of the 
ducts of Bellini, and exfoliation of surface cells.
Swelling of cells reached maximum at 3hr after 
dose. At this time point, occasional collapsed cells were 
seen among the swollen cells (plate 2b). At 4hr after 
treatment most of the surface cells were collapsed, there 
was detachment of cells from cell boundaries, reduction 
in the number of microvilli and the collecting ducts were 
either partially or completely closed (plate 3a, b). At 
6hr there was continued deterioration of the changes 
noted at 4hr after treatment in addition to patchy loss 
of surface cells (plate 4a, b). At 9hr there was complete 
exfoliation of surface cells and the collecting ducts 
were now widely dilated (plate 5a, b ) . No gross 
difference was noted between the rats killed at 9hr and 
those killed at 168 hr (plate 6a, b).
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Plate la - Papilla of a control (untreated) rat; Note
the open collecting ducts (arrows). kxso ♦
Plate lb - Papilla of a control (untreated) rat (high 
magnification) Note the polygonal shaped cells ( *) and 
the raised cell boundaries (arrows) . x4,ooo.
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Plate 2a - Papilla of a rat 3hr after BEA treatment; Note
the cobble stoned cells and the partially/completely
closed collecting ducts (arrows) . x250.
Plate 2b - Papilla of a rat 3hr after BEA treatment (high 
magnification); Note the rounder and more sparsely 
distributed microvilli, the loss of the raised cell 
boundaries (arrows) and the appearance of some collapsed 
cells (*). x4,000.
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Plate 3a - Papilla of a rat 4hr after BEA treatment; 
Note the partially closed collecting ducts (arrows). 
x250.
Plate 3b - Papilla of a rat 4hr after BEA treatment (high 
magnification); Note the collapsed and detached cells and 
the reduced surface microvilli. x4,000.
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Plate 4a - Papilla of a rat 6hr after BEA treatment; Note
the closed collecting ducts and the patchy loss of
surface cells (arrows). x250.
Plate 4b - Papilla of a rat 6hr after BEA treatment (high 
magnification) Note the collapsed and detached cells and 
the presence of microvilli only at cell boundaries 
(arrows).' x4, 000.
'- ^ V s'-' ^ ^
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Plate 5a - Papilla of a rat 9hr after BEA treatment; Note
the now open/dilated collecting ducts (arrows) x250.
Plate 5b - Papilla of a rat 9hr after BEA treatment; Note 
the complete loss of surface cells and microvilli. 
x4,000.
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Plate 6a - Papilla of a rat 96hr after BEA treatment;
Note the wide open collecting ducts (arrows). x250.
Plate 6b - Papilla of a rat 9 6hr after BEA treatment; 
Note the continued absence of surface cells and the 
appearance of cracks (arrows) and debris on cell surface. 
x4,000.
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3.1.3b, Pelvis And Ureter.
The surface of a normal rat pelvis and ureter under
the scanning electron microscope is flat in appearance 
and has numerous randomly distributed surface microridges 
(plate 7a, b). The cells are polygonal in shape with 
raised cell boundaries. The boundaries observed here were 
not as obvious as those noted on the papilla tip and 
(plate lb) and were occasionally lined by short stubby 
microvilli.
Following BEA treatment, there was from about 2hr 
after dosing a decrease in the microridged pattern , 
appearance of short stubby microvilli not only at cell 
boundaries but all over the tissue surface and the 
appearance of holes on the tissue surface (plate 8a, b, 
9a, b). The changes noted between 2 and 6hr were very 
similar. At 9hr after treatment the surfaces of both 
ureter and pelvis were covered by long microvilli and the 
holes noted at earlier time points were no longer 
apparent (plate 10a, b) . At 12hr after treatment
numerous surface blebs and some long microvilli with
bulbous ends were noted (plate 11a, b). The number of 
microvilli gradually decreased with time (plate 12a, b) 
and by 168hr after dose virtually no microvilli, blebs or 
holes were noted and the tissue surface now closely 
resembled those of the control (untreated) rats (plate 
13a, b).
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Plates 7a - (Pelvis) , b (Ureter) of control (untreated) 
rat; Note the flat appearance of tissue surface, the 
numerous surface microridges and the raised cell boundary 
(arrows). X 8 0 0 0 .
Plates 8a - (Pelvis) , b (Ureter) of a rat 3hr after BEA 
treatment; Note the increased number of microvilli, the 
decreased microridged pattern and the appearance of holes 
(arrow head). x8,000.
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Plates 9a - (Pelvis), b (Ureter) of a rat 6hr after BEA 
treatment; Note the continued appearance of holes (arrow 
head) and the rougher appearance of tissue surface . 
x8,000.
Plates 10a - (Pelvis), b (Ureter) of a rat 9hr after BEA; 
Note the numerous microvilli and surface blebs. x8,000.
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Plates lia - (Pelvis), b (Ureter) of a rat 12hr after BEA
treatment; Note the continued presence of microvilli and
surface blebs. x8,000.
Plates 12a - (Pelvis), b (Ureter) of a rat Iweek after 
BEA treatment; Note the absence of holes, microvilli and 
surface blebs^ .. xSOOO.
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3.1.4, Discussion.
Both BEA and analgesic-induced RPN can vary from focal 
damage to total ablation of the papilla tip (Burry, 1968; 
Bach and Bridges, 1985). In the cases where there was 
focal damage, identification of necrosis by light or 
transmission electron microscopy will depend on accurate 
sectioning from the necrosed area, with sections cut from 
the undamaged parts leading to a possible erroneous 
conclusion. It has been shown that, in the focally 
necrosed renal papilla, sections cut from the undamaged 
areas could look quite normal under the light microscope 
(see Bach and Bridges 1985). The scanning electron 
microscopic technique thus offers an advantage over the 
light or transmission electron microscopy in the study of 
RPN because it allows examination of the whole papilla, 
the observed changes were more obvious (plates 1 - 1 3 )  
and appeared earlier than have been reported in light or 
transmission electron microscopic studies. Murray et al, 
(1972) using the light microscopic technique, found that 
the first necrotic changes following BEA administration 
occurred at 6hr after treatment. Sabatini at al, (1981)
reported that their data supports this finding. Hill at 
al. (1972) using the transmission electron microscopic
technique found that the earliest change occurred at 3hr 
after BEA treatment. Changes noted in this study with the 
scanning electron microscope following BEA
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administration included; (a) on the papilla:- swelling of 
cells, partial or complete closure of ducts of Bellini, 
loss of microvilli, detachment of cells from cell 
boundaries, collapse of cells and exfoliation of covering 
epithelium and (b) on pelvis and ureter:- appearance of 
holes, pleomorphic microvilli and surface blebs. Some of 
these changes were noted as early as Ihr after dosing and 
most of these changes have appeared by 3hr after 
treatment.
The observation of the swelling of cells in BEA-induced 
renal papillary necrosis is not surprising as cellular 
swelling is a dominant morphological event in tissue 
necrosis regardless of etiology (see Bowen and Lockshin 
1981). There is evidence that the essential defect is 
loss of control of cell volume (see Bowen and Lockshin, 
1981) . Loss of selective permeability of dying cells is 
the basis of many tests currently used to assess 
viability of cells in suspension. Such tests include 
vital dye exclusion and the ability to retain previously 
internalised radioactive chromium. Freeze - fractured 
preparations of necrotic membranes have demonstrated 
trans - membrane defects and studies of cell permeability 
in vivo to colloidal electron dense material have shown 
that cells undergoing necrosis are abnormally permeable 
to marker molecules. Even cells showing only earlier 
morphological changes preceding high amplitude swelling 
(starting point of irreversible change in tissue
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necrosis) also take up marker molecules. This suggests 
that the abnormal permeability precedes and probably 
causes the morphological changes. Sabatini (1985) did in 
fact observe that administration of BEA does at least in 
vitro cause a change in membrane permeability. She noted 
that, in the urinary bladder of toads and turtles 
exposure to BEA resulted in a significant inhibition of 
sodium - potassium ATPase and a 54% inhibition of sodium 
transport by 3hr after treatment. The reduction in sodium 
transport was evident as early as lOmin after BEA 
treatment. Inhibition of sodium transport will give rise 
to increased cell volume as a result of influx of sodium, 
calcium and water (see below).
The collapse of cells noted in this study is a very 
predictable change and is a product of cellular swelling. 
Extensive swelling of cells will put pressure on the cell 
membrane. If this pressure becomes too much the cell 
membrane will burst. Swollen cells observed in tissue 
necrosis are normally brought about by redistribution 
of ions between the intracellular and extracellular 
fluids. Under normal conditions, the concentrations of 
sodium and calcium are much higher in the extracellular 
fluid compared with the intracellular fluid. The 
concentrations of potassium and magnesium are, on the 
other hand higher in the intracellular fluid compared 
with the extracellular fluid. This unequal distribution 
of ions is maintained by the semipermeability of the
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membrane and by the action of energy- dependent active 
transport systems such as sodium - potassium pump and 
calcium pump. When there is a direct damage to the 
membrane, or when the membrane bound pumps are poisoned, 
or when damage to the mitochondria (the energy producing 
organ of the cell) indirectly leads to cessation of the 
membrane bound ion pumps, (fig. 6) redistribution of ions 
occurs. The pattern of this ion redistribution is 
potassium and magnesium ions leaving the cell down their 
concentration gradient, while sodium and calcium move 
into the cell (also down their concentration gradient) 
with water following passively. The net result of this 
ion shift is an increase in cell volume. Agents which 
have been linked to direct damage to the membrane, 
leading to a change in membrane permeability or damage 
to the membrane bound transport system, include 
mechanical damage and inhibitors of sodium - potassium 
ATPase such as cardiac glycoside. Agents which have been 
linked to inhibition or uncoupling of mitochondrial 
oxidative phosphorylation include anoxia, ischaemia and 
treatment with metabolic inhibitors such as potassium 
cyanide and carbon monoxide (see Bowen and Lockshin, 
1981).
Cellular exfoliation is also a predictable feature of 
tissue necrosis and has been reported for natural cell 
death, chemically - induced cell death and cell death as 
a result of disease including analgesic nephropathy and
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upper urothelial carcinoma. In fact, measurement of the 
amount and type of cells shed in the urine is used 
clinically for detection and follow up of drug - induced 
damage and disease conditions. More recently, scanning 
electron microscopic examination of the surface of cells 
shed in the urine has been suggested a as possible method 
for the detection of upper urothelial and bladder cancer 
and for checking the recurrence of cancer in patients 
whose tumours have been surgically removed (see section 
3.5, this thesis).
To my knowledge, partial or complete closure of 
ducts of Bellini reported in this section and in the 
light microscopic section (section 3.2) has not been 
previously reported in experimentally-induced RPN or in 
analgesic abusers. The light microscopic data (section 
3.2), the scanning and transmission electron microscopic 
data (sections 3.1 and 3.3 respectively) all show that 
the swelling of cells results in partial or complete 
closure of the ducts of Bellini between 3 and 8 hr after 
BEA administration. From 9hr after treatment, the cells 
of papilla tip were exfoliated. After exfoliation of 
papilla tip cells the ducts of Bellini were found not 
only to be open but to be dilated (plates 5a, b). From 
these results, the diuretic effect of BEA would be 
expected to be reduced between 3 and 8hr after treatment 
(time points where the ducts of Bellini were found to be 
completely or partially blocked) and to increase once
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the ducts of Bellini become dilated (from about 9hr after 
dose). Most of the data currently available on the 
diuretic effect of BEA involved measurement of urine 
output over longer term periods (for example, 0 - 12hr, 
12 - 24hr) and, so, could shed very little light on the 
above hypothesis. Wilks at al. (1985) measured urine
output over short time points (30, 60, 90, 12 0, 15 0,
180min) after BEA administration and concluded that BEA 
is diuretic as early as 3 Omin after treatment. 
Unfortunately, this study did not extend over the 
critical time points (3 - 8hr) when the ducts were found 
in my study to be "closed". Bach (1981) also measured 
urine output at short time points after BEA 
administration. The data reported by Bach (1981) 
provides some tentative support for my hypothesis. This 
study showed that, following a single dose of BEA (lOOmg 
/ kg) to rats, the mean urine output was; 4.5ml (at 0 
-2hr), 4.5ml (at 2 - 4hr), 3.9ml (at 4 - 6hr) and 1.9ml 
(at 6 -8hr). Unfortunately, Bach (1981) discontinued 
shorter term measurement of urine output after 8hr so it 
is not possible to see if this reduction in urine output 
noted between 4 and 8hr after BEA treatment was followed 
by increment in urine output at the time points where the 
ducts of Bellini were found in my studies to be dilated 
(from 9hr onwards).
It is, however, possible that even though some of the 
ducts were "closed" between 3 and 8 hr after BEA
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administration, this would not make much difference to 
the overall diuretic effect. The BEA induced diuresis is 
a result of an additive effect of this compound on renal 
concentration capacity, tubular transport, glomerular 
filtration rate and the BEA-induced RPN (Reineck et al. 
1980; Sabatini et al. 1984; Wilks et al. 1985). From this 
it can be deduced that, as the BEA - induced lesion 
progresses more tissue components / constituents, whose 
damage would result in further diuresis, will be damaged. 
It is, therefore, possible that even though some of the 
ducts of Bellini were closed, with passage of time after 
BEA treatment more urine will be available for removal 
from those ducts of Bellini which were not completely 
blocked. This could result in no overall change in urine 
excretion in spite of the closed ducts.
Up to now, blockage of collecting ducts as a 
pathogenesis of BEA-induced renal papillary necrosis has 
been discounted as soon as it is proposed by the same 
people suggesting it (see Murray et al. 1972). It was 
generally thought that the blockage would be brought 
about by disintegrated necrotic papilla tip. However, 
since many of the changes observed following BEA 
administration occur long before the loss of papilla tip, 
the blockage of collecting duct as a mechanism for BEA- 
induced lesion was thought to be highly unlikely. Data 
presented in this thesis shows that, following BEA 
administration the collecting ducts were blocked by
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swollen cells at the outlet of the ducts instead of by 
necrotic papilla tip. It was also observed that the ducts 
of Bellini were blocked only for a short period of time 
(between 3 and 8hr after treatment) and that the 
collecting ducts become widely dilated once the surface 
cells were exfoliated. It is thus possible that, if 
examination was not carried out at this critical point 
when the ducts were blocked, (3 to 8hr in the present 
study) this treatment-related change will not be 
observed. This would partly explain why this BEA-induced 
change has, so far, not been reported. Another reason why 
this change has not been reported before could be because 
closure of ducts of Bellini following BEA treatment was 
much more obvious under the scanning electron microscopy 
compared with light microscopy or transmission electron 
microscopy. Once this change was noted by SEM, it was 
then easier to confirm it by closer examination of the 
light microscopic and the transmission electron 
microscopic photographs. The use of light microscopy or 
transmission electron microscopy in isolation or in 
combination would have led to the conclusion of just 
swollen collecting duct cells, which is what has been 
reported in the literature so far. Only two other 
investigators studied experimentally-induced RPN using 
scanning electron microscopy (see below). The data 
currently available on this lesion was obtained using 
either light microscopy or transmission electron 
microscopy. Blockage of collecting ducts would explain
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the cortical tubule dilation often reported in 
experimentally-induced RPN and in analgesic abusers with 
RPN. The back pressure created in those collecting ducts 
whose outlets were blocked would result in the dilation 
of the tubules from which they originated. Furthermore, 
the cells of those collecting ducts whose outlets were 
blocked will absorb water from the stationary urine. This 
will lead to further swelling of cells and would 
contribute to the collapse of cells noted at later time 
points (plates 2-4) .
Two other investigators studied the changes following 
experimentally-induced RPN using scanning electron 
microscopic technique. Sabatini et al . (1981)
administered BEA (50mg, iv) to rats and observed (by 
scanning electron microscopy) at 24hr after dosing, no 
apparent change in the renal papilla. When the same 
authors examined identical samples by light microscopy, 
they noted gross changes which included:- engorgement of 
the vasa recta, denudation of the epithelium lining the 
collecting duct and necrosis of thin limb of Henle. This 
lack of detection of the early BEA - induced damage by 
SEM observed by Sabatini et al. could be because these 
investigators chose too long a time point (24hr). Plates 
1 - 6  show that the treatment-related changes observed 
with SEM following BEA administration occurred much 
earlier than 24hr after dosing. This sequence of changes 
(swelling of cells, partial/complete closure outlet of
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ducts, loss of microvilli, detachment of cells from cell 
boundaries, collapse of cells and exfoliation of covering 
epithelium) has occurred by about 9hr after treatment. 
After this time-point, the papilla appeared quite normal 
but bald.
Al-Ani (1980) also using the scanning .electron 
microscopic technique, studied the effect of long term 
(40wk) administration of acetylsalicylic acid (aspirin) 
on the mouse renal papilla. The surface features noted in 
the untreated mouse papilla, by this investigator, were 
similar to those reported here for the untreated rat 
papilla (plate 1) except that there was no mention of 
the presence of microvilli on the mouse papilla tip 
cell surface. The microvilli noted on the rat renal 
papilla in my studies were so numerous and distinct that 
it is unlikely that Al-Ani (1980) could have failed to 
notice them if they were also present on the mouse 
papilla. Possible reasons why Al - Ani (1980) failed to 
observe the presence of microvilli on the mouse papilla 
could be that, in the mouse papilla tip cells, microvilli 
were either absent or that they were mo-r-e sparsely 
distributed. tha-n--i-n—the-rat—papilla. Another explanation 
could be that the samples examined by Al-Ani (1980) were 
poorly fixed. Data reported in section 3.4 of this thesis 
showed that the immersion fixed rat renal papilla samples 
contained very much more reduced microvilli in than the 
perfused fixed samples. The immersion-fixed tissues also
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contained more debris than the perfused-fixed ones. This 
could mask the existence of microvilli. Al-Ani (1980) 
fixed his SEM samples by immersion fixation. Consistent 
with the data reported in this section following BEA 
administration, Al - Ani did observe swelling of cells, 
collapse of cells and necrosis of papilla tip following 
long-term (4 0wk) administration of acetylsalicylic acid 
to mouse. This supports the now widely held view that 
many changes noted following acute BEA administration are 
similar to those noted in analgesic abusers and in 
experimental analgesic - induced RPN.
The changes observed in the rat pelvis and ureter 
following BEA treatment were very similar and included 
appearance of : - holes (from 3 - 6hr), long microvilli 
(from 3hr onwards) and surface blebs (from 9hr after 
dose). These changes (which were generally different from 
those noted on the papilla tip) gradually disappeared so 
that, by Iweek after treatment, the tissue surface was 
very similar to those of the untreated animals 
(plates 12a, b) . One explanation for the difference 
between the changes observed in the papilla and those 
observed in the pelvis and ureter could be that BEA 
damaged the renal papilla so much that it never 
recovered, whereas the pelvis and the ureter were less 
damaged and recovered. The covering epithelium of the rat 
papilla is one to two cells thick whereas the covering 
epithelium of the ureter and pelvis is about four cells
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thick (see Newman and Hicks, 1981). Cellular exfoliation 
following BEA treatment probably resulted in shedding of 
"all" papilla tip cells so that not enough cells were 
available to take part in the tissue repair. In the case 
of the ureter and pelvis the fact that, following BEA 
damage, tissue repair rapidly occurred, suggests that 
some cells of this area or adjacent areas escaped damage 
/ exfoliation. The sequence of events noted on the 
papilla tip could therefore be changes leading from 
tissue damage to cell death whereas the sequence of 
events noted on the BEA -treated rat pelvis and ureter 
could be changes leading from tissue damage to recovery.
The microvilli noted on the pelvis and ureter following 
BEA treatment could be a result of exfoliation of the 
layer(s ) of the covering epithelium to reveal the 
immature cells underneath. Newman and Hicks (1981) showed 
that immature cells of the rat urinary bladder contain 
numerous surface microvilli. Cohen et al. (1988) also
showed that rat fetal urinary bladder, from day 15 of 
gestation, contain microvilli and occasional centrally 
located cilia. These microvilli and cilia disappeared 
when the fetal tissue became mature. It is possible that 
the microvilli found on the surface of BEA treated rat 
pelvis and ureter disappeared at Iweek after dose because 
the immature cells revealed following exfoliation of the 
surface cells, have matured by this time point.
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The appearance of surface blebs and microvilli could 
also be an indication of tissue damage. There are 
numerous reports of the appearance of surface blebs 
following chemical and ischaemic injury (see Bowen and 
Lockshin, 1981; Jewell et al. 1982; Farber, 1981). These 
changes are thought to be due to increased water content 
of the cell and alteration in micro tubules and 
microfilaments whose normal function is to maintain cell 
shape (see Bowen and Lockshin, 1981). There is data that 
shows that a change in intracellular calcium homeostasis 
is responsible for the alteration in microtubules and 
microfilaments (fig 6) . The distribution of calcium 
across the membrane is not in equilibrium. Under normal 
conditions free extracellular calcium levels are about 
two times higher than free intracellular calcium. 
Distribution of intracellular calcium is also uneven with 
about 90% localised in the mitochondria. Both calcium 
accumulation by the mitochondria and the uneven 
distribution of calcium between the intracellular and 
extracellular fluid is energy dependent and, as such, is 
susceptible to disruption by anything which is capable of 
causing a change in membrane permeability or capable of 
damaging the membrane-bound active transport mechanism or 
damaging the mitochondria. Cellular energy (ATP) is 
derived from oxidative phosphorylation in the 
mitochondria. Following mitochondrial damage, the 
cellular ATP level drops. This results in the arrest of 
the plasma membrane ion pump mechanisms. These include
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sodium - potassium pump, calcium pump and accumulation of 
calcium by the mitochondria. The ultimate result of this 
is flow of calcium, sodium and water into the cell and 
flow of potassium and magnesium out of the cell. Calcium 
concentration in the intracellular fluid will be 
increased by the flow of calcium out of the mitochondria 
and by the further displacement of calcium from the 
mitochondria by the increased intracellular sodium. 
Increased intracellular calcium concentration has been 
found in cell death due to a variety of causes including 
ischaemia, anoxia, chemicals, viruses, radiation and 
toxin (Farber, 1981; Bowen and Lockshin, 1981).
The appearance of microvilli could also be an 
indication of hyperplasia. Hyperplasia of the urothelium 
following BEA treatment has been reported (Mattingley et 
al. 1985; Bach and Bridges 1985) and data reported in 
section 3.5 of this thesis shows that hyperplastic cells 
have a profuse covering of microvilli. In the tissues 
that normally have very few microvilli such as the pelvis 
and ureter, these microvilli disappeared when the tissues 
were no longer hyperplastic.
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Fig 6 - A diagram illustrating a conceptualisation of the 
effects of injury on ion distribution and the cellular 
events which are triggered.
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3.2, Light microscopic study of 2-Bromoethanamine- 
Induced Renal Papillary Necrosis.
3.2.1, Treatment
18 male Wistar rats weighing between 200 and 250g 
were used. The animals were divided into 2 groups of 4 
control and 14 experimental rats. The control rats were 
untreated. The experimental rats each received an ip dose 
of BEA (lOOmg/kg) . The treated rats were killed at the 
following time points; Ihr (2 rats), 2hr (4rats), 4hr 
(Srats), 6hr (3rats), and 8hr (2 rats). The control rats 
were killed at time points spread out over the 
experimental period. The kidneys were intravascularly 
perfused with 2% Karnovsky's fixative (section 4.31). The 
osmolality of the fixative was adjusted to match that of 
each rat's bladder urine. After perfusion the kidneys 
were dissected out and 2 sections about 1 - 2mm thick cut 
from them. The aim was to have a piece of the papilla tip 
present in each cut section. The samples were further 
fixed by immersion in the same batch of fixative for 12 - 
15hr. The papilla tip was dissected out, washed for 6hr 
in 3 changes of phosphate buffer (pH 7.4), osmicated, 
dehydrated, infiltrated and embedded in Spurr resin 
(section 2.3). The samples were polymerised in an oven at 
70° C for 12hr. Thick sections (5-7fi) were cut, stained 
with toluidine blue and examined under the light 
microscope.
114
3.2.2, Results 
3.2.2a, Osmolality
The osmolality was already reduced at Ihr after BEA 
administration (table 2, fig 7) and continued to decrease 
with time throughout the study. The rate of decrease 
slowed down after 4hr.
3.2.2b, Ultrastructural Changes
The cells of the normal rat renal papilla under the 
light microscope consisted of collecting ducts with 
large lumen and cuboidal shaped cells, thin limb of Henle 
with squamous shaped cells, capillaries with few blood 
cells and interstitial cells with large nucleus and some 
lipid droplets (plates 13a, b).
At Ihr after BEA treatment, the collecting duct 
cells were swollen, distorted and some of their nuclei 
were displaced from the basement membrane. Interstitial 
cells were vacuolated and/or had lost their nucleus. Some 
of the epithelial cells covering the papilla were also 
vacuolated. No obvious change was noted in the 
capillaries and thin limbs of Henle at this time point 
(plates 14a, b).
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At 2hr after BEA treatment there was increased 
interstitial cell damage, exfoliation of covering 
epithelia, nuclear pyknosis in the cells of the 
exfoliating covering epithelia and in some collecting 
duct cells, increased swelling of collecting duct cells, 
a change in shape of collecting duct cells from cuboidal 
to pseudo-columnar and an increase in the displacement of 
collecting duct nucleus from basement membrane (plates 
15a, b).
At 4hr after BEA administration, the collecting duct 
cells were grossly distorted and swollen, interstitial 
cells were reduced in number and the capillaries were 
engorged with blood (plates 16) At 6hr after BEA 
treatment the collecting duct cells were so swollen that 
in many cases the lumen was either completely closed or 
reduced to a narrow slit. Pyknotic nuclei were found in 
collecting ducts, the capillaries and occasionally in the 
thin limb of Henle. There was increased capillary 
congestion. Some capillaries and some collecting duct 
cells were vacuolated and/or had lost their nucleus. 
Interstitial cells were very much reduced in number. Thin 
limbs continued to be the least damaged (plates 17a, b) .
At 8hr after BEA treatment there was complete 
exfoliation of collecting duct cells, thrombus formation 
in the capillaries and complete disappearance of 
interstitial cells. Some intact thin limbs could still be 
seen at this time point (plates 18a, b).
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Table 2, Change In Osmolality With Time After BEA
Administration
Group Osmolality Mean osmolality
Control 1550
(n = 4) 1392 1499
1611 
1411
BEA (Ihr) 780 74 0
700
BEA (2hr) 586
492 578
665
570
BEA (4hr) 4 65
(n = 3) 479 472
472
BEA (6hr) 4 62
(n = 3) 463 469
479 . .
BEA (8hr) 408 . 414
(n = 2) 420
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Plate 13a - Renal papilla tip of a control (untreated) 
rat: note the wide ’ lumen of the collecting ducts (cd), 
the very few blood cells in the capillaries (c), the 
densely populated interstitial cells (ic) and thin limbs 
(TL) with squamous shaped cells. (Toluidine blue x200).
Plate 13b - High magnification of plate 13a - renal 
..papilla tip of a control (untreated) rat : note the
cuboidal shaped collecting duct cells (cd), the squamous 
shaped capillary (c) and thin limb cells (TL) and the 
.interstitial cells (ic) with their large nucleus.
(Toluidine blue x 4 00) .
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Plate 14a - Renal papilla tip of a rat Ihr after BEA 
treatment: note the swollen collecting duct cells (cd) 
and some vacuolated interstitial cells,. (Toluidine blue 
x200).
Plate 14b - High magnification of plate 14a - renal 
papilla tip of a rat Ihr after BEA treatment: note the 
swollen collecting duct cells (cd), displacement of 
collecting duct cell's nucleus from basement membrane, 
cytoplasmic expansion in interstitial cells (ic) 
(Toluidine blue x400).
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Plate 15a - Renal papilla tip of a rat 2hr after BEA 
treatment: note exfoliation of covering epithelium 
(arrows), swelling plus change in shape of collecting 
duct cells (cd), displacement of collecting duct nucleus 
from the basement membrane, nuclear pyknosis in the 
exfoliating covering epithelium and in the collecting 
duct cells (Toluidine blue x200).
Plate 15b - High magnification of plate 15a - renal 
papilla tip of a rat 2hr after BEA treatment : note
swelling of collecting duct cells (cd), displacement of 
collecting duct cell's nucleus from basement membrane, 
loss of staining intensity of interstitial cell's (ic) 
nucleus, disintegration of interstitial cells (arrows), 
and vacuolation of interstitial cells. (Toluidine blue 
x400) .
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Plate 16 - Renal papilla tip of a rat 4hr after BEA 
treatment: note capillary (c) congestion, swelling of 
collecting duct cells (cd), closure of duct of Bellini 
(*) , change in shape of collecting duct cells to 
pseudocollumnar, disintegration of some interstitial 
cells (arrow head) and change in papilla tip covering 
epithelium to pseudocollumnar (arrow). (Toluidine blue
X20JD) .
o8'^  1 ïV Q%, • . '.
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Plate 17a - Renal papilla tip of a rat 6hr after BEA 
treatment: note swelling of collecting duct cells (cd), 
gross narrowing of collecting duct lumen, vacuolation of 
collecting duct cells, displacement of collecting duct 
nucleus from basement membrane, capillary (c) congestion, 
vacuolation/loss of capillary endothelial cells and 
vacuolation/disintegration of interstitial cells (ic) , 
cellular exfoliation in the ducts of Bellini and 
covering epithelium (arrow heads), some nuclear pyknosis 
in thin limbs (TL) ( toluidine blue x200).
Plate 17b - High magnification of plate 17a - renal 
papilla tip of a rat 6hr after BEA treatment: note
swelling of collecting duct cells (cd), vacuolation of 
collecting duct cells, loss of some collecting duct 
nucleus, displacement of collecting duct nucleus from 
basement membrane, vacoulation/loss of capillary (c) 
endothelial cells, capillary congestion, vacoulation of 
some thin limbs cells and disintegration of interstitial 
cells (ic) (toluidine blue x400).
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Plate 18a - Renal papilla tip of a rat 8hr after BEA'^  
treatment: note complete exfoliation of collecting duct 
(cd) cells, congestion of capillaries (c) with blood, 
disappearance of interstitial cells and some still 
intact thin limbs. (Toluidine blue x200)
Plate 18b - High magnification of plate 18a - renal 
papilla tip of a rat 8hr after BEA treatment: note the 
absence of interstitial cells and collecting duct cells, 
congestion of capillaries with blood and a still 
distinguishable thin limbs. (Toluidine blue x400).
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3.2.3, Discussion
The data presented in this section show that BEA 
treatment resulted in the swelling of collecting duct 
cells with complete or partial closure of the collecting 
duct lumen, nuclear pyknosis in collecting duct cells, 
covering epithelia, capillaries and thin limbs, 
disintegration of interstitial cells and exfoliation of 
cells of collecting ducts and those of covering 
epithelia. The thin limbs of Henle were the last to show 
damage and were still evident after the collecting duct 
cells and cells of the capillaries have been exfoliated 
(plates 18a & b) . These changes are consistent with 
those reported by other investigators, following BEA 
treatment (see Bach and Bridges 1985), analgesic-induced 
RPN (Holland, 1978; Henry at al. 1983; Henry and Tange, 
1983, 1987) and in human analgesic abusers ( Gloor, 1978 ; 
Burry, 1978). However, the changes appeared earlier in my 
study than those reported by other investigators and the 
sequence of their appearance was also, in some cases, 
different from those reported by other investigators. 
While the data reported here is in agreement with those 
of others, in that the earliest change appeared in the 
interstitial cells, it also shows that the collecting 
ducts were showing some change (swelling) at this time 
point (Ihr). Many investigators reported that the 
collecting ducts were the last to show damage (Murray et
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al. 1972; Molland 1978; Gobe' and Axelson, 1982, Burrel 
et al. 1990). The sequence of appearance of changes in 
this study were:- interstitial cells /collecting ducts, 
capillaries and then thin limbs of Henle (plates 13 - 
18). The thin limbs were clearly very much evident long 
after the collecting duct cells had been exfoliated 
(plates 18a, b). This observation is supported by the 
transmission electron microscopic data reported in the 
next section of this thesis. Murray et al. (1972)
did report that the swelling of the collecting ducts was 
one of the earliest changes noted following BEA treatment 
but went on to say that the collecting ducts were the 
last to show damage. Perhaps damage in this case meant 
disintegration.
The fact that the collecting duct cells were so 
swollen that in many cases the collecting duct lumen was 
blocked (plates 16 and 17) has not been reported before. 
One of the features of RPN is that cortical change 
(tubular dilation) is secondary to papillary necrosis 
(Gault et al. 1971; Molland, 1978; Bach et al. 1983; Bach 
and Bridges 1985). This cortical change could have arisen 
as a result of back pressure created in those collecting 
ducts whose lumen were blocked. Murray et al. (1972) 
suggested obstruction of collecting ducts as a possible 
cause of cortical dilation following BEA-induced RPN but 
concluded that this was unlikely since the cortical 
changes noted were not as diffused as would be expected
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if the ducts were blocked. They (Murray et al . 1972)
reasoned that, as all nephrons have a final common 
pathway through the ducts of Bellini, blockage of these 
ducts would lead to very diffused cortical dilation. 
This argument will hold if all the ducts of Bellini were 
blocked. However, the data presented in this section and 
in section 3.1 show that, while some of the ducts were 
completely blocked, others were only partially closed. 
The effect of back pressure will thus vary from one area 
to another depending on the degree of blockage of the 
duct of Bellini leading to it.
The loss of interstitial cells and swelling of 
collecting ducts suggests that one of the mechanisms of 
BEA-induced RPN could be vasoconstriction (fig.8). Loss 
of interstitial cells and collecting duct cells could 
lead to loss of medullary prostaglandins whose sites of 
synthesis are located in the interstitial cells and 
collecting ducts (see Mandai and B o h m a n , ,1980). 
Prostaglandins are vasodilators which play a modulatory 
role in the body by damping down the vasoconstricting 
effects of endogenous hormones and chemical messengers 
such as angiotensin and the catecholamines (see Brenner 
1986). Loss of these agents (PGS) will therefore lead to 
"unrestrained" vasoconstriction. The engorgement of the 
capillaries with blood (noted in this study from 4hr) 
could be an indication of the presence of 
vasoconstriction. Furthermore, the swollen collecting
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duct cells would exert pressure on neighbouring blood 
vessels leading to constriction or narrowing of these 
capillaries and then medullary ischaemia. Most of the 
blood cells were found within their capillary enclosure, 
no blood cells were found in the interstitium thus 
suggesting an absence of haemorrhage following BEA- 
induced damage. Blood cells were however, found in the 
ducts of Bellini. This is to be expected since haematuria 
is a common characteristic of RPN.
Vasoconstriction leading to medullary ischaemia has 
been proposed by other investigators as a mechanism for 
BEA-induced RPN (Hill et al. 1972; Wyllie et al. 1972), 
analgesic-induced RPN (Molland, 1978) and RPN caused by 
analgesic abuse (see Bach and Bridges 1985). Wyllie et 
a l . (1972), after observing that a vasodilator drug
(reserpine) protected against BEA-induced RPN, concluded 
that medullary ischaemia induced by vasoconstriction was 
probably responsible for BEA-induced RPN. Cuttino et 
al. (1981) studied the mechanism of BEA-induced RPN by 
microvascular injection studies and found reduced 
perfusion of the vasa recta and postglomerular capillary 
bed by 2hr after injection. This progressed to complete 
obstruction of the vasa recta by 24hr. They (Cuttino et 
al. 1981) concluded that vasoconstriction is a primary 
effect of BEA rather than thrombotic occlusion. Thrombus 
formation also appeared late in my study and might be 
secondary to vasoconstriction brought about by swelling
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of collecting duct cells and loss of interstitial cells.
To test the hypothesis that vasoconstriction plays a 
significant role in the pathogenesis of BEA - induced 
RPN, Solez et al. (1974) measured medullary blood flow
after the administration of BEA (50mg iv) to female 
Holtzman rats. They found that the medullary blood flow 
was normal at 0.5 and Ihr after treatment and that the 
blood flow actually increased at 6hr after treatment. 
There was no increase in prostaglandin A and E which 
would be expected to increase if there was ischaemia. 
They (Solez et al . 1972) concluded that this argues
against ischaemia as a cause of BEA-induced papillary 
necrosis and supports the thesis of direct toxic injury. 
Solez et al. (1972) also confirmed the result of Wyllie
et a l . (1972) that reserpine protected against BEA-
induced RPN but they disagreed with the suggestion of 
Wyllie et al. (1972) that the effect of reserpine is due
to its vasodilator action and suggested that it could be 
due to its ability to prevent cellular storage of BEA. 
Reserpine interferes with the cellular storage of 
catecholamines by acting on "amine carrier" involved in 
the transport across membranes of storage granules. It is 
possible that the cellular content of BEA is affected in 
the same way as that of catecholamines because there is 
structural similarity between catecholamines and the ring 
form of BEA (see below).
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Henry and Tange (1983, 1987 ) also disagreed with the
theory of medullary ischaemia as a mechanism for the 
pathogenesis of RPN.. These investigators administered 
aspirin and paracetamol to Gunn rats and observed damage 
to the interstitial cells, swelling and vacuolation of 
the epithelial cells of collecting ducts and loop of 
Henle, detachment of cells from basement membrane, 
platelet thrombi formation in capillaries and extensive 
necrosis of large a part of the papilla. The damage to 
the interstitial cells was followed by damage to 
collecting ducts and tubules and then damage to the 
capillaries. They concluded that as the damage to
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capillaries was late in onset, that RPN was probably due 
to a direct toxic effect rather than ischaemia. The 
sequence of changes observed by Henry and Tange is 
similar to those reported in this w o r k . The only 
difference is that, while my results are in agreement 
with those of Henry and Tange in that damage to the 
interstitial cells and collecting ducts appeared before 
damage to the capillaries, damage to thin limbs of Henle 
appeared after damage to capillaries in my study. I 
disagree with the conclusion of Henry and Tange that the 
late appearance of capillary damage probably suggests 
that cytotoxicity, rather than ischaemia, is the 
pathogenesis of analgesic-induced RPN. I think that the 
early stages of BEA-induced RPN and probably also 
analgesic-induced RPN are due to cytotoxicty. However, 
the initial cytotoxic damage will be followed by a 
secondary damage of medullary ischaemia. While there is, 
as yet, no evidence that BEA is concentrated in the 
papilla there is definite evidence that a concentration 
gradient of some analgesics exists in the papilla (see 
chapter 1). Furthermore, some of the early damage 
(swelling of cells, damage to collecting ducts and 
interstitial cells) noted in my study and those of Henry 
and Tange (1983, 1987) would give rise to medullary
ischaemia (see section 3.3, fig. 8).
The Possible contribution of cytotoxicity 
resulting from hyperconcentration of BEA in the papilla
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to the pathogenesis of BEA-induced RPN was not tested in 
this study. However, data presented in this thesis show 
that much of the BEA-induced damage occurred long before 
the concentration mechanism was severely damaged. This 
leaves open the possible involvement of cytotoxicity at 
the early stages of BEA-induced lesion. Sabatini (1985) 
showed that, in the toad and turtle bladder exposure to 
BEA resulted in damage to the membrane-bound sodium- 
potassium pump. This damage was evident as early as lOmin 
after exposure. Concentration gradient was still 
moderately intact in my study and in that reported by 
Wilks et ai. (1985) at 3-4hr after BEA treatment. BEA 
produces an apex (point of maximum concentration) limited 
RPN at low dose and the amount of renal papilla damaged 
increases from the papilla tip towards the cortex as the 
dose is increased (Bach et al. 1983 ; Bach and Bridges, 
1985). The congenital diabetes inspidus in Brattleboro 
rats protects them from BEA- induced RPN. This protection 
is lost following prior antidiuretic hormone 
administration (Sabatini et al. 1981). The incidence of 
BEA-induced RPN could be lowered by diuresis and 
increased by antidiuresis (Fuwa and Waugh, 1968) and 
dehydration has been shown to increase the incidence of 
both analgesic nephropathy and experimental papillary 
necrosis (see chapter 1). These findings show that 
hyperconcentration, as a result of the counter-current 
concentration mechanism, could play a part in BEA- and 
analgesic- induced RPN.
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3.3/ Transmission Electron Microscopic Study Of 2- 
Bromoethanamine Induced Renal Papillary Necrosis.
3.3.1 Treatment
Male Wistar rats weighing 200 - 250g each were 
divided into 2 groups. The experimental rats received an 
ip dose of BEA (lOOmg/kg) dissolved in distilled water. 
The control group (4 rats) were untreated. The treated 
rats were killed at the following time points; 2hr (4 
rats ), 4hr (4 rats), 6hr (4 rats) and 8hr (2 rats). The 
control rats were killed at time points spread out over 
the experimental period. The kidneys were intravascularly 
perfused with 2% Karnovsky's fixative (section 2.3, this 
thesis). The osmolality of the fixative was adjusted to 
match that of each rat bladder urine. After perfusion, 2 
sections about l-2mm thick were cut and further fixed in 
the same batch of fixative for 12hr. The aim was to have 
a piece of the papilla tip present in each cut section. 
The samples were washed in phosphate buffer pH 7.4, 
osmicated, dehydrated, embedded in Spurr resin and 
polymerised by placement in an oven at 70°C for 12hr. 
Thin sections (about 0.5jit) were cut, mounted on copper 
grids, doubly stained with uranyl acetate and lead 
citrate arid examined under the transmission electron 
microscope.
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3.3.2 Result
The cells of normal rat renal papilla under the 
transmission electron microscope, consisted of 
interstitial cells with numerous lipid droplets, 
collecting ducts with large lumen and tight junctions and 
capillaries with few blood cells (plates 19a, b & c). The 
changes noted in these structures following BEA treatment 
were as follows
At 2hr after BEA treatment interstitial cells showed 
cytoplasmic expansion and vacuolation,swelling of 
mitochondria and loss of cytoplasmic organelles. The 
capillaries were congested and contained deformed red 
cells. The collecting ducts were swollen and there was 
loosening of the tight intercellular junctions (plates 
20a, b & c).
At 4hr after BEA treatment the interstitial cells 
showed cytoplasmic expansion and vacuolation, swollen 
mitochondria, less densely stained or two toned lipid 
droplets, chromatin clumping and loss of cytoplasmic 
organelles. The capillaries were vacuolated with nuclear 
karyorrhexis. The collecting ducts were swollen with 
cytoplasmic clearing and displacement of nucleus from 
basement membrane. No obvious change was noted in the 
thin limbs at this time point (plates 21a, b).
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At 6hr after BEA administration, interstitial cells 
showed gross vacuolation, very pale- stained lipid 
droplets, swollen mitochondria, loss of cytoplasmic 
organelles and rupture of plasma membrane. The 
capillaries were vacuolated, and were lined with 
platelets. The collecting ducts were swollen, vacuolated 
and there was separation of collecting duct cells from 
intercellular junctions and displacement of the 
collecting duct nucleus from basement membrane (plate 
22a, b).
At 8hr after BEA administration, interstitial cells 
had completely disintegrated. The capillaries were 
profusely lined with platelets and there was vacuolation 
or fragmentation of collecting duct cells. Some thin 
limbs of Henle were still basically intact (plates 23a, b 
& c) .
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Plate 19a - Interstitial cells of a control (untreated) 
rat renal papilla tip: note the large nucleus (n), the 
densely stained lipid droplets (L) and the numerous 
cytoplasmic organelles. x4600
Plate 19b - renal papilla tip of a control (untreated) 
rat: note interstitial cells (ic) with large nucleus and 
the lack of blood cells in the capillaries (c) . xlVOO
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Plate 19c - Renal papilla tip of a control (untreated)
rat: note collecting ducts (cd) with wide lumen,
capillaries (c) and thin limbs of Henle (TL). xl700
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Plate 20a- Interstitial cell of a rat 2hr after BEA 
treatment: note cytoplasmic expansion, swollen/vacuolated 
mitochondria (m) and cytoplasmic vacuolation (*). x4 600
Plate 20b - Renal papilla tip of a rat 2hr after BEA 
treatment: note vacuolation of interstitial cells (ic) 
and congested capillaries (c) with deformed red blood 
cells and a normal thin limb (TL). xl700
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Plate 20c - Renal papilla tip of a rat 2hr after BEA 
treatment: note swollen collecting duct (cd) cells, 
normal looking thin limbs (TL) and vacuolated 
interstitial cells (ic). xlVOO
Plate 20d - Renal papilla tip of a rat 2hr BEA treatment: 
note clearing of capillary (c) endothelial cell 
cytoplasm, chromatin magination in the capillary nucleus 
and congestion of capillaries with blood. x2800.
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Plate 21a - Interstitial cell of a rat 4hr after BEA 
treatment: note cytoplasmic expansion, less densely
stained/two toned lipid droplets ( 1 ) , swollen 
mitochondria (m) and much reduced cytoplasmic organelles. 
X4 600
Plate 21b - Renal papilla tip of a rat 4hr after BEA 
treatment: note gross vacuolated interstitial cells (ic), 
and capillary (c) with deformed red cells. xl7 00
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Plate 22a - Interstitial cell of a rat 6hr after BEA 
treatment: note pale stained lipid droplets (L), nuclear 
dissolution and blebing of interstitial cell (ic) nuclear 
membrane. x4600
Plate 2 2 b- Renal papilla of a rat 6hr after BEA 
treatment: note vacuolation of capillary (c) endothelial 
cell and collecting ducts (cd) cells , blebing of 
interstitial cell (ic) nuclear membrane, and a normal 
thin limb (TL)
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Plate 22c - Renal papilla tip of a rat 6hr after BEA 
treatment: note vacuolation of collecting duct cells (cd) 
and of capillaries (c), separation of collecting duct 
cells from cellulàr junction (arrow head), displacement 
of collecting duct cells nucleus from basement membrane 
and the presence of platelet (p) capillary wall. xl700
22d - Renal papilla of a rat 6hr after BEA treatment: 
note exposure of capillary basement (arrow head) and 
platelet migration to capillary (c). x2800.
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Plate 23a - Renal papilla tip of a rat 8hr after BEA 
treatment: note gross lining of capillary walls with 
platelet (p), exposure of capillary basement membrane 
(arrow head), complete disintegration of interstitial 
cells. X 2 . 8 0 0
Plate 23b - Renal papilla tip of a rat 8hr after BEA 
treatment note gross lining platelet capillary walls, a 
capillary with an "intact" endothelial cell a normal 
looking thin limb and some disintegrated interstitial 
cells. X1700
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3.3.3, Discussion
Following BEA treatment, interstitial cells showed 
cytoplasmic expansion, vacuolation, mitochondrial 
swelling followed by disintegration, loss of staining 
intensity of lipid droplets, loss of cytoplasmic 
organelles and disintegration of interstitial cells. The 
capillaries contained occasional white blood cells and 
some platelets from 4hr and were profusely lined with 
platelets by 6hr after dose. The collecting ducts were 
swollen as early as 2hr after treatment and showed 
cytoplasmic clearing, displacement of nucleus from 
basement membrane and separation of cells from 
intercellular junctions at later time points. Gross 
mitochondrial damage was noted as early as 2hr after 
treatment. The thin limbs of Henle were the least 
affected and some still basically intact thin limbs were 
noted at 8hr when interstitial cells had completely 
disappeared and the capillaries and collecting ducts were 
grossly damaged (plates 23a & b) . These changes are 
consistent with those reported in the light microscopic 
section of this thesis (section 3.2). These changes
are also consistent with those reported by Abraham 
(1970) who gave a mixture of analgesics (aspirin, 
phenacetin and caffeine) to rats and noted accumulation 
of red cells and platelets in the vasa recta, damage to 
the lining of collecting ducts but no change in the thin
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limbs. He suggested that medullary ischaemia and possibly 
a direct toxic effect of the drug on collecting duct 
cells was responsible for analgesic induced RPN in rat 
and man.
There are some discrepancies between the sequence of 
changes reported by Hill et al. (1972) after 
administration of BEA to rats and those reported in my 
experiments. Hill et al. (1972) found that the thin 
limbs and the vasa recta suffered the earliest damage, 
with the interstitial cells and collecting ducts being 
the most resistant. They concluded that their evidence 
was limited and that they were unable to choose between 
cytotoxicity as a result of hyperconcentration of BEA at 
the medulla, and medullary ischaemia as a mechanism for 
BEA-induced RPN. I cannot offer any explanation for this 
difference in the two results. The only differences 
between the Hill et al. (1972) experiments and mine were 
that they used female Holzman rats whereas I used male 
Wistar rats, they administered the drug by iv injection 
and I administered it by ip injection. There are reports 
that the route of administration could affect the 
severity of damage and that some strains of rats are more 
resistant or sensitive to BEA-induced RPN (see Bach and 
Bridges 1985) . I have not seen any report stating that 
route of administration or strain can effect the sequence 
of appearance of BEA-induced damage.
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Ljunqvist et al. (1967) and Lee et al. (1967) showed 
that after injection of human serum to rats, necrosis of 
the endothelium of the vasa recta was complete between 
3 0min and Ihr. Numerous platelets were adherent to the 
capillary wall forming occasional thrombi. With BEA, the 
time course of appearance of platelets was more 
protracted, the first adherent platelets did not appear 
until 4hr in the studies reported in this thesis and not 
until 12hr in those reported by other investigators (Hill 
et al. 1972). Furthermore, in serum-induced RPN 
epithelial alterations seem to occur after, and be 
consequent to, the vascular phenomena. Both these 
observations suggest that the serum-induced RPN and the 
BEA model could have different pathogenic mechanisms.
Many mechanisms have been proposed for BEA-induced 
RPN and investigators have tended to favour one or other 
of these mechanisms depending on where they think the 
damage started or was more severe. For example, the 
supporters of cytotoxicity due to hyperconcentration of 
BEA at the papilla argue that BEA-induced damage always 
starts at the papilla tip (point of maximum 
concentration), is reduced or prevented by diuresis and 
diabetes insipidus and is increased by dehydration or 
prior administration of ADH to rats with congenital 
diabetes insipidus and that all these findings support 
hyperconcentration as a mechanism for BEA- induced RPN. 
The supporters of vasoconstriction leading to medullary
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ischaemia, on the other hand, argue that interstitial 
cells (site of prostaglandin synthesis) are damaged early 
in the course of BEA-induced RPN, that reserpine (a 
vasodilator) protects against BEA-induced damage and that 
this evidence support medullary ischaemia rather than 
hyperconcentration as possible mechanism of BEA induced 
RPN.
I think that the above two mechanisms and possibly a 
few others (chapter 1, fig. 8) could be involved in BEA- 
induced RPN. The BEA-induced damage is probably a result 
of an additive effect of several mechanisms running 
parallel or in sequence with the dominant mechanism 
observed by an investigator depending on technique(s) 
used to identify damage, strain or species of animal used 
and time points and dosage chosen (see below).
Light microscopic, scanning electron microscopic and 
transmission electron microscopic techniques provide 
different but complementary pictures on a given condition 
(sections 3.1, 3.2 & 3.3, this thesis). Isolated use of 
any of these techniques could lead to incomplete or 
erroneous conclusions. The time point is crucial in 
identifying the mechanism of BEA-induced toxicity. 
Sabatini et al. (1982), for example, chose 24hr as a 
first time point after BEA administration. They concluded 
that gross changes were noted with light microscopy at 
24hr but that with the scanning electron microscopy no
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obvious change was evident at this time point. Data 
presented in section 3.1 show that, with scanning 
electron microscopy, changes were noted much earlier than 
with light or transmission electron microscopy. These 
changes culminated in complete exfoliation of the 
papillary covering epithelia by 8 - 12hr after dose. 
After this time point, the papilla could appear quite 
normal (plates 5a, 5b, 6a, 6b). Strain and dosage are
also important. The Wistar rats used in this study 
appeared more sensitive to BEA than the female Holtzman 
rats used by Murray et al. (1972) and Hill et al. (1972). 
Brattleboro rats are resistant to BEA (Sabatini et al. 
1981) whereas Gunn rats are very sensitive to BEA (Henry 
and Tange, 1983, 1987). The rabbit is more sensitive to 
BEA than Wistar rats or Holzman rats (Oka, 1913; Calton 
and Engelhardt, 1989) whereas the Swiss ICR mice are more 
resistant to BEA than Wistar rats or Holzman rats (Wolf 
and Calton, 1990). BEA produces an apex-limited RPN at 
low dose . The lesion then increases from the tip of the 
papilla towards the cortex as the dose is increased (see 
Bach and Bridges, 1985). An apex-limited lesion could 
lead to the conclusion that hyperconcentration is the 
only mechanism involved in BEA-induced RPN whereas a 
lesion which progressed to its full expression would 
allow more time for other contributing secondary 
mechanisms to occur.
The data presented so far shows that the
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mitochondria, interstitial cells and collecting ducts were 
damaged very early in the course of BEA-induced RPN (from 
l-2hr). At this time point, the concentration mechanism 
was still very much intact and no obvious damage was 
noted in the capillaries or thin limbs of Henle (section 
3.2, 3.3, this thesis). Data reported in section 3.2 show 
an intermediate loss in concentration gradient between 1 
and 2hr after BEA treatment. Wilks et al. (1986) found 
that the urine osmolality only started to decrease from 
3hr after BEA treatment. It is thus possible that the 
changes noted up to about 2hr after BEA could be due to 
cytotoxicity as a result of hyperconcentration of BEA at 
the papilla. A possible contribution of cytotoxicity to 
BEA-induced lesion is supported by data reported by 
Thielemann et al. (1990). These investigators showed 
that prior administration of compounds that increase 
renal glutathione levels (glutamine + glycine + cystine 
or N-acetyl-L-cystine) protected the kidney from BEA- 
induced papillary necrosis. One of the primary functions 
of glutathione in the body is to prevent tissue damage by 
reacting with reactive intermediates (electrophiles and 
free radicals) which otherwise would cause tissue damage 
by binding covalently to critical cellular components 
such as proteins, RNA and DNA. In aqueous solution BEA 
has been shown to yield ethylenamonium ion which is a 
strong electrophile and, as such, could decrease the 
intercellular glutathione by binding with them. This 
would leave the tissue more susceptible to damage by free
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ethylenamonium ion and other reactive intermediates that 
are also normally "neutralised” by combining with 
glutathione. Also, as mentioned earlier, the fact that 
BEA-induced damage "always" start at the papilla tip 
(point of maximum concentration) and then moves towards 
the cortex as the dose is increased provides evidence for 
the possible involvement of cytotoxicity in BEA-induced 
lesion. Burrell at al (1990), however, disagreed with 
this view (section 3.2) after finding, following 
analgesic administration, a lesion which started in the 
mid-papillary region instead of at the papilla tip.
Damage to the mitochondria (the principal energy- 
producing organelle of the cell) would result in a fall 
in ATP levels and thence to a slowing down or cessation 
of the sodium-potassium pump. This would lead to a change 
in intercellular ion homeostasis, the ultimate result of 
which is increased cellular calcium, sodium and water. 
This could contribute to the edema noted in the 
collecting ducts cells and the cells of the covering 
epithelia of BEA treated rats. Direct effect of BEA on 
cell membrane leading to a change in membrane 
permeability could also lead to edema. Sabatini (1985) 
has shown that, in the turtle and toad bladder exposure 
to BEA does change membrane permeability by inhibiting 
the energy-dependent membrane-bound ion pump. As pointed 
out earlier, swollen collecting duct cells would exert 
pressure on neighbouring capillaries leading to
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narrowing/constriction of the capillary walls. This 
vasoconstriction will be potentiated by loss of 
interstitial cell prostaglandins (see Mandai and Bohman, 
1980) . Interstitial cells and collecting duct cells are 
sites of prostaglandin synthesis. The loss or reduction 
in the number of these cells would, therefore, lead to a 
reduction or loss of medullary prostaglandins. No obvious 
change in number or size of interstitial cell lipid 
droplets were noted in this study. Lipid droplets did, 
however, become lighter in colour at later time points 
(plates 12a & 22a). This change in colour could represent 
a change in the constitution of these droplets as a 
result of having lost some of their content or it could 
be a result of dilution of these lipids by some lipid 
soluble substance in the cell cytoplasm. The data 
presented in sections 3.1, 3.2 & 3.3 thus show that the 
primary effect produced by BEA could be cytotoxicity as a 
result of hyperconcentration of this compound at the 
papilla. This is followed by secondary damage of 
medullary ischaemia (fig. 8) brought about by the 
vasoconstriction as a result of:- (1) loss of precursors 
of prostaglandins in the interstitial cells and 
collecting duct cells (2) the pressure exerted on 
neighbouring capillaries by swollen collecting duct cells 
and (3) damage to platelets (these were found in large 
number in blood vessels of BEA treated rats from 4hr 
onwards) leading to release of vasoactive substances.
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Fig 8 - Possible Mechanisms of BEA induced RPN.
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3.4, Scanning Electron Microscopic Study Of Normal Rat 
Kidney Tissues Fixed By Immersion Fixation Or 
Retrograde Perfuse Fixation
This experiment was performed to check if retrograde 
perfusion, which has so far been used in this project, 
offers enough advantage over the much simpler immersion 
fixation to justify its further use in the remainder of 
this project.
3.4.1, Animals And Treatment
Six male Wistar rats weighing between 200g and 250g 
were divided into two groups. All rats were anaesthetised 
with Sagatal (60mg/kg)^ The kidneys of rats in group 1 
were dissected out and the poles were cut off prior to 
immersion fixation in 2% phosphate buffered 
glutaraldehyde (pH 7.3 - 7.4). The kidneys of rats in 
group 2 were retrograde perfused (section 2.4) with 
fixative from the same batch as was used for immersion 
fixation of rats in group 1. After perfusion the poles of 
the kidneys were cut off and the samples further fixed in 
the same batch of fixative. At the end of 48hr fixation, 
all kidneys (immersion or retrograde perfusion fixed) 
were prepared for SEM analysis (section 2.3).
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3.4.2, Results
Visual examination of the kidney samples showed that 
the immersion-fixed kidneys ureters were twisted and 
possibly contracted. The retrograde-perfused rat ureters 
had a hollow rounded appearance, whereas the immersion- 
fixed ones had collapsed or flattened appearance (plate 
24). This made it virtually impossible to dissect the 
immersion fixed ureters in preparation for SEM 
examination of the inner surface.
Under the SEM, the retrograde-perfused rat papilla 
tip cells were polygonal shaped with raised cell 
boundaries and numerous microvilli (plate 25) . In
contrast, the papilla tip cells of the immersion fixed 
rat kidney were sunken with very little microvilli and 
clumps of debris (plate 26) . The surfaces of both 
retrograde-perfused pelvis and ureter were flat with 
numerous microridged patterns (plates 27 & 29) . The 
immersion-fixed rat pelvis and ureter, in contrast, had 
protruding appearance, coarse microridges and numerous 
vertical and horizontal grooves (plates 28 & 30).
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Plate 24 - Immersion vs. Retrograde Perfusion of the rat 
Kidney
IMMERSION FIXED
RETROGRADE PERFUSION FIXED
Note that the immersion fixed kidney ureters are twisted 
and contracted. Also the retrograde perfused ureters had 
a hallow rounded appearance whereas the immersion fixed 
ones had collapsed/ flattened appearance.
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Plate 25 - Retrograde perfused fixed rat renal papilla; 
note the polygonal shaped cells with raised cell 
boundaries and numerous short stubby microvilli. x4000 
(glutaraldehyde and osmium fixed)
Plate 2 6 - Immersion fixed rat renal papilla; note the 
almost complete absence of microvilli, the pronounced 
concavity of cellular surface and the presence of clumps 
of debris on tissue surface. x4000 (glutaraldehyde and 
osmium fixed).
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Plate 27 - Retrograde perfuse fixed rat ureter; note the 
flattened appearance of tissue surface and the numerous 
"fine" microridged pattern. x4000 (glutaraldehyde and 
osmium fixed).
Plate 28 - Immersion fixed rat ureter; note the protruded 
appearance of tissue surface, the numerous surface 
grooves and the coarse microridged pattern. (x4 000 
glutaraldehyde and osmium fixed).
t^  " iz*; 4-j
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Plate 29 - Retrograde perfuse fixed rat renal pelvis; 
note the flattened appearance of tissue surface. (x4000 
glutaraldehyde and osmium fixed).
Plate 30 - Immersion fixed rat renal pelvis; note the 
protruded appearance of tissue surface and the numerous 
horizontal and vertical grooves. (x4000 glutaraldehyde 
and osmium fixed).
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3.4.3, Discussion.
The iitimersion-fixed tissue samples were more 
disorganised than the retrograde-perfused ones. The 
immersion-fixed rat papilla tip cells had virtually no 
microvilli, the cells were sunken and the tissue surface 
contained clumps of debris. The ureter and pelvis of 
immersion-fixed rat kidney were similarly disorganised; 
the cells appeared protruded and tissue surface contained 
numerous vertical and horizontal grooves.
I was surprised to see this gross distortion in the 
immersion fixed samples. At the onset of this experiment 
I reasoned that the changes noted between the immersion 
and retrograde-perfused samples under the light or 
transmission electron microscope were mainly due to the 
post-mortem changes which occurred during the time it 
took the fixative to diffuse from the outside to the 
inside of the immersion-fixed samples that since SEM 
probably only requires adequate fixation of surface 
structures the difference between the immersion and 
retrograde-fixed samples under this technique would 
probably be minimal.
The papilla tip cells of the immersion fixed samples 
probably appeared sunken as a result of having lost their 
surface microvilli. This may, however, not be the only
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factor involved. Hansen (1960) in a study in mice showed 
that cessation of blood flow is associated with changes 
which included draining away of blood from the kidney and 
collapse of proximal and distal tubules as a result of 
post-mortem draining away of urine from these segments of 
the nephron. All of these could contribute to the sunken 
appearance noted in the immersion-fixed papilla tip 
samples.
The changes noted in the pelvis and ureter were 
similar but different from those noted in the papilla tip 
cells. The surface of immersion-fixed pelvis and ureter 
appeared protruded instead of sunken. This discrepancy is 
not surprising because while the cells of the normal rat 
papilla tip have a profuse covering of microvilli and 
well delineated prominent cell boundaries, the normal rat 
pelvis and ureter cells have very little microvilli and 
the prominent cell boundaries are not as obvious. Thus, 
if the concavity noted in the immersion fixed rat papilla 
tip cells was a result of loss of surface microvilli, 
this will have a less obvious consequence in the ureter 
and pelvis.
The protrusion of tissue surface noted in both 
ureter and pelvis could be due to swelling of cellular 
organelles, while the grooves noted in these samples
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could be due to retraction of cells from basement 
membrane. Bancroft and Stevens (1982) reported that 
autolysis is associated with changes which include 
nuclei condensation, fragmentation, and lysis; 
cvtoplasmic granulation and swelling and desguamation of 
epithelium with retraction of cells from basement 
membrane.
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3.5, Upper Urothelial Surface Changes Associated With N- 
butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) initiated 
carcinoma.
3.5.1 INTRODUCTION
A link between upper urothelial carcinoma (UUC) and 
abusive consumption of analgesics is now well 
established. Numerous studies have documented the 
coexistence of analgesic-induced papillary necrosis and 
transitional cell carcinoma of renal pelvis or ureter 
(see Bengtsson, et al. 1978; Lomax-Smith and Seymour, 
1980a,b; Gonwa et al.1980; Blohme'and Johansson, 1981, 
McCredie et al. 1983, 1986; Dubach et al. 1991). It has 
also been noted that patients with analgesic-associated 
nephropathy are eight times more likely to develop 
transitional cell carcinoma than those without analgesic- 
associated nephropathy (see Gonwa at al. 1980). In the 
"normal" population, UUC is a predominantly male disease 
with a male to female ratio of 2:1. In analgesic abusers, 
this ratio is reversed (a female to male ratio of 2.5:1). 
As with renal papillary necrosis, UUC appears at a 
younger age in analgesic abusers compared with non 
abusers. The tumour is diffused, poorly differentiated 
and rapidly spreading (Lomax-Smith .and Seymour, 1980). 
The induction time of UUC is usually 20-3 0 years from the 
start of analgesic abuse. Unlike analgesic induced RPN,
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where cessation of abuse can lead to stabilisation of 
renal function or even recovery, patients who discontinue 
analgesic abuse still develop UUC. This has led to the 
suggestion that, with the improved dialysis programme and 
the resultant increased longevity of patients with 
analgesic nephropathy, the incidence of UUC will probably 
increase. The prognosis for patients with UUC is poor due 
to the difficulty in diagnosis and compromised renal 
function of patients with RPN. The diagnosis of UUC is 
difficult because as with RPN, UUC progresses silently 
with few clinical symptoms to indicate the early 
development of the lesion (see Bach and Bridges, 1985). 
The main symptom, gross haematuria, does not alert 
doctors since it is also associated with RPN, a lesion 
which normally precedes UUC. UUC has a poor response to 
radiotherapy and chemotherapy, and reoccurrence often 
occurs after surgery. Mihatsch et al, estimated the mean 
survival time of patients with UUC to be about 22 months.
Many of the early investigations into the cause of 
analgesic-induced UUC concentrated on phenacetin which, 
as with RPN, was thought to be the sole cause of this 
condition. While several of these studies produced 
tumours in extrarenal sites, the only reproducible effect 
on the kidney with phenacetin was urothelial hyperplasia 
(see Bach and Bridges 1985). Johansson and Angerval 
(1976) fed rats a daily dose of 0.54% phenacetin for 110 
weeks and noted hyperplasia in 80% of the animals.
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Nakanishi et al. (1979) noted transitional cell 
hyperplasia and UUC in rats fed 2.5% phenacetin. 
Anderstrom and Johansson (1983) treated rats with 0.535% 
of phenacetin in the diet for 70 weeks and noted 
urothelial hyperplasia but no tumour.
There are several animal models of bladder carcinoma 
(Hicks, 1980, 1983; Cohen et al. 1983,) but, to date,
there is very little data available on the link between 
analgesic-induced RPN and upper urothelial carcinoma. 
This is mainly due to the protracted period of time 
required to induce RPN experimentally with analgesics or 
NSAlDs and the variability in the extent of the resultant 
lesion (see Rosner, 1976; Prescott, 1982; Bach and 
Bridges, 1985).
The acute nature of BEA-induced RPN and the 
considerable similarity between the BEA-induced lesion 
and analgesic-induced lesion makes this compound a good 
model for the study of RPN and its relationship to UUC. 
The aim of the present investigation was to induce cancer 
of the upper urothelium with BEA and OH-BBN using a 
multistage mechanism and to study the resultant surface 
features using scanning electron microscopy. The 
multistage model of carcinogenesis was proposed to 
account for the observed pattern of tumour development in 
the skin , liver, lung and bladder (see Hicks and 
Chowenie, 1978; Hicks, 1983; Barrett and Wiseman, 1987).
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Such a model involves the initiation of neoplastic change 
in a few cells by threshold dose of a carcinogen, 
followed by conversion of those initiated cells into 
cancer cells by further dosage of the same and/or other 
carcinogen(s) and/or non carcinogenic promoting agent(s).
In the present study initiation was carried out with 
low dose of OH-BBN, a known bladder carcinogen (Nakanishi 
et al. 1978; Hicks and Chowenie, 1978) and promotion
y achieved with BEA-induced RPN. p)  ^ Al ^
3.5.2 Treatments
Male Wistar rats received oral dose of OH-BBN 
(0.088g) dissolved in 20% ethanol (0.5ml) twice weekly 
for 5 weeks. After a 7 days respite, the animals were 
dosed with a single ip injection of BEA (lOOmg/kg). The 
control animals received either OH-BBN (0.085g/0.5ml of 
20% ethanol) twice weekly for 5 weeks or 20% ethanol 
(0.5ml) twice weekly for 5 weeks, followed by an ip dose 
of BEA (lOOmg/kg) after a 7 days respite. The animals 
were sacrificed as follows; at 12 weeks after the start 
of the study (6 weeks after BEA treatment) : - BEA only 
group (6 rats), BBN only (5 rats), BBN + BEA group (6 
rats). At 18 weeks after the start of study (12 weeks 
after BEA treatment) : - BEA only group (6 rats), BBN only 
(6 rats), BBN + BEA group (5 rats). At 26 weeks after the
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start of the study (20 weeks after BEA t r e a t m e n t ) B E A  
only group (9 rats), BBN only (8 rats), BBN + BEA group 
(9 rats). At 46 weeks after the start of study (40 weeks 
after BEA treatment)BEA only group (4 rats), BBN only 
(5 rats), BBN+BEA group (6 rats). At 57 weeks after the 
start of the study (51 weeks after BEA t r e a t m e n t ) B E A  
only group (2 rats), BBN only (2 rats), BBN + BEA 
group(2 rats).
The kidneys were retrograde-perfused with 2% 
glutaraldehyde (section 2.3). The kidneys, together with 
attached ureter, were further fixed for not less than 
72hr in the same batch of fixative. The papilla tip, the 
pelvic area around the papilla tip and the upper 2/3 of 
the ureter were dissected out and prepared for SEM 
examination (section 2.3 ).
3.5.3 Result
3.5.3a Macroscopic Observations
Increased urine output occured in the BEA treated rats 
from the first day until the end of the study. No obvious 
difference was noted in the body weights of BBN only, BEA 
only and the BBN + BEA treated rats at any of the time 
points. The BEA and BBN + BEA treated rats kidneys 
contained scars from 12weeks after the start of study (6 
weeks after BEA treatment) onwards. There was no
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difference in the degree of scaring noted in the BEA only 
and the BBN + BEA treated rats. Cysts were found on the 
kidneys of some of the BEA only and BBN + BEA treated 
rats. More cysts were noted on the kidneys of BBN + BEA 
treated rats compared with those of BEA only treated 
rats. Cysts also appeared earlier in the kidneys of BBN + 
BEA treated compared with those of BEA only treated 
rats. No scars or cysts were noted in the kidneys of BBN 
only treated rats (table 3).
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Table 3 - Body Vfeights And Macroscopic Observations
TIME GROUP 
POINT
BODY WEIGHTS 
individual 
value
mean
MACROSCOPIC OBSERVATIONS 
scared cystic
-kidney kidney
6 weeks 
BEA
treatment
BBN
517, 443,
508 483 483
456
BEA
399 475 
490 473 
427 480 45'
BBN +BEA 480 488 
445 427 
527 ' 466
472
0%
83%
83%
0%
0%
12 weeks 
a fte r BEA 
treatment
BBN
600 527
500 540
480 537 531
BEA
527 . 418 
507 455 
500 578
503
BBN + BEA 468 565 
600 500 
560
539
0%
100%
100%
0%
0%
20%
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Table 3 - Body Vfeights And Macroscopic Ctoservations (continued)
TIME GROUP 
POINT
BODY WEIGHTS
individual
value
mean
MACROSCOPIC OBSERVATIONS
scared cystic
kidney kidney
20 weeks 
BEA
treatment
BBN
539 553 
609 486 
576 651 
560 509
560 Oi
BEA
481 528 
650 551 
494 589 
553 529 
603
553 11%
BBN +BEA
498 561 
637 593 
514 565 
552 557 
443
547 100% 56%
40 weeks BBN 
after BEA
558 666 
635 665
678
640
0: 0Î
treatment BEA
592 693
426
723
609 75%
635 628
BBN + BEA 652 557 
567 649
615 100% 67%
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3.5.3b Scanning Electron Microscopy Of The Papilla
Under the scanning electron microscope the normal rat 
renal papilla looks like a cone with a rounded end 
(plate la). The papilla tip contained about 14 slit-like 
openings (the ducts of Bellini). The surface cells were 
polygonal shaped with raised cell boundaries and a turf­
like covering of microvilli (plate lb)
At 12 weeks after the start of study (6 weeks after 
BEA treatment) necrosis of the papilla tip was noted in 
all BEA only and all BBN + BEA treated rats (plates 31 & 
32 ) . Loss of the papilla tip was noted in only one BEA
treated rat. No papillary necrosis was noted in the BBN 
only treated rats.
At 18 weeks after the start of the study (12 wk 
after BEA treatment) loss of the papilla tip was noted in 
all BEA only and all BBN + BEA treated rats. Re- 
epithelisation of papilla stump (evident as numerous 
cobble stoned cells often packed on top of one another ) 
was noted in all BEA only and all BBN + BEA treated rats 
(plates 33a, b & 34a,b). Closer examination of these 
"new” cells of the papilla stump revealed two distinct 
cell types. Type A cells were cobble stoned with numerous 
short stubby microvilli and occasional single cilia. Type 
B cells were flat with raised cell boundaries and 
numerous ropey microridges (plates 33b 34b).
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At 2 6 wk after the start of study (2 0 wk after BEA 
treatment), the cells noted on the papilla stump of the 
BEA only and the BBN + BEA treated rats were less cobble 
stoned than observed in rats in this group at 18 weeks 
(plates 3 5a,b & 36a,b). The surface features of the BEA 
only treated rat papilla stump cells were similar to 
those noted for rats in this group at 18wk except that 
some cell boundaries can now be seen among the cobble 
stoned cells (plate 35b).The very cobble stoned cells 
were no longer apparent in the papilla stump of the BBN + 
BEA treated rats; instead, some flat polygonal shaped 
cells with raised cell boundaries, numerous short stubby 
microvilli and occasional longer microvilli were noted 
(plate 36b).
At 4 6wk after the start of study (4 Owk after BEA 
treatment) the regenerated cells of the papilla stump of 
BEA only treated rats had surface features very similar 
to those of the untreated rats. These cells were flat and 
polygonal shaped with raised cell boundaries (plates 
37a,b) . In contrast, the cells of BBN + BEA treated rats 
has once again become grossly hyperplastic (plates 
38a,b). Close examination of these cells revealed four 
distinct cell types. Type A cells were flat with raised 
cell boundaries, short stubby microvilli and some ropey 
microridges. Type B cells were flat, polygonal shaped 
with raised cell boundaries, numerous short stubby 
microvilli and occasional round indentations (holes).
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Type C cells were flat with raised cell boundaries and no 
microvilli. Type D cells were cobble stoned and non- 
uniform in size with numerous longer microvilli. Some of 
the cells of area D had numerous raised circular patterns 
(plate 38b).
At 57wk after the start of the study (51wk after BEA 
treatment), the BEA only treated rat papilla stumps 
acquired more microvilli and were now looking very much 
like the untreated rat papilla tip cells (plates 39a, b). 
The BBN + BEA treated rat papilla stump were, in 
contrast, even more hyperplastic than noted in this group 
at 2 6wk (plate 4 0a). On higher magnification 3 distinct 
areas were noted. Area A cells were polygonal shaped 
with round fluffy microvilli and occasionally crinkled 
surfaces. Area B cells were cobble stoned with short 
stubby microvilli. Some cells of this area had a fluffy 
appearance. Area C cells were cobble stoned and non- 
uniform in size. Cells from this area contained a few 
short stubby microvilli, occasional cilia and a crinkled 
surface (plate 40b).
No obvious change was noted in the papilla of BBN only 
treated rats (plates 41a, b).
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Plate 31 - Renal papilla of a BEA only treated rat 12wk 
after the start of study (6wk after BEA treatment):note 
detachment of papilla tip. xlOOO
Plate 32 - Renal papilla of a BBN + BEA treated rat 12wk 
after the start of study (6wk after BEA treatment) : note 
that though the papilla tip has not undergone abscission 
it is nevertheless necrotic. xlOOO
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Plate 33a - Renal papilla of a BEA only treated rat 18wk 
after the start of study (I2wk after BEA treatment); note 
the reappearance of surface cells (regeneration). x250
Plate 33b High magnification of plate 33a - renal 
papilla of a BEA only treated rat 18wk after the start of 
study (12wk after BEA treatment): note the existence of 2 
distinct areas. Area A cells were cobble stoned with 
numerous short stubby microvilli and occasional single 
cilia. Area B cell were flat, polygonal shaped with 
raised cell boundaries, some shot stubby microvilli and 
ropy microridges. Area A, xZOOO, Area B, x2000
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Plate 34a - Renal papilla of a BBN + BEA treated rat 18wk 
after the start of study (12wk after BEA treatment): note 
the reappearance of surface cells (regeneration). x250
Plate 34b - High magnification .of plate 34à - renal 
papilla of a BBN + BEA treated rat 18wk after the start 
of study (12wk after BEA treatment): note the existence 
of 2 distinct areas. Area A cells were cobble-stoned with 
numerous microvilli and occasional single cilia. Area B 
cells were flat, polygonal- shaped with raised cell 
boundaries, some short stubby microvilli and numerous 
ropey microridges. Area A, xlOOO, Area b, x2000
T J 1 mm
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Plate 35a - Renal papilla of a BEA only treated rat 26wk 
after the start of study (20wk after BEA treatment): note 
that the papilla stump surface is now flatter than 
observed at 18wk. x250
Plate 35b - High magnification of plate 35a - renal 
papilla of a BEA only treated rat 2&wk after the start of 
study (20wk after BEA treatment): note the existence of 2 
distinct areas. Area A cells were cobbled stoned with 
short stubby microvilli, occasional single cilia and 
raised cell boundaries. Area B cells were flat polygonal 
shaped with raised cell boundaries, some short stubby 
microvilli and some centrally located ropey microridges. 
Area A, x4000. Area B, x2000
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Plate 3 6a - Renal papilla of a BBN + BEA treated rat 26wk 
after the start of study (20wk after BEA treatment): note 
that the papilla stump surface is now flatter than 
observed at 18wk. x500
Plate 36b - High magnification of plate 36a - renal 
papilla of a BBN + BEA treated rat 26wk after the start 
of study (2 0wk after BEA treatment): Note the existence 
of 2 distinct areas and the lack of cobble-stoned cells. 
Area A cells were polygonal-shaped with raised cell 
boundaries, some short stubby microvilli and ropey 
microridges. Area B cells were polygonal- shaped with 
raised cell boundaries, numerous short stubby microvilli 
and occasional longer microvilli. Area A, x2000. Area B, 
X 4 0 0 0
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Plate 37a - Renal papilla of a BEA only treated rat 46wk 
after the start of study (40wk after BEA treatment): Note 
that the papilla stump surface is now flat. x250
Plate 37b - High magnification of plate 37a - renal 
papilla of a BEA only treated rat 4 6wk after the start of 
study (40wk after BEA treatment) : Note that the cells of 
the papilla stump now resemble those of the untreated rat 
(plate lb, pg 65). x 4000
% -
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Plate 38a - Renal papilla of a BBN + BEA treated rat 4 6wk 
after the start of study (4 0wk after BEA treatment): Note 
that the papilla stump has become once again 
hyperplastic. x50
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Plate 38b - High magnification of plate 38a - renal 
papilla of a BBN + BEA treated rat 4  6wk after the start 
of study ( 4  0wk after BEA treatment): Four distinct areas 
were observed. Area A cells were polygonal- shaped with 
ropey microridges and some short stubby microvilli. Area B 
cells were flat with numerous surface blebs. Area C cells 
were flat with raised cell boundaries and some short 
microvilli. Area D cells were cobble-stoned with granular 
appearance and long microvilli. Area A, x 4 0 0 0 ,  Area B, 
X 4 0 0 0 ,  Area C, x 2 0 0 0 ,  Area D, x 2 0 0 0
mm
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Plate 39a - Renal papilla of a BEA only treated rat 57wk 
after the start of study (51wk after BEA treatment): Note 
polygonal shaped cells with raised cell boundaries and 
numerous microvilli. xlOOO
Plate 39b - High magnification of plate 39a - renal 
papilla of a BEA only treated rat 57wk after the start of 
study (51wk after BEA treatment): Note that the papilla 
stump cells are now very similar to those of the 
untreated rat (plate lb, pg65). x4000
39b
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Plate 40a - Renal papilla of a BBN + BEA treated rat 57wk 
after the start of the study (51wk after BEA treatment): 
Note that the papilla stump is grossly hyperplastic. xlOO
183
Plate 40b - High magnification of plate 40b - renal 
papilla of a BBN + BEA treated rat 57wk after the start 
of the study (51wk after BEA treatment): Three distinct 
areas were noted. Area A cells were flat with crinkled 
surface, raised cell boundaries and round (bead-like) 
microvilli. Area B cells were cobble-stoned with short 
stubby microvilli and occasional fluffy appearance. Area 
C cells were cobble-stoned with few short stubby 
microvilli, occasional crinkled surface and occasional 
longer microvilli. Area A, x4000. Area B, x2000. Area C, 
X4000.
40b
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Plate 41a - Renal papilla of a BBN only treated rat 57wk 
after the start of study: Note that BBN did not induce 
any RPN. x250
Plate 41b - High magnification of plate 41a - Renal 
papilla of a BBN only treated rat 57wk after the start of 
study: note that the surface feature of the papilla is 
similar to those of the untreated rat (plate lb). 
XlOOO
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3.5.3c Scanning Electron Microscopy Of The Ureter 
and Pelvis
The epithelial lining of the normal rat ureter and pelvis 
is a transitional epithelium which is about 3-5 cells 
thick (Newman and Hicks, 1981). Under the scanning 
electron microscope, the surface cells were found to be 
polygonal shaped with raised cell boundaries and randomly 
distributed microridges (plate 7). Occasionally 
microvilli were noted at the cell boundaries. After 
treatment of the rats with BBN only, BEA only or BBN + 
BEA the following changes were noted.
At 12wk after the start of study (6wk after BEA 
treatment) no obvious changes were noted in the ureter 
and pelvis of BEA only , BBN only or BBN+ BEA treated 
rats.
At ISwk after the start of study (12wk after BEA 
treatment) the pelvis and ureter of BEA only treated rat 
and those of BBN only treated rats were normal. The 
pelvis of BBN + BEA treated rats were also normal. Focal 
papilloma were however found in the ureter of 2 out of 4 
rats examined at this time point (plates 42a,b).
At 26wk after the start of study (2Owk after BEA 
treatment), the pelvis and ureter of BEA only treated 
rats and those of BBN only treated rats were normal. 
Gross hyperplasia was found in the ureter of 1 out of 3
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BBN + BEA treated rats examined at this time point (plates 
43a,b).
At 46wk after the start of study (4Owk after BEA 
treatment), the pelvis and ureter of BEA only treated 
rats were normal. Pleomorphic microvilli were found in 
the pelvis of 3 out of 4 BBN + BEA treated rats examined 
at this time point. Pleomorphic microvilli and 
hyperplasia were also found in the ureter of 1 out of 4 
BBN + BEA treated rats (plates 46a, b) . Pleomorphic 
microvilli were also found in the pelvis of 1 out of 3 
BBN only treated rat and in the ureter of the same BBN 
only treated rat. (plates 47a,b).
At 57wk after the start of study (5Iwk after BEA 
treatment), the pelvis and ureter of BEA only treated 
rats and those of BEA only treated rats were normal. The 
pelvis of BBN + BEA treated rats were also normal. 
Pleomorphic microvilli were found in the ureter of one of 
the 2 BBN + BEA treated rats (plates 48b,).
3.5.3d Light Microscopy
The light microscopic study were prepared by my 
colleague Dr N Gregg. His observations are summarised in 
the discussion to chapter (pp 2 06-2 08).
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Plate 42a - 2 papillomas found in the ureters of 2 BBN + 
BEA treated rats killed at 18wk after the start of study 
(12wk after BEA treatment) - note the variation in cell 
size and the cobble stoned areas around papilloma B. 
papilloma A, x260, papilloma B, xlOO.
i42a
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Plates 42b - High magnification of plates 42a - 2 
papillomas found in the ureters of 2 BBN + BEA treated 
rats at 18wk after the start of study (12wk after BEA 
treatment) - note the variation in cell sizes and 
surface features and the cluster of bald cells on 
papilloma A. Papilloma A, xlOOO, papilloma B, x500.
42 b
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Plates 4 3 - a, b, ureters of a BBN only and a BEA only 
treated rats, c, d, e; pelvis of a BBN only, BEA only and 
a BBN + BEA treated rat killed at 18wk after the start of 
study (12wk after BEA treatment). Note that these surface 
features are similar to those of the untreated rats. 
X 4 0 0 0
p4 3
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Plate 44a - Hyperplastic area found in the ureter of a 
BBN + BEA treated rats killed at 2 6wk after the start 
of the study (2Owk after BEA treatment). x250
Plate 44b - High magnification of plate 44a - 
hyperplastic area found in the ureter of a BBN + -BEA 
treated rat killed at 26wk after the start of study (20wk 
after BEA treatment) - note the variation in cell sizes 
and the coarse microridged pattern. x4,000.
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Plate 45 - a, b; ureters of a BBN only and a BEA only 
treated rats 2 6wk after the start of study (2Owk after 
BEA treatment). c,d & e; pelvis of a BBN only, BEA only 
and BBN + BEA treated rats 26wk after the start of study 
(2 Owk after BEA treatment). Note that the surface 
features of these cells are similar to those of the 
untreated rats.
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Plate 4 6a _ Two distinct areas noted in the ureter of a 
BBN + BEA treated rat at 46wk after the start of study 
( 4 Owk after BEA treatment) . Note the pleomorphic 
microvilli, the surface blebs, the coarse microridges and 
the different sized cells, (i) x8000, (ii) x4,0000.
Plate 46b - Surface features noted in the pelvis of a BBN 
t BEA treated rat at 46wk after the start of study (40wk 
after BEA treatment). Note the pleomorphic microvilli, 
surface blebs and coarse microvilli. x4000.
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Plate 47a -Ureter of a BBN only treated rats killed at 
46wk after the start of study. Not the presence of 
pleomorphic microvilli. x4000.
Plate 47b - Pelvis of a BBN only treated rat killed at 
4 6wk after the start of study (4Owk after BEA treatment). 
Not the presence of pleomorphic microvilli and surface 
blebs. X 4 0 0 0 .
-ïs.-
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Plate 48a - Ureter of a BBN treated rat and a BEA treated 
rat at 57wk after the start of study (51wk after BEA 
treatment). Note that the tissue surface is similar to 
those of the untreated rats. x8000.
Plate 48b - Ureter of a BBN" + BEA treated rat at 57wk 
after the start of study (5iwk after BEA treatment). Note 
the numerous surface blebs and the medium length 
microvilli. x8,000.
48a
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Plate 49 - Pelvis of a BBN only treated rat, a BEA only 
treated rat and a BBN + BEA treated rat at 57wk after the 
start of the study (5Iwk after BEA treatment) . Note that 
the surface features of these cells are similar to those 
of untreated rats. xSooo.
a4 9
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3.5.4, Discussion
Results from this study show that, at the dose used, 
BBN on its own did not cause hyperplasia or carcinoma. 
BEA produced papillary necrosis and reversible 
hyperplasia but not carcinoma. The combination of this 
dose of BBN and a single ip dose of BEA, however, 
resulted in an initial reversible hyperplasia followed by 
irreversible hyperplasia (carcinoma) at later time 
points. Both the reversible and irreversible hyperplastic 
phases were associated with the appearance of pleomorphic 
microvilli. However, the microvilli associated with 
irreversible hyperplasia were more pleomorphic than those 
associated with reversible hyperplasia. Whereas only two 
types of microvilli (short stubby microvilli and 
occasional long cilia-like microvilli) were noted in the 
cells of BEA only treated rats and those of BBN + BEA 
treated rats at early time points, microvilli of varied 
shapes and size were noted in the cells of BBN + BEA 
treated rats at late time points. These included short 
stubby microvilli, long thin microvilli with bulbous 
ends, long thick microvilli with bulbous end and 
invaginations, round fluffy microvilli and leafy 
microvilli. The fact that the population of microvilli 
associated with cancer cells were different from those 
noted on cells undergoing reversible hyperplasia suggests 
that careful study of surface microvilli may be useful 
in distinguishing neoplastic cells from normal cells.
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Pleomorphic microvilli have also been noted by other 
investigators on the tissue surface of carcinogen treated 
animals, on the surface of human cancer cells and on the 
cell surface of various organs following chemical and 
mechanical injury (Newman and Hicks, 197 6; Aria et al, 
1979; Jacob et al, 1981; Fukushima et al, 1981; Hicks, 
1983; Suzuki et al. 1986). So far it has not been 
suggested that the microvilli noted on cells undergoing 
reversible hyperplasia may be different from those noted 
on cancer cells. It has, however ,been suggested that the 
numbers of microvilli on the cell surface increase and 
becomes more pleomorphic with increase in the grade of 
tumour (Fukushima et al, 1981; Jacob et al, 1981). The 
grade of tumour induced was not measured in this study. 
However, it was noted that the number of microvilli on 
the cell surface increased and became more pleomorphic 
with time.
The development of pleomorphic microvilli on the 
urinary surface of cells in carcinogen-treated bladder 
has been reported by many investigators and was 
originally thought to represent the expression of new 
phenotype which appeared to be a convenient marker of 
neoplastic transformation of the bladder (Jacob et al, 
1977; Friedel et al, 1977; Hicks and Chowenie 1978). 
Subsequent observation of such microvilli on urothelial 
cells after treatment with either saccharin alone 
(Fukushima and Cohen 1980) or with cyclophosphamide alone
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(fukushima et al, 1981) led to the suggestion that 
microvilli might be associated with the later stages 
rather than with the initiation of carcinogenesis in this 
tissue. More recently, pleomorphic microvilli have been 
observed after treatment of the bladder with formalin and 
after wounding the urothelium by surgery or freezing 
(Fukushima et al, 1981). All these treatments produce 
reversible regenerative hyperplasia of the urothelium and 
the appearance of pleomorphic microvilli coincide with 
the time of maximum proliferation. Thus the production of 
microvilli in the carcinogen treated bladder is probably 
a marker for cell proliferation rather than a specific 
marker for neoplastic transformation or promotion of 
tumour growth.
My results show that the microvilli observed on 
cells regenerating as a result of damage were different 
and less pleomorphic than those found on the surface of 
neoplastic cells. Furthermore, only two types of surface 
features were found on the cells of regenerating 
urothelium. These surface features (plates 33b, 34b) were 
similar to those reported for immature cells by Newman 
and Hicks (1981 ) and those observed by Cohen et al, 
(1988) on rat fetal urinary bladder between days 15 and 
17 of gestation. The cells of BBN + BEA treated rats on 
the other hand contained numerous surface features. These 
included cells with bald wrinkled surfaces, cells with 
wrinkled surfaces and fluffy microvilli, cobbled stoned
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cells with coarse microridges, cobble stoned cells with 
surface blebs and long microvilli with bulbous tips, 
cells with coarse microridges, surface blebs and long 
thick microvilli with bulbous tip and invaginations. 
Bizarre microvilli, surface blebs, bald cells and coarse 
microridges have been noted by other investigators on 
human cancer cells and on the cells of carcinogen treated 
animals (Newman and Hicks, 1977; Suzuki at al. 1986;
Newman et al. 1988).
From this study it can be concluded that careful use of 
SEM to study not only the microvilli population but also 
the type of surface features present would be useful in 
distinguishing normal cells from neoplastic cells. SEM 
techniques would also be useful in urinary cytology 
studies. Both analgesic-induced RPN and UUC leads to 
shedding of cells in the urine. SEM study of the surface 
of these cells would give an indication of the presence 
of carcinoma. Study of urinary cytology specimens with 
SEM would also be useful in patients with low grade 
transitional cell carcinoma. Jacob et at, (1977) showed 
that, whereas SEM is useful in the diagnosis of low grade 
carcinoma of the bladder the examination of urinary 
cytological preparations by light microscopy was only of 
value in the diagnosis of bladder cancer in humans when 
the grade of the tumour was of high histologic value. SEM 
examination of urinary cytology specimens would also be 
useful clinically in follow-up studies of patients with
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low grade transitional cell carcinoma of the bladder 
previously excised by transurethral resection. In such 
patients recurrence can be detected earlier by following 
the patients with examination of exfoliative cytology 
specimens.
In human tumour bearing bladder the urothelium away 
from the transitional cell tumour is not recognisable as 
being pre-neoplastic by light microscopy (Suzuki et al. 
1986). SEM observation of cancer cells in this study and 
those of other investigators (Newman and Hicks, 1977; 
Herd and William, 1984) has shown the presence of 
pleomorphic microvilli on areas distant from the tumour 
in the carcinogen treated animals. This suggests that 
scanning electron microscopy of the urothelium away from 
the tumour may be of prognostic value in indicating the 
subsequent biological behaviour of the urothelium.
The urothelium initiated by low dose of BBN was 
promoted to carcinogenesis following a single ip dose of 
BEA. As it has been shown that initiation is almost 
instantaneous, whereas promotion requires more frequent 
or prolonged administration (see Hicks, 1983) it is more 
likely that the promotion was a result of the persistent 
irritation caused by BEA-induced RPN rather than by the 
direct effect of a single dose of BEA. BEA is very 
quickly cleared from the blood and a single dose would 
normally have been eliminated within 24hr (see Bach,
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1981). This suggests that one way by which analgesics 
could cause UUC is by indirectly acting as promoting 
agents. There is suggestion that about 2 0% of patients 
with transitional cell carcinoma may have had 
occupational exposure to proven carcinogens such as 
nitrosamines, dyes, rubber or tar (see Gonwa et al, 
1980) . Many compounds such as coffee, tea, alcohol, 
artificial sweeteners and cigarettes which are consumed 
in large quantities by large sections of the population 
have been linked with carcinogenesis (Gonwa et al. 1980; 
McCredie, 1983; McCredie and Stewart, 1988; Slattery et 
al.1988). Nitrosamines have not only been detected in 
many "foods" (beer, whisky, cheese, cooked bacon and 
tobacco smoke) but can be formed in gastrointestinal 
tract by nitrosation of secondary amines by inorganic 
nitrites which are either used as food preservatives or 
are derived from conversion in the saliva of nitrates 
present in vegetables into nitrites (Craddock, 1990). 
Such exposure to carcinogens could, in some individuals, 
result in initiated urothelium which, following analgesic 
abuse, could be promoted to carcinogenesis by analgesic- 
induced RPN. This would explain why not all analgesic 
abusers with RPN progress to develop UUC since probably 
not all of these patients have initiated urothelium. 
Summation effect has been demonstrated experimentally 
following sequential exposure to sub-carcinogenic doses 
of several carcinogens (Tatematsu et al. 1977). These 
investigators administered 0.01% N-butyl(-N-(4-
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hydroxybutyl)nitrosamine (BBN), 0.15% N-(4-(5-nitro-2-
furyl)-2-thiazolyl)formamide (FANFT), 0.025% N-2-fluore-
nylacetamide (2-FAA) or .3% 3, 3'-dichlorobenzidine 3,
(3'-DCD) to male Wistar rats and examined the urinary 
bladder for the presence of cancer cells. They (Tatematsu 
et al.) observed no bladder cancer in rats treated with 
any of the above compounds, on its own, but significant 
incidence of bladder cancer following sequential 
administration of all four chemicals. Ito et al. (1983) 
also found synergistic and additive effects following 
administration of BBN, 2-FAA, FANFT and 3,3'-DCD in 
combination or in sequence. It is, however, appreciated 
that variability in response to a given compound would 
contribute, as will longevity of patients. The induction 
time for UUC is about 20- 3 Oyears (see Blohme and 
Johansson, 1981; Prescott, 1982; Bach and Bridges, 1985) 
and many patients with RPN may die long before this 
period is reached. There is evidence to show that 
patients who continue to abuse analgesics after RPN is 
diagnosed have a poor prognosis and rapidly develop 
endstage renal disease,:: while patients who discontinue 
the abuse stabilise or show improved renal function 
(Prescott, 1982; Bach and Bridges, 1985; Schwarz, 1987; 
Henrich, 1988; Kincaid-Smith, 1988). It is probably this 
latter group that are more likely to live long enough to 
develop UUC.
While the above model is very plausible, it is worth
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pointing out that many attempts to induce RPN with 
analgesics have been negative (see Rosner, 1976; 
Prescott, 1982). Furthermore, with the exception of 
phenacetin, which has been reported by some investigators 
to be a week carcinogen (see Anderstrom and Johansson, 
1983; McCredie and Stewart, 1988), in many experimental 
investigations of the link between analgesic abuse and 
UUC the only consistent effect produced was hyperplasia 
(see Bach and Bridges, 1985). These hyperplasia were, in 
many cases, observed in the absence of RPN thus 
suggesting that the analgesic rather than analgesic- 
induced RPN is the promoter.
It is also possible that analgesics could be 
carcinogens. Carcinogenic aromatic amines and amides are 
activated by N-hydroxylation and subsequently by 
estérification of the N-hydroxy group. Phenacetin is an 
aromatic amide which gives rise to N-hydroxylated 
metabolites (see Bengtsson et al. 1978). Peroral 
administration of N-hydroxyphenacetin to rats induced 
high frequency hepatomas. Nitrosation of phenacetin has 
been demonstrated to yield a substance which induces 
tumourj locally upon sc administration. Nery (1971) found 
azoxy-4-ethoxy-benzene, a condensation product of N- 
hydroxy phenacetin or N-hydroxy-4-phenetidine in the 
urine of rats fed phenacetin. This indicates that 
phenacetin could be carcinogenic. This does not mean that 
phenacetin is the only probable carcinogenic analgesic.
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Plate 50 (from N Gregg, 1989
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Figure 5.5 Papillary and nodular hyperplasia in ureter 13 weeks 
after BBN/BEA treatment. Toluidine blue x 223.
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Figure 5.6 Higher magnification of an "invasive" area shown above 
(arrow) projecting down through lamina propria (LP) and beginning to 
invade lamina muscularis (Mu). Toluidine blue x 1085.
Much of the background data currently available on RPN 
and UUC are concentrated around phenacetin which was 
earlier thought to be the sole cause of these two 
lesions. It is possible that, as more data becomes 
available on other analgesics, other compounds with 
carcinogenic potential will be found.
Long microvilli with bulbous ends were noted on the 
ureter and pelvis of one BBN only treated rat at 4 0wk 
after BEA treatment. If the appearance of pleomorphic 
microvilli represents a transformation from the normal 
condition to neoplasia, it suggests that this BBN only 
treated rat would have developed tumour with time. Many 
investigators have shown that BBN is a complete 
carcinogen in the bladder (Hicks and Chowenie, 1978; 
Nakanishi et al. 1978 ; Hicks, 1983, Hirao et al. 1987). 
It is possible that this BBN only treated animal was more 
sensitive than the rest of the animals in this group. 
Thus while the dose of BBN used in this study was sub­
threshold in the other animals it was high enough to act 
as a complete carcinogen in this rat. Hicks and Wakefield 
(1976) reported the occasional appearance of cilia in old 
animals. I do not think that the long microvilli noted in 
this BBN only treated rat was due to old age since no 
long microvilli were noted in the BEA only treated rats 
at this time point or in the BEA only treated rats and 
the remaining BBN only treated rats at later time points.
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Plate 51 (from N Gregg, 1989)
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Figure 5.11 Papilla stump (Pap) with severe hyperplastic covering 
epithelium and nodular hyperplasia of adjacent pelvic urothelium 
(arrow), 30 weeks after BBN/BEA treatment. Giemsa x 89.
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Figure 5.12 Higher magnification of nodular hyperplastic pelvic 
urothelium (from above figure) invading renal parenchymal tissue 
(arrow), note collecting duct (CD) with mitotic figure present. 
Giemsa x 357.
Though it is not possible to prove beyond doubt 
using SEM that the protrusions noted in the BBN + BEA 
treated rats in this study were tumour cells, many of the 
observations suggest that they were probably cancer 
cells. These includes : (1) the BEA only treated rat
kidney reverted to normal after a bout of regenerative 
hyperplasia whereas the BBN + BEA treated rats showed an 
initial recovery followed by a more hyperplastic phase. 
This biphasic development of the lesion in the BBN + BEA 
treated rats may reflect a change from reversible to 
irreversible lesion (2) The surface features noted on the 
BBN + BEA treated rat were similar to those observed on 
proven cancer cells by other investigators (Jacob at al. 
1981; Fukushima at al. 1981; Suzuki at al. 1986; Newman 
at al. 1988). (3) The sub-group of rats used in this
study examined under the light microscope (Gregg 1989) 
in agreement with the scanning electron microscopic data 
reported here, showed appearance of hyperplasia in both 
the BEA and BBN + BEA treated rats at early time 
points. This initial hyperplasia was followed in both 
studies by the appearance of tumour in the papilla, 
pelvis and ureter of the BBN + BEA treated rats by 46wk 
after the start of study (4 0wk after BEA treatment). No 
tumour was reported in both studies in the BEA only 
treated rat.
The changes observed with the scanning electron 
microscopy mirrored those noted with light microscopy
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Plate 52 (from N Gregg, 1989)
Figure 5.19 Macroscopic photograph of enlarged upper ureter portion 
(arrowheads) containing tumour (shown below) found 40 weeks after 
BBN/BEA treatment, x 3 approximately.
Figure 5.20 Papillary transitional cell tumour found in upper 
ureter, with nodular basal region,40 weeks after BBN/BEA treatment 
Giemsa x 36.
(Gregg, 1989). This suggests that the criteria (cobbled 
stoned cells, variation in cell size, shape and surface 
appearance and appearance of pleomorphic microvilli) used 
in the literature and in this study to distinguish 
neoplastic cells from normal cells under the scanning 
electron microscope were probably correct. Some 
differences in observation were however noted between the 
light microscopic and scanning electron microscopic 
studies. Scanning electron microscopy showed a continued 
recovery in the BEA only treated animals from 26wk after 
the start of study and a transient regression in the BBN 
+ BEA treated rats at 2 6wk after the start of study. This 
was followed by a more hyperplastic phase after this time 
point. No regression was reported in the BEA only or BBN 
+ BEA treated rats at any of the time points with the 
light microscopy (Gregg, 1989). However the photograph 
(plate 50, fig. 5.6) presented by Gregg shows a picture 
consistent with my own study, namely a smooth surface 
layer covering a still hyperplastic epithelium.
This results highlights the difference between light 
microscopy and scanning electron microscopy. In light 
microscopy hyperplasia is present if there is an increase 
in the number (layer) of cells and if there is appearance 
of mitotic figures. With this technique only a small cut 
section from a sample can be examined at a time. As a 
result, it is difficult to conclude that because section 
A contained mitotic figures and 3 layers of cells the
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tissue from which it was cut from is less hyperplastic 
than the tissue from which section B with mitotic figures 
and 5 layers of cells was cut. Section A could have come 
from a less hyperplastic area of the original tissue. 
With scanning electron microscopy on the other hand an 
overall view of tissue is obtained allowing easy 
assessment of variation in morphology over the tissue 
surface. However, hyperplasia by SEM is identified by 
cobbled stoned appearance of tissue surface and/or 
stacking of cells forming papillary outgrowths and the 
presence of pleomorphic microvilli. It is my experience 
that the more hyperplastic the tissue the more cobble 
stoned it is. As a result of the above, it is easy to 
look through various time points of an SEM study and be 
able to tell at a glance whether the tissue surface has 
become more or less cobble-stoned (hyperplastic) with 
time. This ability of SEM to demonstrate regression will 
however become a limitation if the aim is to demonstrate 
complete recovery from hyperplasia for there remains the 
possibility that a normal surface layer cover a still 
altered interior. Gregg (1989) showed that at the time 
point (26wk) where my SEM study showed a virtually normal 
urothelium, the cells were still hyperplastic under the 
light microscopy. Nevertheless the results presented in 
this section show clearly how much information on the 
development of neoplastic lesion can be achieved by the 
scanning electron microscope.
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CHAPTER 4
GENERAL DISCUSSION
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Long term analgesic abuse can lead to renal papillary 
necrosis (RPN) and subsequently to end-stage renal 
disease (ESRD) or upper urothelial carcinoma (UUC).
Research into RPN and its relationship to UUC has been 
hampered by the fact that (1) In man RPN has a long 
induction time (an average of 10- 2 0 years of analgesic 
abuse) . (2) The lesion is silent and can only be
diagnosed with a reasonable degree of accuracy at an 
advanced stage. Most of the early symptoms of RPN are 
similar to those of many other disease conditions 
(chapter 1, this thesis). Attempts to experimentally 
induce RPN in animals has also met with difficulties 
which included the requirement of large doses of 
analgesic administration over a long period of time. This 
protracted period of administration could overlap with 
the time when kidney damage and carcinoma occur naturally 
as a result of old age in laboratory animals such as the 
mouse and rat. Furthermore, the lesions produced 
following analgesic administration have been found to 
vary widely within the same dose group and to be 
irreproducible (see Prescot, 1982; Bach and Bridges, 
1985). A non-analgesic papillotoxin, 2-bromoethanamine 
hydrobromide (BEA) has been reported to induce, within a 
short period in approximately 100% of the animal, RPN 
which is similar to those induced by anlgesics (see Bach 
and Bridges, 1985). The light microscopic, scanning 
electron microscopic and the transmission electron 
microscopic data reported in this thesis support the view
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that BEA induces RPN within a short time of 
administration. Changes were noted in the BEA treated 
rats as early as Ihr after treatment and papilla necrosis 
was present in most animals by 8- 12hr after dose.
Following BEA treatment the papilla tip cells underwent 
swelling with complete or partial closure of the ducts of 
Bellini, loss of surface microvilli, detachment of cells 
from cellular junctions and collapse of cells followed by 
cellular exfoliation. These changes were different from 
those noted on the ureter and pelvis which included 
appearance of holes, microvilli and surface blebs. It was 
suggested that the reason for the difference between the 
changes noted in the papilla and those noted in the 
pelvis and ureter could be that, in the papilla, the 
changes noted were events from tissue damage to cell 
death, whereas in the pelvis and ureter the changes noted 
were events from tissue damage to recovery/repair. The 
evidence which led to this suggestion is as follows:- If 
BEA is concentrated in the papilla as a result of counter 
current concentration mechanism then the papilla will be 
more damaged than the pelvis and ureter where the 
concentration of this compound is lower. The data 
presented in sections 3.1 and 3.5 which show that the 
pelvis and ureter recovered within one week of BEA 
treatment, whereas the papilla never recovered and 
underwent abscission by 3-4 weeks after treatment, 
suggests that the papilla was more damaged than the
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pelvis and ureter. Data reported by other investigators 
which show that the BEA induced lesion always starts at 
the papilla tip (point of maximum concentration) suggests 
that this compound might be concentrated at the papilla 
(see Bach and Bridges, 1985). Experimental results 
reported in this thesis (sections 3.2 & 3.3) show that 
interstitial cells , mitochondria and collecting ducts 
were damaged before BEA grossly damages the concentration 
mechanism. This leaves open the possibility that BEA may 
have produced this early damage by a direct toxic effect 
(cytotoxicity) . Even if BEA is not concentrated at the 
papilla, provided the cells of the papilla, pelvis and 
ureter are of equal sensitivity following exposure to 
toxic agent the papilla is very likely to come out worse 
off than the pelvis and ureter. The papilla tip is made 
up of one to two layers of cells, whereas the pelvis and 
ureter are made up of four to five layers of cells. In a 
multi-layered tissue the top layers of cells protect the 
cells underneath from direct impact from toxic agents. 
The tissue will only become irreversibly damaged when all 
its layers of cell becomes irreversibly damaged. Damage 
to one or several layers of the tissue will result in 
repair/regeneration from the undamaged cell layer(s). The 
microvilli noted on the surface of the pelvis and ureter 
after BEA treatment were thought to be a result of either 
exfoliation of the top layer(s) of cells to reveal the 
immature cells underneath or an indication of 
hyperplasia. Microvilli have been noted on intermediate
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cells, very young cells and on regenerating cells (Newman 
and Hicks, 1981; Cohen et al. 1988; section 3.5, this 
thesis).
Partial or complete closure of the ducts of Bellini 
reported here following BEA treatment has not been 
reported before. Data presented in sections 3.1 and 3.2 
show that swelling of cells at the outlet of ducts of 
Bellini resulted in complete or partial blockage of these 
openings between 3 and 6hr after treatment. The ducts of 
Bellini became dilated once the surface cells were 
exfoliated at later time points. It was suggested from 
this result that (1) the diuretic effect of BEA would 
decrease at the time points where the ducts of Bellini 
were completely or partially closed and would increase 
once the surface cells become exfoliated (at this point 
the ducts of Bellini were found to be dilated) . Data 
reported by Bach (1981) offer some support for this 
hypothesis. (2) The medullary ischaemia that is 
constantly proposed as a mechanism of both BEA- and 
analgesic-induced RPN could have arisen as a result of 
pressure on neighbouring capillaries by swollen 
collecting duct cells. (3) The cortical tubular dilation 
often reported in analgesic nephropathy and in 
experimentally-induced RPN was probably brought about by 
the back pressure created in those collecting ducts whose 
outlets were blocked.
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Interstitial cells, collecting ducts and mitochondria 
were damaged before the concentration mechanism was 
grossly affected. This was suggested as a possible 
indication that direct toxicity as a result of 
hyperconcentration of BEA at the papilla may be involved 
in the BEA-induced lesion. One of the main arguments put 
forward against the involvement of cytotoxicity in BEA- 
induced RPN is that BEA damages the concentration 
mechanism so it cannot be acting by being concentrated in 
the papilla. Data reported by Sabatini (1985) show that 
BEA causes inhibition of sodium-potassium ATPase and 
sodium-potassium pump by a direct effect on the membrane.
Though the pathological features of BEA-induced RPN 
is similar to those of analgesic-induced RPN (a lesion 
which takes an average of 10- 20 years to induce) , it is 
quite possible that the mechanism of the acute BEA model 
is different from that of the chronic lesion of analgesic 
nephropathy. To date, at least five different mechanisms 
has been proposed for analgesic -induced RPN (chapter 1) 
and investigators tend to favour one or other of these 
mechanisms. So far there has been little or no 
suggestion that analgesic nephropathy could result from 
an additive effect of several of these proposed 
mechanisms. Data reported in this thesis shows that the 
BEA-induced lesion could be a product of at least two 
different mechanisms. These include:- (1) the initial
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BEA-induced damage could be due to a direct toxic effect 
as a result of high concentration of this compound at the 
papilla. I have not seen any report that BEA is 
concentrated at the papilla; however, most reports show 
that the BEA-induced lesion always starts at the papilla 
tip (point of maximum concentration). The results 
presented in this thesis show that interstitial cells, 
collecting ducts and mitochondria were damaged before the 
concentration mechanism is affected. This leaves open the 
possibility that these structures could have been damaged 
by direct toxic effect of a high concentration of BEA at 
the papilla. A direct effect of BEA on the membrane 
leading to inhibition of sodium-potassium ATPase has been 
reported (Sabatini, 1985). (2) The initial BEA-induced
lesion (direct toxic effect on the mitochondria, 
collecting duct and interstitial cells) will be followed 
by medullary ischaemia as a result of damage to these 
structures. Damage to interstitial cells and mitochondria 
will lead to medullary ischaemia as a result of loss of 
renal prostaglandins (fig. 8) . Interstitial cells and 
mitochondria are major sites of prostaglandin synthesis 
and prostaglandins are endogenous vasodilators which play 
a modulatory role in the body by balancing the 
vasoconstricting effects of endogenous hormones and 
chemical messengers such as catecholamines and 
angiotensin. Loss of prostaglandins will therefore lead 
to "unrestrained" vasoconstriction and subsequently to 
medullary ischaemia. Loss of mitochondria would also
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indirectly lead to medullary ischaemia. Mitochondria are 
responsible for cellular energy production; their loss 
would lead to a fall in cellular ATP and, subsequently, 
to cessation of energy-dependent ion pumps followed by 
cellular swelling as a result of ion shift across the 
membrane (sections 3.1, 3.2, 3.3,). Swollen collecting
duct cells will exert pressure on neighbouring 
capillaries leading to narrowing/ vasoconstriction in 
these capillaries and ultimately to medullary ischaemia 
(fig. 8). One hypothesis which can therefore be proposed 
from these results is that the BEA-induced lesion is 
fast, probably because this compound produces its damage 
by a multiple mechanism whereas analgesics produce their 
damage mainly by one mechanism. Of course, the 
mechanism involved could vary from one analgesic to 
another depending on whether they are concentrated at the 
papilla, metabolically activated or damage some primary 
cellular constituent. This could explain why a single 
dose of BEA could, in a matter of hours, produce an 
effect similar to those induced following many years of 
analgesic abuse. This hypothesis can be tested by 
superimposing BEA on maximum analgesic-induced RPN. If a 
further increment in response is obtained then BEA could 
also be acting by a mechanism different from that used by 
the analgesic (see future work)
Data reported in section 3.5 shows that, at the dose used 
BBN did not cause hyperplasia or carcinoma. BEA
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produced reversible hyperplasia but no carcinoma. The 
combination of this dose of BBN and BEA resulted in an 
initial hyperplasia followed by irreversible hyperplasia 
(carcinoma). Both the reversible and the irreversible 
hyperplastic phases were associated with the appearance 
of pleomorphic microvilli. However, the microvilli 
associated with irreversible hyperplasia were more 
pleomorphic than those associated with reversible 
hyperplasia. Furthermore, neoplastic cells contained 
numerous surface features whereas the cells undergoing 
reversible hyperplasia contained only two surface 
features which were very similar to those found on 
immature cells (section 3.5). It was concluded from this 
result that BEA-induced RPN is capable of promoting 
initiated urothelium to carcinoma and that a careful use 
of SEM to study the microvilli population and the type of 
surface feature present would be useful in distinguishing 
neoplastic cells from normal cells. Pleomorphic 
microvilli, in addition to being present on tumour cells, 
were also found in areas distant from the tumour. It was 
suggested from this that, if a link is found between 
certain type of microvilli and tumour cells, then 
identification of these particular microvilli in areas 
without tumour could be useful in predicting the future 
biological behaviour of the tissue.
A link between analgesic abuse and RPN is now well 
established. Compared with the generally healthy
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population, analgesic abusers tend to have more RPN and 
UUC. Furthermore, the appearance of RPN always precedes 
UUC. In the study reported in section 3.5 BEA was able to 
promote an initiated urothelium to carcinoma. If, as has 
been suggested, analgesics behaves similarly to BEA then 
this suggests that analgesics are not only papillotoxins 
but are also carcinogens since they are capable of 
producing both renal papillary necrosis and upper 
urothelial carcinoma. On the other hand it is possible 
that the patient with UUC already had an initiated 
urothelium and that analgesic-induced RPN merely promotes 
this urothelium. Many environmental and food 
contaminants such as cigarette smoke, nitrosamines, 
rubber and dyes have been linked with carcinogenesis and 
summation effect following exposure to low dose of 
several carcinogens has been noted (see section 3.5, this 
thesis) . It is thus possible that exposure to these 
contaminants can in some individuals result in 
acquisition of initiated urothelium. The existence of 
initiated urothelium in those patients who develop UUC 
could explain why not all analgesic abusers with RPN 
develop UUC. There is, however, a high mortality rate in 
those patients who continue to abuse analgesics after RPN 
was diagnosed, so possibly many of these patients would 
have developed UUC if they had lived long enough. The 
improvement in the dialysis programme is now resulting in 
increased longevity in analgesic abusers who would have 
previously died of end stage renal disease. If this
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increased longevity leads to a sharp increase in the 
number of analgesic abusers who subsequently develop UUC, 
this would shed some light on whether many analgesic 
abusers with RPN failed to develop UUC because they did 
not live long enough.
ALthough there is uncertainty as to whether microvilli 
are indicative of neoplastic transformation, there is no 
doubt that microvilli are present in large numbers on 
neoplastic cells and that, with scanning electron 
microscopy, these microvilli are more obvious and are 
also noted in areas surrounding the lesion. This is an 
advantage of SEM over both light microscopy and 
transmission electron microscopy when searching for a 
focal lesion. The chances of finding a small focal lesion 
with light microscopy and transmission electron 
microscopy will be low. Sections cut from areas distant 
from the tumour could appear quite normal under the light 
or transmission electron microscope. With scanning 
electron microscopy, on the other hand, following initial 
scan of the whole tissue, the microvilli population will 
give an indication of areas in which to concentrate 
attention, (see Bach and Bridges, 1985). Scanning 
electron microscopy is thus a very complementary tool to 
light microscopy and transmission electron microscopy in 
understanding the events leading to renal papillary 
necrosis and upper urothelial carcinoma.
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One of the things I set out to do at the beginning of 
this project was to find out how useful scanning electron 
microscopy is in biological science. The data presented 
here has shown that with the SEM we were able to see new 
characteristics/changes in BEA-induced RPN which have not 
been previously reported because these changes were more 
obvious at the cell surface. Also, the other changes 
noted were very complementary to the light microscopic 
and the transmission electron microscopic data currently 
available and have helped to clarify the mechanisms of 
BEA-induced renal papillary necrosis. I reserve judgment 
on whether the SEM is/will be as useful or more useful 
than the light microscopy or transmission electron 
microscopy because I feel that, at the present stage of 
SEM development this would be an unfair and unbalanced 
judgment. The light microscopy and transmission electron 
microscopy have been around for a long time and as such 
have acquired enough background data for the changes 
observed to be linked to pathological conditions. In 
contrast SEM is still a novel tool which is found in 
large institutions. The high cost of this equipment and 
its requirement of trained technicians has so far put it 
beyond the reach of small laboratories. The true value of 
this equipment can therefore only be fairly assessed in 
the future when it has been used widely and enough 
attempts have been made at linking the changes observed 
with pathological conditions. However, one obvious 
possible unique use of this equipment worthy of
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speculation is its potential in the detection and follow- 
up of chemically-induced injury. The cell surface is 
normally the first point of contact between an exogenous 
toxin and the cell. Thus it will probably be exposed to 
higher level of the toxin than the organelles inside the 
cell. If, at some point in SEM development, we are able 
to link changes at the cell surface with what is 
happening inside the cell, then SEM will not only be a 
very useful tool but an essential one in research 
institutions for screening samples before light 
microscopic and transmission electron microscopic 
examination of the inside of the cell and in clinical 
practice for detection and follow-up of drug-induced 
toxicity.
FUTURE WORK
(1) It would be worthwhile to study by transmission 
electron microcopy, the upper urothelial surface changes 
associated with N-butyl-N-(4-hydroxybutyl)-nitrosamine 
initiated and BEA-induced RPN promoted carcinoma. These 
would be very complementary experiments to section 3.5 of 
this thesis where this problem was studied by scanning 
electron microscopy.
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(2) It would also be worthwhile to study analgesic 
induced RPN using scanning electron microscopy and to 
compare the surface changes noted following analgesic 
treatment with those observed following BEA treatment 
(section 3.1, this thesis). This investigation has been 
performed in the mouse by Al-Ani (198 0) and some of the 
changes noted by this investigator were similar to those 
I observed. However, some of my major observations such 
as the numerous microvilli population on rat papilla tip 
cells and the fact that BEA treatment resulted in 
complete or partial blockage of ducts of Bellini were not 
reported by Al-Ani (1980). It will be interesting to see 
if the difference in the two results arose because of the 
choice of laboratory animal. Also, Al-Ani only examined 
the papilla but not the ureter and pelvis. As shown 
earlier, the changes observed in the papilla were 
different from those observed in the pelvis and ureter.
(3) Many mechanisms have been proposed for analgesic- 
induced RPN (chapter 1) . Data currently available on 
experimental analgesic-induced RPN suggests that the 
mechanism of this lesion may vary from one analgesic to 
another. For example compounds that are concentrated at 
the papilla could produce their effect by cytotoxicity, 
while those which target the interstitial cells could 
produce the damage by medullary ischaemia (see Shelley, 
1978; Molland, 1976, 1978; Prescot, 1982). The data
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presented in sections 3.1, 3.2 & 3.3 of this thesis shows 
that the BEA-induced lesion is probably a product of at 
least three additive mechanisms. This could explain why 
BEA can, within a few hours, produce an effect similar to 
those produced following chronic analgesic 
administration. The hypothesis of a multiple mechanism 
for BEA- induced lesion can be tested by superimposing 
BEA on a maximum (chronic) analgesic-induced lesion. An 
increased damage at this stage will show that, in 
addition to the mechanism used by the analgesic BEA also 
uses other mechanism(s) to induce RPN. Bach et al , 
(1988) showed, in an acute study, that administration of 
two successive doses of paracetamol, phenacetin or N- 
phenylanthranilic acid followed by a single dose of BEA 
resulted in a more pronounced response. Dose response 
relationship has been noted with both BEA and analgesic- 
induced RPN (Fuwa and Waugh , 1968; Carlton and
Engelhardt, 1989). It is, therefore, not possible to say 
from the above experiment whether the increment in 
response noted on superimposition of BEA on acute 
analgesic dosage was due to opening-up of a "new channel" 
of damage by BEA or whether it is a result of additive 
effect of two compounds acting by the same mechanism.
(4) Data reported in section 3.1 shows that BEA treatment 
caused swelling of papilla tip cells. This led to partial 
or complete closure of ducts of Bellini between 3 and 8hr
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after treatment. The ducts of Bellini became dilated once 
the surface cells were exfoliated at a later time point. 
A hypothesis was proposed that the diuretic effect of BEA 
will decrease at the time points where the ducts of 
Bellini were found to be completely or partially blocked 
and increase once the surface cells were exfoliated 
(ducts of Bellini became dilated after exfoliation of 
surface cells). The data reported by Bach (1981) support 
the hypothesis that the urine output was decreased 
between 3 and 8hr after BEA treatment but this experiment 
did not extend to the point where the urine out put was 
expected to increase as a result of dilation of cells 
following exfoliation of surface cells. It will, 
therefore, be useful to measure urine output at short 
time points after BEA treatment to see if this decrease 
in urine output, confirmed by Bach (1981), was followed 
by an increase in urine output at the time points where 
the ducts were found to be dilated.
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